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“Todo principio no es mas que una continuación, 
y el libro de los acontecimientos se encuentra siempre abierto a la mitad.” 
----------------------------------------------------------- 
 “Every beginning is only a sequel, after all, 
and the book of events is always open halfway through.” 
 
― Wisława Szymborska 
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Abreviaturas / Abbreviations 
 
[Ca2+]i Concentración de calcio 
intracelular 
Intracellular calcium 
concentration 
3D Tridimensional  Three-dimensional 
Ab Anticuerpo Antibody 
ADNc/cDNA Ácido desoxiribonucleico 
complementario 
Complementary 
desoxiribonucleic acid 
AH/HA Ácido hialurónico Hyaluronan acid 
AKC Queratoconjuntivitis atópica Atopic keratoconjunctivitis 
ARNm/mRNA Ácido ribonucleico mensajero Messenger ribonucleic acid 
BAC/BAK Cloruro de benzalconio Benzalkonium chloride 
BC Citología por cepillado Brush cytology 
BCA Ácido bicinconínico Bicinchoninic acid 
bp Pares de bases Base pairs 
BSA Albúmina sérica bovina Bovine serum albumin 
CALT Tejido linfoide asociado a la 
conjuntiva 
Conjunctival-associated 
lymphoid tissue 
Cch Carbacol Carbachol 
CERS Células epiteliales corneales 
obtenidas tras cirugía refractiva 
Corneal epithelial cells obtained 
after refractive surgery 
CFE Eficiencia de formación de 
colonias 
Colony forming efficiency 
CK Citoqueratina Cytokeratin 
DMEM Medio de cultivo Eagle 
modificado de Dulbecco 
Dulbecco’s modified Eagle’s 
medium 
EALT Tejido linfoide asociado al ojo Eye associated lymphoid tissue 
ECM Matriz extracelular Extracellular matrix 
EDTA Ácido etildiaminotetraacético Ethylenediaminetetraacetic acid 
EGF Factor de crecimiento 
epidérmico 
Epidermic growth factor 
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ELISA Ensayo de inmunoabsorción 
enzimática 
Enzyme-linked immunosorbent 
assay 
ELLA Ensayo con lectina ligado a 
enzima 
Enzyme-linked lectin assay 
EMT Transición epitelio mesénquima Epithelial mesenchymal 
transition 
ERK Quinasa regulada por señal 
extracelular 
Extracellular signal-regulated-
kinases 
FBS Suero fetal bovino Fetal bovin serum 
GAPDH Gliceraldehído 3 fosfato 
deshidrogenasa 
Glyceraldehyde-3-phosphate 
dehydrogenase 
GPC Conjuntivitis papilar gigante Giant papillar conjunctivitis 
GVHD Enfermedad injerto contra 
huesped 
Graft versus host disease 
H/E Hematoxilina/eosina Hematoxylin/eosin 
HARC Complejo receptor de ácido 
hialurónico 
Hyaluronic acid receptor 
complex 
HBD9 Defensina humana beta 9 Human beta defensin 9 
HCE Línea celular de epitelio corneal 
humano 
Human corneal epithelial cell 
line 
HPA Helix pomatia agglutinin Helix pomatia agglutinin 
IF Inmunofluorescencia Immunofluorescence 
IFN-γ Interferón gamma Interferon gamma 
Ig Inmunoglobulina Immunoglobulin 
IL Interleuquina Interleukin 
IOBA-NHC Línea celular de epitelio 
conjuntival humano 
Normal human conjunctival 
epithelium cell line 
IP3 Inositol trifosfato Inositol trisphosphate 
KRB Krebs-Ringer bicarbonato Krebs-Ringer bicarbonate 
LDALT Tejido linfoide asociado al 
sistema de drenaje lagrimal 
Lacrimal drenaige associated 
lymphoid tissue 
MALT Tejido linfoide asociado a 
mucosas 
Mucosal associated lymphoid 
tissue 
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MAPK Proteín quinasa activada por 
mitógenos 
Mitogen activated protein kinase 
MUC Mucina Mucin 
OCT Optimal Cutting Temperature Optimal Cutting Temperature 
PAS Ácido periódico de Schiff Periodic acid Schiff 
PBS Tampón fosfato salino Phosphate buffered saline 
PCL Policaprolactona Polycaprolactone 
PI-3K Fosfatidil inositol 3 quinasa Phosphoinositide 3 kinase 
PIP2 Fosfatidilinositol bifosfato Phosphatidylinositol 
biphosphate 
PLA Ácido poli-láctico Poly-lactic acid 
PLGA Ácido poliláctico co-glicólico Poly-lactic-co-glycolic acid 
RHAMM Receptor de la motilidad 
mediada por ácido hialurónico 
Receptor for hyaluronan 
mediated motility 
RIPA Ensayo de 
radioinmunoprecipitación 
Radioinmmunoprecipitation 
asssay 
rRE Retículo endoplasmático rugoso Rough endoplasmic reticulum 
RT Temperatura ambiente Room temperature 
RT-PCR Reacción en cadena de la 
polimerasa con 
retrotranscripción 
Reverse transcription 
polymerase chain reaction 
sCD44 CD44 soluble Soluble CD44 
SEM Microscopía electrónica de 
barrido 
Scanning electron microscopy 
SJS Síndrome de Stevens Johnson Steven’s Johnson syndrome 
SS Síndrome de Sjögren Sjögren’s syndrome 
TGF-β Factor de crecimiento 
transformante beta 
Transforming growth factor beta 
Th T colaboradora T helper 
TNF-α Factor de necrosis tumoral alfa Tumor necrosis factor alpha 
Treg T reguladora T regulator 
UEA-1 Ulex europaeus aglutinina I Ulex europaeus agglutinin I 
UFL/LFU Unidad funcional lagrimal Lacrimal functional unit 
VKC Queratoconjuntivitis vernal Vernal keratoconjunctivitis 
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WB Western blotting Western blotting 
ZO Zonula occludens Zonula occludens 
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 “Nada en la vida deber ser temido, solamente comprendido. 
Ahora es el momento de comprender más, para temer menos” 
------------------------------------------------------------------------------------------ 
“Nothing in life is to be feared, it is only to be understood.  
Now is the time to understand more, so that we may fear less.”  
 
― Marie Skłodowska-Curie 
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SINOPSIS DEL TRABAJO 
 
En esta tesis doctoral se presenta un nuevo modelo tridimensional de 
conjuntiva humana. El desarrollo de un nuevo modelo es necesario para superar las 
limitaciones de los modelos in vitro disponibles y, permitir con ello, reducir el 
número de animales de experimentación que son usados en los ensayos in vivo 
sobre enfermedades inflamatorias de la superficie ocular.  
Para desarrollar este nuevo modelo, primero se elaboró un protocolo 
optimizado para cultivar células epiteliales y fibroblastos a partir de muestras de 
tejido conjuntival obtenido de donante cadáver. Además, se llevaron a cabo algunos 
experimentos para seleccionar un biomaterial que resultara adecuado para 
mantener viables a las células y que sirviera como andamio para el modelo 
tridimensional de conjuntiva. Las matrices de fibrina resultaron adecuadas para este 
propósito y fue el biomaterial escogido.  
Los fibroblastos se cultivaron en el interior de las matrices de fibrina y las 
células epiteliales encima. Dichas células epiteliales fueron capaces de estratificar, 
alcanzando 5-6 capas a los 14 días de cultivo sobre las matrices. Además, se 
observaron algunas células de tipo caliciforme. Una vez que el modelo 
tridimensional estuvo puesto a punto, se llevó a cabo una prueba de concepto para 
demostrar su utilidad para estudiar enfermedades inflamatorias de la superficie 
ocular.  
El modelo tridimensional fue expuesto a distintas condiciones, como el cultivo 
aireado, la desecación o el tratamiento con citoquinas. Después de la exposición a 
estas condiciones adversas, se analizaron los cambios producidos en el modelo, 
tanto los estructurales como en los marcadores celulares. Tanto las condiciones 
experimentales como los marcadores a analizar fueron seleccionados gracias al 
conocimiento adquirido en estudios de inflamación en los distintos tipos de células 
conjuntivales. En dichos estudios, se comprobó la implicación de los receptores de 
ácido hialurónico CD44 y RHAMM en enfermedades inflamatorias de la superficie 
ocular, y se analizó también el papel de varias citoquinas sobre las células 
caliciformes. Los resultados obtenidos en el modelo tridimensional fueron acordes a 
lo esperado teniendo en cuenta los datos obtenidos en pacientes con patologías 
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oculares. Por ejemplo, cuando el modelo fue expuesto a IL-13, los niveles de 
secreción de MUC5AC aumentaron, tal y como ocurre en pacientes con conjuntivitis 
alérgica donde esta citoquina está elevada. Cuando el modelo se sometió a 
condiciones de desecación, se encontró un descenso en la expresión de RHAMM, 
al igual que ocurría en pacientes con síndrome de Sjögren o rosácea.  
Los resultados obtenidos en los distintos estudios que componen esta tesis 
indican que el nuevo modelo tridimensional desarrollado puede ser una herramienta 
útil para llevar a cabo estudios relacionados con la inflamación conjuntival. 
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ESTRUCTURA DE LA MEMORIA DE 
TESIS 
 
 Esta tesis se presenta en la modalidad compendio de publicaciones y 
opta a la mención de “doctorado internacional”. La normativa de la Universidad de 
Valladolid para esta modalidad exige que: 1) “incluya una introducción, de al menos 
veinte páginas, que justifique la relación temática de las publicaciones, contenga los 
objetivos perseguidos, la metodología empleada, los resultados obtenidos y las 
conclusiones más relevantes”; 2) “debe incluir al menos tres artículos aceptados 
para su publicación en revistas científicas con factor de impacto”; y 3) “se debe 
haber realizado una estancia de investigación en un centro extranjero durante al 
menos 3 meses”. El primer requisito se cumple en los apartados “Resumen en 
español” (páginas 15-70), y “Summary in English” (páginas 71-110). 
 En esta tesis se han incluido un total de ocho estudios (Figura 1), de los 
cuáles cinco han dado lugar a artículos que están publicados o en prensa (estudios 
1-5) y otros tres que están en preparación (estudios 6-8), con lo que se cumple el 
segundo requisito.  
  Por último, el cuarto estudio de esta tesis se realizó en el instituto de 
investigación Schepens Eye Research Institute, en Boston (Estados Unidos), 
cumpliendo con ello el tercer requisito. Los resultados obtenidos del trabajo 
realizado allí han dado lugar a una publicación científica que se recoge en el 
estudio 4. Debido a la inclusión de artículos de investigación publicados, y al 
carácter internacional de la tesis, la mayor parte de esta memoria se ha escrito en 
inglés.  
Después del resumen general, incluido tanto en español como en inglés, 
esta memoria de tesis se organiza en tres capítulos temáticos en los que se 
incluyen los ocho estudios (Figura 1).  
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Figura 1. Esquema en el que se incluyen los distintos estudios de esta tesis doctoral 
agrupados en 3 capítulos. 
 
En el Primer Capítulo, “Estudio de moléculas relevantes en la 
inflamación ocular”, se han incluido cuatro estudios (que han dado lugar a cuatro 
artículos) en los que se analiza el papel de moléculas inflamatorias en distintas 
células conjuntivales. El estudio 1 es un estudio descriptivo de la expresión de 
CD44 y RHAMM en los tejidos de la superficie ocular. Se consideró necesario 
realizar este análisis puesto que el ácido hialurónico se usa en muchos tratamientos 
oculares, pero sus receptores apenas estaban estudiados a pesar de la demostrada 
implicación de los mismos en enfermedades extraoculares. Se comprobó que tanto 
CD44 como RHAMM se expresaban en las células del epitelio conjuntival, y que los 
niveles de expresión en líneas celulares diferían notablemente de los obtenidos en 
células procedentes de citologías. Una vez realizado este análisis, se desarrolló el 
trabajo recogido en el estudio 2. En él, se analizó la expresión diferencial de estos 
receptores, fundamentalmente RHAMM, en células epiteliales recogidas mediante 
citología de pacientes con enfermedades inflamatorias. Los dos siguientes estudios 
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se centraron en el papel de las células caliciformes en inflamación. El estudio 3 es 
una revisión bibliográfica del efecto de las lentes de contacto y distintas citoquinas 
en las células caliciformes de la conjuntiva. A continuación, teniendo en cuenta lo 
recogido en la revisión bibliográfica, en el estudio 4 se llevó a cabo un estudio 
funcional en células caliciformes humanas y de rata. En él, se estudió el papel 
modulador del IFN-γ y el carbacol en la función de dichas células.  
 Los trabajos del primer capítulo arrojaron datos interesantes sobre el papel 
de las células conjuntivales en la inflamación. Sin embargo, para avanzar más en 
su estudio era necesario contar con un buen modelo in vitro. Con este objetivo, el 
Segundo Capítulo de esta tesis, “Obtención de materiales para construir un 
nuevo modelo tridimensional de conjuntiva humana”, se centró en la búsqueda 
de los distintos componentes necesarios para desarrollar un modelo in vitro 
adecuado con el que continuar el estudio de la inflamación. Dentro de este bloque, 
en el estudio 5 se presenta un protocolo para obtener y expandir fibroblastos y 
células epiteliales de conjuntiva humana a partir de muestras de donante cadáver. 
De esta forma se logró evitar el uso de líneas celulares. En el estudio 6 se 
realizaron pruebas para determinar qué biomaterial resultaba más adecuado para 
usar como andamiaje de las células conjuntivales. Se concluyó que las matrices de 
fibrina eran una buena opción.  
 Finalmente, el Tercer Capítulo de esta tesis, “Desarrollo de un modelo 
tridimensional de conjuntiva humana” se compone de los dos últimos estudios. 
En el estudio 7 se desarrolló el modelo tridimensional empleando matrices de 
fibrina y células epiteliales y fibroblastos conjuntivales. Se llevó a cabo una 
caracterización de dicho modelo. Por último, en el estudio 8, se expuso al modelo 
tridimensional a distintas condiciones para intentar simular algunas de las 
enfermedades inflamatorias de la conjuntiva y obtener una prueba de concepto de 
su utilidad para el estudio de sus enfermedades.  
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INTRODUCCIÓN 
 
1. SUPERFICIE OCULAR Y UNIDAD FUNCIONAL LAGRIMAL  
 El término de superficie ocular fue introducido por primera vez por Richard 
A. Thoft en 1977 (Thoft y Friend, 1977), para referirse a la unidad anatómica y 
funcional formada por los epitelios de la córnea, la conjuntiva y el limbo, así como 
por la película lagrimal y los tejidos adyacentes. Su función principal es preservar la 
visión, protegiendo al globo ocular de la entrada de agentes nocivos a la vez que se 
mantiene la transparencia corneal. 
 Años más tarde, y siguiendo la misma filosofía de Thoft de aunar todas 
aquellas estructuras del ojo que funcionaban de manera conjunta, Michael E. Stern 
estableció el término de unidad funcional lagrimal (Stern et al., 1998). En este caso, 
a la superficie ocular se unieron las glándulas lagrimales y las interconexiones 
nerviosas, tanto sensoriales como motoras (Figura 2).  
 
 
 
Figura 2. Unidad funcional lagrimal. Imagen tomada de Beuerman et al. The Lacrimal 
Functional Unit  in Dry Eye and Ocular Surface Disorders (Pflugfelder, Beuerman, Stern eds.) 
Marcel-Dekker Inc., New York, 2004, 1004:11-40. 
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2. CONJUNTIVA  
La conjuntiva es uno de los tejidos que forma parte de la superficie ocular y, 
por lo tanto, de la unidad funcional lagrimal. Se trata de la membrana 
semitransparente que cubre la superficie ocular desde el borde externo de los 
párpados hasta el limbo. Entre sus funciones destaca la producción de moco, que 
estabiliza la película lagrimal y ayuda a mantener la córnea húmeda y protegida 
(Dartt, 2006).  
Anatómicamente, la conjuntiva se divide en tres zonas: 
1) Tarsal o parpebral, que recubre la parte interior de los párpados 
2) Bulbar, que cubre la esclera del segmento anterior del globo ocular 
3) Fondo de saco o fórnix, que es la unión entre la conjuntiva tarsal y 
la bulbar 
 
La conjuntiva está formada por un epitelio especializado que reposa sobre un 
estroma o sustancia propia (Figura 3).  
 
Figura 3. Fotografía de una sección de conjuntiva humana teñida con ácido 
periódico de Schiff (PAS). Se observa un epitelio estratificado con células 
caliciformes en las capas más superficiales, teñidas de color fucsia por la 
acción del colorante PAS. Imagen cedida por el laboratorio de Patología Ocular 
del IOBA. 
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2.1. Epitelio  
El epitelio conjuntival es un epitelio cuboidal estraficado escamoso no 
queratinizado. Presenta entre 2 y 10 capas de células epiteliales, dependiendo de la 
zona de la conjuntiva de la que se trate (Hoang-Xuan et al., 2001). Hay cinco tipos 
de células epiteliales en la conjuntiva (Figura 4), que fueron descritas en 1989 por 
K. P. Steuhl en función de sus características ultraestructurales (Steuhl, 1989).  
El tipo I son las células caliciformes. Son un tipo celular  especializado en la 
secreción de mucinas (Gipson y Argüeso, 2003). La mayor parte de su citoplasma 
está cargado con gránulos mucosos y normalmente tienen un aparato de Golgi bien 
diferenciado. Son las únicas células de la conjuntiva que secretan la mucina (MUC) 
5AC. Expresan marcadores de epitelio con perfil secretor, como la citoqueratina 
(CK) 7, y reaccionan a lectinas, que se unen a los glicoconjugados de alto peso 
molecular que secretan, entre los que se encuentra la MUC5AC (Krenzer y Freddo, 
1997). Algunas de las lectinas más empleadas para su detección son las derivadas 
de Ulex europeaus (UEA-1) y Helix pomatia (HPA).  
El tipo II son células epiteliales con un alto contenido de vesículas 
secretoras. Al observar estas células mediante microscopía electrónica se aprecian 
en su citoplasma numerosos gránulos secretores electrodensos de gran tamaño, 
entre 60 y 300 nm. Estas células están distribuidas por toda la conjuntiva, siendo el 
tipo más común en la conjuntiva humana.  
El tipo III se reconoce por sus complejos de Golgi bien desarrollados. A 
menudo se encuentran varios aparatos de Golgi alrededor del núcleo. Se cree que 
estas células también contribuyen a las secreciones mucosas de la película 
lagrimal.  
El tipo IV se caracteriza por la alta presencia de retículo endoplasmático 
rugoso (rRE) que se observa en su citoplasma. Este tipo es muy frecuente en la 
conjuntiva humana. También se pueden apreciar pequeñas cantidades de 
mitocondrias y aparatos de Golgi. 
El tipo V son células epiteliales que se identifican por su alto contenido en 
mitocondrias. Debido al elevado número de mitocondrias es raro localizar otros 
organelos celulares como el rRE o el aparato de Golgi.  
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Figura 4. Tipos de células epiteliales que se encuentran en la conjuntiva humana, según lo 
descrito por K. P. Steuhl en 1989. 
 
Los tipos celulares del II al V a menudo se agrupan y se denominan células 
epiteliales escamosas estratificadas no caliciformes. En conjunto constituyen 
aproximadamente el 85-90% de las células del epitelio conjuntival. Expresan 
marcadores tales como CK4 y CK19. Están unidas entre sí mediante uniones 
adherentes, entre las que destaca la formada por E-cadherina, y por uniones 
estrechas, mediante moléculas tales como zonula occludens (ZO) 1 y ZO2. Estas 
células expresan las mucinas MUC1, MUC4 y MUC16, que aportan estabilidad a la 
lágrima.  
Una característica esencial para la diferenciación de las células epiteliales es 
la polarización (Roignot et al., 2013). Las células epiteliales conjuntivales, como las 
de otros epitelios mucosos, tienen microvellosidades en su superficie apical. Las 
microvellosidades aumenta la superficie disponible para la adhesion de la lágrima, y 
están además implicadas en la adhesión celular, la absorción y la secreción. Los 
cambios o malformaciones en las microvellosidades están presentes en muchas 
enfermedades. En el caso de la conjuntiva, se han encontrado microvellosidades 
anormales en varias patologías, como el síndrome de Sjögren y la enfermedad de 
injerto contra huesped (Mancel et al., 1993; Tatematsu et al., 2012). 
 
2.2. Membrana basal 
La membrana basal es una fina membrana de tejido conectivo que separa el 
epitelio del estroma subyacente. La membrana basal conjuntival está formada 
fundamentalmente por colágeno de tipo IV, laminina, nidógeno 1 y 2, y 
trombospondina-4 (Schlotzer-Schrehardt et al., 2007). 
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2.3. Estroma 
El estroma conjuntival está compuesto por moléculas, tales como colágeno, 
laminina, o ácido hialurónico (AH), entre otras. Además, tiene un importante 
componente celular. Las células más numerosas del estroma conjuntival son los 
fibroblastos que, entre otras funciones, se encargan de secretar gran parte de la 
matriz extracelular que compone el estroma conjuntival.  
La conjuntiva es un tejido altamente vascularizado y con abundates vasos 
linfáticos. También es un tejido con una rica inervación sensorial, lo que hace que 
se encuentren en él células nerviosas. Finalmente, la conjuntiva tiene un tejido 
linfoide asociado, conocido como CALT (Conjunctival-associated lymphoid tissue) 
(Knop y Knop, 2000). Junto con el tejido linfoide asociado al sistema de drenaje 
lacrimal (LDALT) forma el tejido linfoide asociado al ojo (EALT), un componente 
más del tejido linfoide asociado a mucosas, conocido como MALT. Debido a la 
presencia del CALT, en el estroma conjuntival están presentes células de la 
defensa inmune innata, como son los macrófagos y los mastocitos, y células de la 
respuesta inmune específica, como los linfocitos, las células plasmáticas y las 
células dendríticas. El CALT no solo ejerce su función protectora sobre la 
conjuntiva, sino que actúa también sobre la córnea (Knop y Knop, 2005), reforzando 
así la idea de la conjuntiva como un tejido protector de toda la superficie ocular.  
 
 
3. IMPLICACIÓN DE LA CONJUNTIVA EN ENFERMEDADES INFLAMATORIAS 
 
3.1. Enfermedades inflamatorias de la superficie ocular 
La conjuntiva está implicada en diversas patologías que afectan a la 
superficie ocular (Figura 5). Y ello se debe, al menos en parte, a su papel protector. 
Las células de la conjuntiva son participantes activos en la defensa de la superficie 
ocular. Para ello secretan distintos tipos de moléculas, como citoquinas, 
quimioquinas, (Enríquez-de-Salamanca et al., 2008) o péptidos antimicrobianos 
como la defensina beta 9 (HBD9), que es secretada por las células epiteliales 
conjuntivales (Mohammed et al., 2010).  
Aunque son muchas las enfermedades con afectación conjuntival, tan solo se 
mencionarán aquí dos de las más comunes, el síndrome de ojo seco y las alergias 
oculares. 
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Figura 5. Imágenes de un paciente con síndrome de ojo seco (izquierda) y con 
conjuntivitis alérgica (derecha), donde se puede observar afectación conjuntival. 
Imágenes cedidas por la Prof. M. Calonge. 
 
El síndrome de ojo seco es una enfermedad inflamatoria multifactorial de la 
superficie ocular y la película lagrimal que se produce por una disfunción de la 
unidad funcional lagrimal (Stern et al., 2004; Stern et al., 2013). Su alta incidencia 
(Schaumberg et al., 2003; Schaumberg et al., 2009) y su gran capacidad para 
afectar a la calidad de vida de los individuos que la sufren (Schiffman et al., 2003), 
hacen que sea una de las patologías de la superficie ocular que más interés ha 
despertado en los últimos años. Entre las manifestaciones típicas del ojo seco se 
encuentran la irritación ocular, el dolor, la visión borrosa y la fotofobia. Las 
características del epitelio conjuntival de pacientes de ojo seco se estudian a 
menudo a partir de muestras obtenidas por citología de impresión conjuntival. Se 
trata de una técnica mínimamente invasiva en la que se coloca un pequeño filtro 
sobre la superficie conjuntival. Tras presionar el filtro durante unos segundos éste 
se retira, llevándose con él una o dos capas de células conjuntivales. Después de 
realizar las tinciones correspondientes se analiza el grado de metaplasia de las 
células epiteliales y el número de células caliciformes. En las citologías de 
pacientes con ojo seco puede observarse con frecuencia un menor número de 
células caliciformes que en las citologías de individuos sanos (Mantelli et al., 2013; 
Marko et al., 2013; Kumar et al., 2014).  
La alergia es una reacción anormal y exagerada del sistema inmune hacia 
antígenos inofensivos que están presentes normalmente en el ambiente. En las 
personas que no muestran esta hipersensibilidad, dichos antígenos no producen 
ninguna respuesta. En las alergias oculares la conjuntiva tiene un papel 
fundamental. Hay varios tipos de alergia ocular que van desde las formas más leves 
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(conjuntivitis alérgica estacional y conjuntivitis alérgica perenne) hasta las más 
severas (queratoconjuntivitis vernal y queratoconjuntivitis atópica) que pueden 
comprometer la visión debido a la afectación corneal (Leonardi, 2013). En todas 
estas formas hay participación directa del tejido conjuntival y, en concreto, de las 
células epiteliales y las células caliciformes (Saban et al., 2013). Las alergias 
oculares se asocian con hipersecreción mucosa y, a menudo, se encuentran 
mayores densidades de células caliciformes o hiperplasia de las mismas en la 
conjuntiva de pacientes con estas patologías.  
 
3.2. Moléculas implicadas en enfermedades conjuntivales 
El número de moléculas descritas implicadas en las enfermedades 
inflamatorias que afectan a la conjuntiva aumenta a medida que avanza el 
conocimiento que tenemos del propio proceso inflamatorio. Debido a la 
imposibilidad de realizar una revisión exhaustiva sobre todas ellas, se mencionarán 
tan solo dos tipos: las citoquinas y los receptores de AH. 
 
3.2.1. Citoquinas 
Las citoquinas son pequeñas proteínas no estructurales. Su peso molecular 
varía entre 8 y 40.000 daltons (Dinarello, 2000). Son agentes inmunomoduladores 
producidos por varios tipos celulares, incluyendo las células epiteliales de la 
superfice ocular. De hecho, a excepción de los glóbulos rojos, todas las células del 
organismo son capaces de producir citoquinas y de responder a ellas (Dinarello, 
2007). Como reguladores de la respuesta inmune algunas citoquinas ejercen 
acciones proinflamatorias (Dinarello, 2000), otras tienen efectos antiinflamatorios 
(Opal y DePalo, 2000) y muchas tienen efectos duales.  
Las citoquinas se clasifican en distintos tipos, dependiendo del tipo de célula 
T colaboradora (T helper, Th) que las produce (Steinman, 2007). Los tipos 
principales son Th1, Th2 y Th17 (Figura 6).  
Entre las citoquinas de tipo Th1, dos de las más estudiadas son el factor de 
necrosis tumoral alfa (TNF-α) y el interferón gamma (IFN-γ). Estas citoquinas 
suelen estar elevadas en el síndrome de ojo seco. Entre las citoquinas del tipo Th2, 
la interleuquina (IL) 4, la IL-5 y la IL-13 han sido ampliamente estudiadas en 
alergias, donde normalmente se encuentran niveles más altos.  
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Figura 6. Esquema de las principales citoquinas clasificadas según el tipo de célula Th 
que las secreta mayoritariamente. 
 
 
3.2.2. El ácido hialurónico (AH) y sus receptores 
El AH es un polisacárido de tipo glicosaminoglicano cuyo peso molecular 
puede variar notablemente. Forma parte de la matriz extracelular de muchos 
tejidos, incluidos los oculares, ya que ayuda a absorber agua y a aumentar el 
espacio intercelular. Además, participa en la remodelación tisular. Un efecto 
importante del AH es estimular la producción de colágeno por parte de los 
fibroblastos. Este es el efecto que ha hecho que el AH sea ampliamente utilizado en 
cosmética.  
El AH participa también en el proceso inflamatorio, donde puede presentar un 
papel dual ligado al tamaño de los fragmentos de AH. El AH de bajo peso molecular 
tiene efectos proinflamatorios, mientras que hay evidencias de que el AH de alto 
peso molecular puede proteger la integridad del tejido epitelial, ayuda en el cierre 
de heridas y puede ejercer acciones antiinflamatorias (Stern et al., 2006; Campo et 
al., 2009). 
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Para unirse a las células y ejercer algunas de sus funciones, el AH se une 
principalmente a dos receptores: el CD44 y el receptor de la movilidad mediada por 
hialurónico (RHAMM) (Turley, 1982; Entwistle et al., 1996). El papel de estos 
receptores en varios procesos patológicos se ha estudiado desde hace tiempo. Así, 
hay claras evidencias de su papel directo en enfermedades oncológicas 
(Giannopoulos et al., 2006; Balla et al., 2009) y también en enfermedades 
inflamatorias como la osteoartritis (Dunn et al., 2009). El receptor CD44, además de 
su forma transmembrana, presenta una forma soluble (sCD44), que ha sido 
ampliamente estudiada en el glaucoma, donde se han encontrado niveles elevados 
que podrían ser una de las causas del aumento en la presión intraocular que 
produce la enfermedad (Nolan et al., 2007; Giovingo et al., 2013).  
Sin embargo, a pesar de la importancia de estos receptores en varias 
patologías y al uso continuo del AH en distintas formulaciones que se aplican sobre 
la superficie ocular, la presencia de estos receptores y su función específica apenas 
se han estudiado en el tejido conjuntival. 
 
 
4. MODELOS DE ESTUDIO DE LA CONJUNTIVA 
Debido a la importancia patofisiológica de la conjuntiva y a su implicación en 
distintas patologías de la unidad funcional lagrimal, su estudio es esencial tanto 
para comprender el funcionamiento normal de la superficie ocular, como para 
buscar nuevas estrategias terapéuticas que permitan tratar mejor las enfermedades 
que la afectan. Previo a los ensayos clínicos que permitirán introducir en el mercado 
sanitario nuevos fármacos, la investigación debe desarrollarse en el laboratorio, en 
modelos animales (in vivo) y, previamente, en modelos in vitro.  
 
4.1. Modelos in vivo 
Los modelos de estudio in vivo implican el uso de animales de 
experimentación, tales como ratones, ratas, conejos, etc. Al emplear un organismo 
vivo, la complejidad de las interacciones entre los distintos órganos y sistemas, 
hace que se obtenga mucha información que se espera pueda ser extrapolada al 
ser humano. Sin embargo, a pesar de ser necesarios por legislación, estos modelos 
in vivo tiene varias limitaciones relacionadas, fundamentalmente, con aspectos 
éticos, los elevados costes, la reducida similitud con las estructuras humanas en 
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estudio y la necesidad de personal con un alto grado de especialización y 
experiencia, y de instalaciones adecuadas. 
 
4.2. Modelos in vitro 
La sociedad demanda cada vez más a la comunidad científica que haga 
esfuerzos mayores por erradicar, o al menos, reducir, la experimentación in vivo. En 
esta línea, los modelos in vitro permiten avanzar en el conocimiento celular evitando 
el uso de animales de experimentación. Esto, junto con el menor coste y la 
posibilidad de controlar mejor los parámetros de estudio, hace que sea posible 
probar muchas más condiciones experimentales en los modelos in vitro que en los 
modelos in vivo, lo que supone otro valor añadido. Por lo tanto, el desarrollo y uso 
de modelos in vitro más sofisticados debería ser una prioridad en investigación, 
puesto que no sólo permitiría reducir el uso de animales de laboratorio, sino que 
también abarataría notablemente los costes de los ensayos preclínicos.  
 
4.2.1. Líneas celulares y cultivos primarios 
Las líneas celulares están constituidas por células que se han transformado, 
de manera espontánea o inducida, y que son capaces de replicarse de manera 
ilimitada en condiciones controladas en el laboratorio. Además, estas células suelen 
perder su capacidad de inhibición por contacto, lo que hace que normalmente 
continúen proliferando una vez que han cubierto por completo toda la superficie de 
cultivo (lo que se denomina alcanzar la confluencia). Las principales ventajas de las 
líneas celulares son su disponibilidad y la facilidad de mantenerlas en cultivo, así 
como la homogeneidad de los resultados que se obtienen, ya que todas las células 
tienen un mismo origen. Como principal inconveniente destaca el hecho de que al 
sufrir la transformación que las convierte en líneas celulares, estas células ya no 
son un fiel reflejo de las células de las que proceden.  
Los cultivos primarios son aquellos que se obtienen de células directamente 
recogidas del organismo. Esto hace que sean mucho más parecidas al tejido 
original y, por lo tanto, los resultados que se obtienen con cultivos primarios son 
más fiables y valiosos. Sin embargo, presentan varios inconvenientes o dificultades, 
que hacen que su uso no esté más extendido. En primer lugar, su disponibilidad es 
limitada, ya que estas muestras suelen proceder de biopsias o de tejidos obtenidos 
de donantes cadáver. Además, la investigación con estas muestras está sujeta a 
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estrictas regulaciones para garantizar el cumplimiento de normas éticas. Y, por 
último, su cultivo es más difícil y su crecimiento in vitro es limitado.  
 
4.2.2. Cultivos en monocapa y cultivos tridimensionales 
La manera más habitual de hacer crecer las células en el laboratorio es lo 
que se denomina un cultivo en monocapa. En ellos, las células, ya sean líneas 
celulares o cultivos primarios, crecen sobre la superficie especializada de cultivo 
creando una única capa celular que va recubriendo toda la superficie hasta alcanzar 
la confluencia. 
Por el contrario, los cultivos tridimensionales pretenden recrear la estructura 
tridimensional que tienen los tejidos. Esto permite estudiar la interacción entre 
distintos tipos celulares, o ente las células y una matriz extracelular (ECM). La 
organización de las células en un espacio tridimensional y su relación con ese 
ambiente extracelular son los factores que determinan su fenotipo, por lo que este 
tipo de cultivos permite obtener datos más válidos.  
Los cultivos tridimensionales pueden emplearse para el estudio de los 
órganos en condiciones normales o patológicas. El uso de estos cultivos 
tridimensionales ha ido aumentando con el creciente conocimiento sobre las 
interacciones célula-célula y célula-ECM que ha aportado el avance de la ingeniería 
de tejidos.  
 
 
5. INGENIERÍA DE TEJIDOS 
La ingeniería de tejidos es, según Robert S. Langer y Joseph P. Vacanti, “un 
campo interdisciplinario que aplica los principios de ingeniería y ciencias de la vida 
para el desarrollo de sustitutos biológicos que restauren, mantengan o mejoren la 
función de un tejido o de un órgano completo” (Langer y Vacanti, 1993). Por lo 
tanto, el fin último de la ingeniería de tejidos es el uso clínico. Sin embargo,  
también pueden emplearse estos órganos o tejidos artificiales como complejos 
modelos in vitro. 
Hay dos componentes fundamentales que se combinan en la ingeniería de 
tejidos: las células y los andamios o andamiajes que las alojan.  
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5.1. Células 
Las células que se emplean en la ingeniería de tejidos pueden ser líneas 
celulares o células primarias. Además, dependiendo de su origen, las células 
pueden ser autólogas (si proceden del mismo paciente que recibirá el tejido) o 
heterólogas (si proceden de otro donante). 
Los tipos celulares empleados en la ingeniería de tejidos dependerán, 
obviamente, del tejido que se quiera reconstruir. En el caso de la conjuntiva, los 
principales tipos celulares son células epiteliales (incluyendo células caliciformes) y 
células estromales, principalmente fibroblastos.  
 
5.2. Andamiajes  
Los andamiajes son las estructuras acelulares capaces de soportar la 
formación del tejido en las tres dimensiones. Dan un apoyo estructural temporal a 
las células y guían su crecimiento. Es por ello que se consideran una parte 
fundamental de la ingeniería de tejidos.  
Un buen andamiaje tiene que ser biocompatible, biodegradable y debe 
favorecer la adhesión celular. Además, pueden ayudar en el transporte de 
nutrientes y facilitar la formación de tejidos funcionales (Lee et al., 2011). Para que 
el tejido artificial sea lo más parecido al real, el biomaterial utilizado para el 
andamiaje, además de dar soporte a las células, deberá ser lo más parecido posible 
a la ECM.  
Para elaborar los andamiajes se pueden usar biomateriales naturales o 
sintéticos. Las principales ventajas de los biomateriales naturales frente a los 
sintéticos son su biocompatibilidad y su mayor parecido a la ECM. Algunos de los 
biomateriales naturales más empleados como andamiajes son la membrana 
amniótica, el colágeno, el quitosano, la fibrina y el AH (Rosso et al., 2005), mientras 
que entre los biomateriales sintéticos destacan el ácido poli-láctico (PLA), el ácido 
poli-láctico-co-glicólico (PLGA) y la policaprolactona (PCL) (Saltzman, 1999; 
Putman, 2001). 
 
5.3. Aproximaciones en la superficie ocular 
Se han publicado estudios en los que se aplica la ingeniería de tejidos a la 
superficie ocular. La mayoría de ellos están encaminados a diseñar una córnea 
artificial que permita sustitutir los trasplantes de córnea convencionales (Griffith et 
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al., 2009) con el fin de tratar a aquellos pacientes con síndrome de insuficiencia 
límbica (Xu et al, 2012). Con este fin, también se ha propuesto llevar a cabo un 
trasplante de células limbares (Pellegrini et al., 2014), células del epitelio oral 
(Utheim, 2015), y equivalentes conjuntivales (Tanioka et al., 2006; Di Girolamo et 
al., 2009). Varios estudios han demostrado el enorme potencial de los cultivos 
conjuntivales para tratar la enfermedades que conducen a la ceguera y, en 
concreto, el síndrome de insuficiencia límbica (Di Giralomo et al., 2009; Jeon et al., 
2013). 
M. Alaminos y colaboradores (Alaminos et al., 2006) desarrollaron un 
sustituto corneal completo de conejo con el fin de emplearlo como modelo de 
estudio in vitro. Para el desarrollo de este modelo utilizaron los tres principales tipos 
celulares de la córnea: células endoteliales, fibroblastos y células epiteliales. Como 
andamiajes emplearon matrices de fibrina y agarosa. Construyeron un cultivo 
organotípico de córnea que representaba la ultraestructura del tejido nativo. Este 
trabajo es un buen ejemplo de como la ingeniería de tejidos puede emplearse con 
fines de investigación in vitro, además del uso habitual en medicina regenerativa.  
En el año 2007, S. H. Chung y colaboradores (Chung et al., 2007) publicaron 
un modelo tridimensional de conjuntiva humana que producía MUC5AC. La 
ausencia de producción de este mucina in vitro es una de las principales 
limitaciones de muchos modelos de conjuntiva. Esto se debe a la dificultad de 
mantener en cultivo células caliciformes. Sin embargo, en este modelo esa 
limitación está superada. A partir de pequeñas biopsias de conjuntiva lograron 
cultivar células epiteliales que, posteriormente, fueron sembradas sobre insertos. 
Mediante cultivo aireado consiguieron que las células epiteliales estratificaran, 
llegando a obtener 6-8 capas a las dos semanas. En estas condiciones observaron 
secreción de MUC5AC. Este trabajo aporta un buen modelo de estudio del epitelio 
conjuntival, pero no de la conjuntiva completa, ya que el estroma no está 
representado.  
A pesar de estos avances, hasta el momento, no se ha publicado ningún 
modelo tridimensional completo de conjuntiva humana que permita avanzar en el 
conocimiento de la fisiología del tejido o emplearlo para probar nuevos fármacos o 
tratamientos.  
 

 
RESUMEN EN ESPAÑOL 
	   37 
 
JUSTIFICACIÓN 
 
A pesar de que la conjuntiva se haya estudiado mucho menos que la córnea, 
es el principal tejido implicado en algunas de las enfermedades más prevalentes de 
la superficie ocular y que pueden llegar a afectar a la visión, como son el síndrome 
de ojo seco o las alergias oculares.  
Para avanzar en el conocimiento de los procesos fisiopatológicos de este 
tejido y encontrar nuevas estrategias terapéuticas que ayuden a tratar las 
enfermedades mencionadas, es necesario disponer de buenos modelos de estudio.  
En el caso de la conjuntiva, consideramos que los modelos disponibles 
actualmente no resultan suficientes. Se trata de modelos que están excesivamente 
simplificados al ser monocapas de un único tipo celular. Además, normalmente 
estas monocapas están formadas por líneas celulares que, tras inmortalizarse, poco 
se parecen ya a las células que las originaron. Por lo tanto, hay que ser muy cauto 
a la hora de extraer conclusiones de los experimentos realizados en estos modelos.  
Una de las funciones más importantes de la conjuntiva, y que suele estar 
alterada en los procesos inflamatorios, es la de secretar mucinas que lubriquen, 
humecten y protejan la superficie ocular. Si bien la mayoría de las células epiteliales 
conjuntivales son capaces de secretar algún tipo de mucina, hay un tipo de célula 
que está especializado en esta función. Se trata de las células caliciformes que, 
además, son las únicas que secretan MUC5AC, una de las mucinas más 
importantes de la película lagrimal. Por lo tanto, el estudio de las células 
caliciformes y de su función secretora resulta especialmente relevante.  
Teniendo todo esto cuenta, creemos que es necesario desarrollar un nuevo 
modelo de conjuntiva humana, más complejo e integrador. Para superar las 
limitaciones de los modelos existentes, éste debería estar elaborado con células 
primarias y no con líneas celulares. Además, debería representar la estructura 
tridimensional de la conjuntiva, con un estroma poblado por fibroblastos y un 
epitelio en el que se intercalen células caliciformes.   
Para probar la validez de este modelo para el estudio de enfermedades 
inflamatorias, es necesario conocer en profundidad el efecto de este proceso en las 
distintas células de la conjuntiva, de tal forma que después se puedan intentar 
simular estas condiciones en el modelo tridimensional desarrollado.  
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Dentro de este contexto se encuadra esta tesis doctoral, cuyo objetivo 
principal es el desarrollo de un modelo in vitro de conjuntiva humana que, por sus 
características, permita profundizar en el estudio de las enfermedades inflamatorias 
reduciendo al máximo el uso de modelos in vivo.  
Para abordar un proyecto de este tipo es necesario contar con el apoyo y la 
colaboración de un equipo multidisciplinar. El Grupo de Superficie Ocular del IOBA 
está muy implicado en el estudio de las enfermedades inflamatorias que afectan a 
la superficie ocular. Para ello, cuenta con especialistas médicos que aportan un 
punto de vista clínico que nunca debe perderse en la investigación que se centra en 
aspectos más moleculares. Además, el equipo liderado por la Dra. Yolanda Diebold 
tiene amplia experiencia en técnicas de cultivos celulares y una carrera establecida 
en nanomedicina, donde cuenta con colaboraciones en el campo de los 
biomateriales con investigadores del Departamento de Farmacia y Tecnología 
Farmacéutica de la Universidad de Santiago de Compostela, y el Banco de Tejidos 
de la Fundación Clínica San Francisco, de León. Varios proyectos nacionales 
conjuntos obtenidos en concurrencia competitiva avalan esta colaboración.  
Por lo tanto, la necesidad de profundizar en el estudio de la conjuntiva y de 
probar las nuevas estrategias terapéuticas que se desarrollen dentro del grupo 
justifica la idea de desarrollar un modelo tridimensional de conjuntiva humana. La 
trayectoria de todo el Grupo de Superficie Ocular garantiza que se contará con los 
apoyos y las colaboraciones necesarias para poder llevar a cabo este proyecto de 
tesis doctoral.  
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HIPÓTESIS 
 
 
En esta tesis doctoral se han planteado dos hipótesis relacionadas entre sí:  
 
• Es posible desarrollar un modelo tridimensional de conjuntiva humana 
que contenga células estromales y epiteliales, incluyendo células de tipo 
caliciforme, que sean capaces de secretar mucinas. 
 
• Este nuevo modelo tridimensional in vitro será capaz de responder a 
estímulos externos, demostrando así su utilidad para llevar a cabos 
estudios relacionados con procesos inflamatorios que afecten a la 
conjuntiva humana.  
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OBJETIVOS 
 
Objetivo general 
 
• Desarrollar un modelo tridimensional de conjuntiva humana con tres tipos 
celulares (fibroblastos, células epiteliales y células caliciformes) y una 
matriz biocompatible que permita el estudio fiable de cambios en la 
expresión de moléculas asociadas a la inflamación. 
 
 
Objetivos específicos 
 
1. Estudiar la implicación de los receptores de ácido hialurónico en 
enfermedades inflamatorias de la superficie ocular (estudios 1 y 2). 
 
2. Estudiar el papel de citoquinas relevantes en enfermedades de la superficie 
ocular sobre la función de las células caliciformes (estudios 3 y 4). 
 
3. Establecer cultivos primarios de células epiteliales y estromales de 
conjuntiva humana (estudio 5). 
 
4. Seleccionar un material biocompatible que sirva como andamio para 
desarrollar un modelo tridimensional (estudio 6). 
 
5. Desarrollar un co-cultivo tridimensional de células epiteliales caliciformes y 
no caliciformes, y de fibroblastos de conjuntiva humana (estudio 7). 
 
6. Simular enfermedades inflamatorias de la superficie ocular aplicando 
distintas condiciones al modelo tridimensional previamente desarrollado 
(estudio 8). 
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METODOLOGÍA 
  
La metodología empleada para lograr cada uno de los objetivos planteados está 
descrita de manera detallada en los estudios correspondientes. Por ello, a 
continuación se presenta tan solo un resumen de las principales muestras 
biológicas utilizadas y de las principales técnicas usadas.  
 
 
1. MUESTRAS UTILIZADAS 
 
En el desarrollo de esta tesis doctoral se utilizaron muestras humanas de 
distinta procedencia. Algunas procedían de tejidos obtenidos a partir de donante 
cadáver, cedidos por el banco de ojos de la Clínica Barraquer (Barcelona, España) 
o por los bancos de ojos Heartland Lions Eye Bank (Kansas City, MO, EE. UU.) y 
Michigan Eye Bank (Ann Arbor, MI, EE. UU.), siempre bajo acuerdos vigentes y con 
la aprobación de los Comités correspondientes.  
Otras muestras fueron obtenidas directamente de pacientes, mediante 
citología por cepillado conjuntival (brush cytology, BC) o recogidas de pacientes que 
estaban siendo sometidos a cirugía refractiva. En todos los casos los donantes 
firmaron un consentimiento informado en el que permitían que se recogieran las 
muestras correspondientes, así como su uso en investigación. Todos los proyectos 
en los que se recogieron muestras de pacientes estuvieron aprobados por el 
Comité Ético de Investigación Clínica. 
Todos los experimentos se desarrollaron siguiendo las directrices de la 
Declaración de Helsinki y siguiendo la normativa del Real Decreto 1716/2011, de 18 
de noviembre, por el que se establecen los requisitos básicos de autorización y 
funcionamiento de los biobancos con fines de investigación biomédica y del 
tratamiento de las muestras biológicas de origen humano, y se regula el 
funcionamiento y organización del Registro Nacional de Biobancos para 
investigación biomédica.  
Además de las muestras humanas, en el estudio 4 se usaron también 
muestras de conjuntiva de ratas Sprague Dawley. Todos los experimentos que 
 
RESUMEN EN ESPAÑOL 
	   44 
involucraron animales se llevaron a cabo atendiendo a la Declaración de ARVO 
para el uso de animales en investigación oftalmológica 
(http://www.arvo.org/About_ARVO/Policies/Statement_for_the_Use_of_Animals_in_
Ophthalmic_and_Visual_Research/). 
 
1.1. Líneas celulares 
Las líneas celulares de epitelio corneal humano (HCE) de Araki-Sasaki et al. 
(1995) y de epitelio conjuntival humano (IOBA-NHC) de Diebold et al. (2003) se 
emplearon con fines comparativos en experimentos dentro del estudio 1. Además, 
la línea IOBA-NHC fue utilizada también en experimentos realizados en el estudio 6 
de esta tesis doctoral.  
 
1.2. Cultivos primarios 
Se desarrollaron cultivos primarios de fibroblastos, células epiteliales y 
células caliciformes de conjuntiva humana a partir de tejido conjuntival de donante 
cadáver (Figura 7). Dichos tejidos fueron enviados por la Clínica Barraquer 
(estudios 5-8) y el Heartland Lions Eye Bank y Michigan Eye Bank (estudio 4).  
 
 
Figura 7. Obtención de cultivos a partir de conjuntiva de donante cadáver (izquierda). Se 
aisló la conjuntiva a partir del anillo corneoscleral (medio-izquierda). A continuación se 
realizaron fragmentos de unos 2 mm (explantes) que se colocaron sobre la superficie de 
placas de cultivo (medio-derecha). A partir de dichos explantes se pudo observar el 
crecimiento de células epiteliales a partir de 1-2 días (derecha). 
 
 
También se realizaron cultivos de células caliciformes a partir del tejido 
conjuntival obtenido de ratas macho Sprague-Dawley, de 4-5 semanas de edad 
(estudio 4). 
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1.3. Muestras frescas de pacientes 
Se obtuvieron muestras de epitelio corneal de pacientes sometidos a cirugía 
refractiva (CERS) mediante la técnica de queratectomía fotorrefractiva. Estas 
muestras fueron empleadas en el estudio 1.  
Las muestras de epitelio conjuntival fueron recogidas en donantes sanos y en 
pacientes con enfermedades de la superficie ocular mediante citología por cepillado 
conjuntival, para su uso en los estudios 1 y 2 de esta memoria de tesis. 
 
 
2. DETERMINACIÓN DE PARÁMETROS CELULARES 
 
2.1. Estudio de la proliferación celular mediante el reactivo alamarBlue® 
La proliferación celular se determinó en los estudios 5, 6 y 7 de esta tesis 
mediante el ensayo colorimétrico con alamarBlue® (AbD Serotec, Oxford, Reino 
Unido). El alamarBlue® es un colorante fluorescente no tóxico que se añade a las 
células diluido en medio de cultivo. La actividad metabólica de las células reduce 
este compuesto emitiendo fluorescencia a 590 nm cuando se excita a una longitud 
de onda de 560 nm. La fluorescencia emitida es proporcional al número de células 
presentes en el cultivo. Como este compuesto no afecta ni a la viabilidad ni a la 
proliferación de las células, puede usarse en el mismo cultivo a lo largo del tiempo. 
 
2.2. Estudio de la proliferación de células caliciformes mediante Cell Counting 
Kit-8 
La proliferación celular de las células caliciformes de rata del estudio 4 fue 
determinada con el kit comercial Cell Counting Kit-8 (Dojindo Molecular 
Technologies, Gaithersburg, MD, EE. UU.). El producto WST-8 (una sal de 
tetrazolio) presente en el kit se añadió a las células en cultivo y, tras 45 min de 
incubación, se retiró el medio. Se leyó la absorbancia del mismo en un 
espectrofotómetro a 450 nm de longitud de onda. El valor de absorbancia obtenido 
es proporcional a la proliferación celular.  
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2.3. Estudio de la viabilidad celular mediante el ensayo de toxicidad in vitro 
XTT 
El test XTT es otro ensayo colorimétrico que se utilizó para analizar la 
potencial citotoxicidad de los hidrogeles de gelano-espermidina analizados en el 
estudio 6. Las células conjuntivales en contacto con los hidrogeles se incubaron 
durante 17 h con la sal de tetrazolio XTT (2,3-bis2-metoxi-4-nitro-5-sulfofenil-
2Htetrazolio-5-carboxianilida) en medio RPMI sin rojo fenol (Invitrogen-GIBCO, 
Inchinnan, Reino Unido). Como control positivo de toxicidad se empleó una solución 
de cloruro de benzalconio (BAC, Sigma-Aldrich, St. Louis, MO, EE. UU.) al 0,001 %. 
Pasado el tiempo de incubación con XTT se midió la absorbancia de cada pocillo en 
un espectrofotómetro a 450 nm, siendo el valor obtenido proporcional al número de 
células presentes en el pocillo. 
 
 
3. ANÁLISIS DE PROTEÍNAS 
 
3.1. Inmunofluorescencia 
La inmunofluorescencia es una técnica de detección de proteínas basada en 
la reacción antígeno anticuerpo. En ella se utilizaron diversos anticuerpos primarios 
(ver Tabla 1) que se unieron de manera específica a la proteína de interés. Las 
condiciones de incubación dependieron del anticuerpo, siendo las más comunes 1 
hora a 37º C o toda la noche a 4º C. Después se realizaron tres lavados con PBS 
para retirar el exceso de anticuerpo primario y se añadió a continuación un 
anticuerpo secundario marcado con un fluoróforo. El anticuerpo secundario se 
incubó durante 1 hora a temperatura ambiente. Este anticuerpo secundario se unió 
al primario, marcando así de manera fluorescente la proteína estudiada. Los 
núcleos celulares fueron teñidos con Hoechst 33342 (Sigma-Aldrich), dilución 
1:1000, durante 10 minutos a temperatura ambiente. Las preparaciones se 
observaron en el microscopio de fluorescencia Leica CTR6000 (Leica 
Microsystems, Wetzler, Alemania) donde se realizaron fotografías a distintos 
aumentos. 
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Tabla 1. Anticuerpos primarios y lectinas utilizados en los distintos estudios. 
Anticuerpo/Lectina Casa comercial Dilución IF 
Dilución 
WB Estudio 
CD44 Calbiochem-Merck 1:100 1:500 1 
RHAMM Santa Cruz Biotechnology 1:50 1:500 1 
CK4 Abcam 1:100 - 4 
CK7 Abcam 1:100 - 4 
MUC5AC Abcam 1:100 - 4 
IFN-γ-R1 Novus Biologicals 1:100 - 4 
CK19 Dako 1:50 1:1000 5, 7, 8 
CK4 Sigma-Aldrich - 1:250 5 
CK7 ThermoScientific 1:100 1:200 5, 7, 8 
MUC5AC EMD Millipore Corp. 1:500 1:500 5, 7, 8 
Vimentina Santa Cruz Biotechnology 1:500 1:200 5 
FSP-1 Abcam 1:100 - 5 
Ki67 Dako 1:50 - 5, 7, 8 
E-caderina BD Bioscience 1:100 1:1000 5, 7 
ZO-1 Invitrogen 1:50 1:250 5 
Lectina UEA-1 Sigma Aldrich 1:500 - 4 
Lectina HPA Sigma Aldrich 1:500 - 3, 4, 7, 8 
IF: inmunofluorescencia; WB: Western blotting 
 
 
3.2. Electroforesis y Western blotting 
El Western blotting es una técnica de determinación de proteínas que 
consiste en transferir a una membrana las proteínas previamente separadas en gel 
de poliacrilamida mediante una electroforesis con dodecil sulfato sódico. Las 
proteínas se separan en función de su peso molecular y, una vez en la membrana, 
se lleva a cabo su reconocimiento mediante anticuerpos.  
Para llevar a cabo esta técnica es necesario obtener lisados celulares. Esto 
se consiguió mediante un tratamiento enzimático de las células con el tampón de 
lisis celular del ensayo de radioinmunoprecipitación (RIPA). Una vez extraidas las 
proteínas totales se cuantificaron con el kit Pierce BCA Protein assay kit (Thermo 
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Scientific, Rockford, IL, EE. UU.), basado en ácido bicinconínico (BCA). A 
continuación, las muestras se cargaron en un gel de poliacrilamida al 10% que se 
sometió a una corriente eléctrica (15 minutos a 70 voltios y 90 minutos a 110 
voltios). De esta forma, mediante electroforesis, se separaron las proteínas en 
función de su peso molecular. A continuación se llevó a cabo el proceso de Western 
blotting o transferencia a la membrana, en el que las proteínas separadas en el gel 
se transfieren a una membrana de nitrocelulosa aplicando durante 90 minutos una 
corriente de 350 miliamperios de intensidad. Finalmente, sobre dicha membrana, se 
llevó a cabo un proceso de inmunodetección, incubando la membrana con 
anticuerpos primarios frente a las proteínas de interés (ver Tabla 1). Para concluir 
con el proceso se añadieron anticuerpos secundarios marcados con luminol y se 
reveló la membrana, observándose bandas en el lugar en el que se encontraban las 
proteínas inmunodetectadas.  
 
3.3. Ensayo por inmunoabsorción ligado a enzimas (ELISA) 
La determinación de proteínas secretadas se llevó a cabo mediante la técnica 
de ELISA. Para ello se utlizaron kits comerciales frente a IL-6 (IL-6 ELISA, Diaclone, 
Besançon, Francia) en los estudios 5 y 8, sCD44 (Human sCD44std Instant ELISA, 
eBioscience, Viena, Austria) en los estudios 1 y 8, y MUC5AC (Shanghai Yehua 
Biological Technology Co., Ltd., Shanghai, China) en el estudio 8. En todos los 
casos se siguieron las indicaciones de los fabricantes. Los límites de detección 
oscilaron entre 6,25 - 200 pg/ml para la IL-6, 62,5 - 4.000 pg/ml para sCD44 y 5 - 
1.000 ng/ml para MUC5AC. 
 
 
4. ANÁLISIS GENÉTICO 
 
4.1. RT-PCR convencional y electroforesis en gel de agarosa 
Para analizar los niveles de expresión genética en los estudios 1 y 4, se 
realizó una reacción en cadena de la polimerasa (PCR) con transcripción reversa 
(RT), RT-PCR. Para ello, primero se extrajo el ARN mensajero (ARNm) de las 
células de interés mediante el kit comercial Rneasy Mini Kit (Qiagen, Valencia, CA, 
EE. UU.). Después se llevó a cabo la transcripción reversa para obtener así ADN 
complementario (ADNc). Los genes de interés se amplificaron a partir de ese ADNc 
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con una PCR convencional, mezclando para ello el ADNc con cebadores para los 
genes correspondientes (ver Tabla 2), nucleótidos, tampón para PCR comercial 
(Biotools B&M Labs, S.A., Madrid, España) y Taq polimerasa. Para visualizar el 
resultado de dicha amplificación se llevó a cabo una electroforesis en gel de 
agarosa.  
 
4.2. RT-PCR a tiempo real 
En otros experimentos (estudios 1, 2 y 4) se llevó a cabo una RT-PCR a 
tiempo real. Se trata de una variante de la PCR semicuantitativa. Es un avance 
tecnológico con respecto a la RT-PCR convencional que permite obtener resultados 
más homogéneos y precisos, de una manera más rápida y con menor riesgo de 
contaminación. Además, a menudo se alcanza una mayor sensibilidad, por lo que 
es una técnica más útil cuando se trata de comparar niveles de expresión entre 
varias muestras. Para realizarla se mezclan 10 ng de ADNc con 1 µl de cebadores 
(Tabla 2) y 10 µl de SYBR Green PCR Master Mix. La reacción se llevó a cabo en 
las siguientes condiciones: desnaturalización durante 10 minutos a 95º C, seguida 
de 40 ciclos de 15 segundos a 95º C (desnaturalización) y 60 segundos a 60º C 
(elongación). Finalmente la reacción acabó con un ciclo de 90 segundos a 95º C. 
Después de cada ciclo de elongación se leyó la fluoresencia. El análisis de los 
datos se llevó a cabo mediante el método semicuantitativo 2-ΔΔCt (Livak y 
Schmittgen, 2001). 
 
     Tabla 2. Cebadores utilizados en los distintos estudios. 
Cebador Casa comercial Pares de bases Estudio 
CD44 SABioscience-Qiagen 106 1, 2 
RHAMM SABioscience-Qiagen 108 1, 2 
GAPDH Sigma 250 1, 2, 4 
P53 SABioscience-Qiagen 188 2 
MUC5AC Sigma-Aldrich 85 4 
Human IFN-γ-R1 OriGene Technologies Inc. 169 4 
Rat IFN-γ-R1 Qiagen 169 4 
 
 
 
 
RESUMEN EN ESPAÑOL 
	   50 
 
5. TÉCNICAS ESPECIALES 
 
5.1. Medida del calcio intracelular 
En el trabajo descrito en el estudio 4 se llevó a cabo la medida de los niveles 
intracelulares de calcio [Ca2+]i de las células caliciformes de rata y humano. 
También se evaluaron los cambios que se producían en respuesta a varios 
estímulos, como fueron el IFN-γ y el carbacol.  
Para ello, las células cultivadas en placas de cultivo con fondo de cristal 
fueron incubadas en tampón KRB (120 mM NaCl, 25 mM NaHCO3, 10 mM HEPES, 
4,8 mM KCl, 1,2 mM MgCl2, 1,2 mM NaH2PO4, 1 mM CaCl2) con 0,5 % de albúmina 
de suero bovino (BSA), 8 µM de ácido plurónico F127, 250 µM sulfinpirazona y 0,5 
µM Fura-2/AM. La incubación se llevó a cabo durante 1 hora a 37º C. Fura-2/AM es 
una molécula fluorescente que indica los niveles de [Ca2+]i. Después de la 
incubación las células se lavaron con el tampón KRB con sulfinpirazona y las placas 
de cultivo se observaron bajo el microscopio con el sistema de visualización de 
calcio InCyt Im2 (Intracellular Imaging, Cincinnati, OH, EE. UU.). Este programa 
permite medir los niveles emitidos de Fura-2 a 505 nm de longitud de onda tras la 
estimulación a 340 nm y 380 nm.  
Para llevar a cabo los experimentos se seleccionaron al menos 10 células 
individuales y se realizó una lectura basal de 15 segundos antes de añadir ningún 
compuesto. Se valoró el cambio en el pico máximo de [Ca2+]i, obtenido al restar del 
valor máximo el valor basal.  
 
5.2. Preparación de matrices de fibrina 
Las matrices de fibrina elaboradas en los estudios 6, 7 y 8, se preparon 
siempre en condiciones de esterilidad y empleando plasma fresco congelado o 
crioprecipitado obtenido del Centro de Hemoterapia y Hemodonación de Castilla y 
León (CHEMCYL).  
Para su elaboración se mezclaron 400 µl/ml de plasma o 333 µl/ml con 40 
µl/ml de ácido tranexámico (Rottapharm, Valencia, España) y 40 µl/ml de cloruro 
cálcico (Braun, Barcelona, España), todo ello diluido en medio de cultivo. Esta 
mezcla se colocó sobre el soporte correspondiente (pocillos de placa de cultivo o 
insertos) y se dejó polimerizar durante al menos 2 horas en un incubador a 37º C.  
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Cuando se cultivaron fibroblastos en el interior de las matrices, éstos se 
incorporaron durante el proceso de preparación de la propia matriz, a una 
concentración de 100.000 células/ml. Las células epiteliales cultivadas sobre las 
matrices se sembraron encima tras 24 horas de polimerización, con una densidad 
de 100.000 células/cm2. 
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RESULTADOS Y DISCUSIÓN 
  
Esta memoria de tesis se ha estructurado en 8 estudios diferentes. A 
continuación se presenta un resumen de los resultados de cada estudio.  
 
 
ESTUDIO 1 - Receptores ácido hialurónico en la superficie ocular humana: un 
estudio descriptivo y comparativo de CD44 y RHAMM en tejidos, líneas 
celulares, y muestras recién recogidas  
 
En este trabajo se demostró que los dos principales receptores de AH, 
CD44 y RHAMM, están presentes en los tejidos de la superficie ocular.  
Mediante Western blotting se pudo observar que tanto en la conjuntiva 
como en el limbo había mayores niveles proteicos de RHAMM que de CD44, algo 
que no ocurría en el tejido corneal. Mediante inmunfluorescencia se vio que en la 
córnea había mayor distribución de CD44 en las capas basales del epitelio, 
mientras que en el limbo se detectó mayor intensidad en las capas suprabasales. 
RHAMM se expresaba en todo el epitelio de la superficie ocular y, además, en el 
estroma conjuntival. El análisis genético llevado a cabo mediante RT-PCR a tiempo 
real reveló mayores cantidades de ARNm de CD44 que de RHAMM, tanto en la 
córnea como en la conjuntiva. 
También se analizó la expresión de estos receptores en líneas celulares de 
córnea (HCE) y de conjuntiva (IOBA-NHC). A nivel proteico se encontraron mayores 
niveles de RHAMM que de CD44 en ambas líneas celulares, mientras que a nivel 
genético los niveles de CD44 fueron mayores. Es decir, que se encontró la misma 
discrepancia entre proteína y ARNm que en el caso de los tejidos.  
Por último, se estudió la distribución de estos receptores en células 
epiteliales primarias de córnea y de conjuntiva obtenidas directamente de donantes 
sanos. En el caso de la córnea, estas células se obtuvieron de pacientes sometidos 
a cirugía refractiva y en el caso de la conjuntiva mediante citología por cepillado 
conjuntival. Los niveles proteicos de RHAMM fueron mayores que los de CD44 en 
ambos casos, mientras que a nivel de ARNm se detectó más CD44. Al comparar los 
datos obtenidos en estas muestras con los de las líneas celulares se encontraron 
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diferencias estadísticamente significativas. Las líneas celulares sobreexpresan el 
receptor RHAMM, por lo que no se recomienda realizar estudios relacionados con 
AH en estas líneas celulares.  
El receptor CD44 tiene una fracción soluble (sCD44) que fue detectada en 
un 32% de las muestras de lágrima analizadas.  
Este estudio demostró que los receptores de AH están ampliamente 
distribuidos en la superficie ocular, y que su expresión difiere de unos tejidos a 
otros. A su vez, se observó que la expresión de CD44 y RHAMM en alguna de las 
líneas celulares oculares más empleadas difiere notablemente de la expresión en 
células recogidas directamente de pacientes. Por lo tanto, se puso de manifiesto el 
gran valor que tiene trabajar con cultivos primarios, y la necesaria cautela que debe 
tenerse al analizar datos obtenidos de líneas celulares.  
 
 
ESTUDIO 2 – Los receptores de ácido hialurónico CD44 y RHAMM en la 
inflamación de la superficie ocular humana  
  
 En este estudio se analizaron los niveles de expresión de CD44 y RHAMM 
en pacientes con enfermedades inflamatorias de la superficie ocular con afectación 
conjuntival y se demostró que éstos cambiaban en los procesos inflamatorios. 
 Las muestras de 17 pacientes (41,5 ± 4,9 años; 8 hombres y 9 mujeres) y 
de 14 donantes sanos (30,1 ± 3,0 años; 6 hombres y 8 mujeres) fueron obtenidas 
mediante citología por cepillado conjuntival. Los pacientes fueron clasificados en 
dos grupos: enfermedades inmunes de base atópica y enfermedades inmunes no 
atópicas. A su vez, se dividieron las muestras según los pacientes tuvieran 
inflamación leve/moderada o severa. Se aisló el ARNm de las muestras y se analizó 
la expresión genética de CD44 y RHAMM mediante RT-PCR a tiempo real. 
Se observó que en el grupo de enfermedades atópicas severas los niveles 
de CD44 eran significativamente mayores que en el grupo control de donantes 
sanos. En este mismo grupo de enfermedades atópicas se detectó un aumento 
progresivo y estadísticamente significativo en los niveles de RHAMM, llegando a 
triplicarse los niveles en el caso de los pacientes con inflamación severa.  
En el grupo de pacientes con enfermedades inmunes no atópicas se vio 
una tendencia hacia niveles más bajos de CD44 que en el grupo control, aunque 
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este cambio no fue estadísticamente significativo. Sin embargo, los niveles de 
RHAMM en los pacientes con inflamación severa fueron significativamente 
inferiores que en el grupo de donantes sanos.  
Además, se analizó la expresión de p53, un represor de RHAMM, para 
comprobar si un aumento o un descenso en la expresión de este gen podría ser el 
responsable de los cambios observados en RHAMM. Sin embargo, no se 
encontraron resultados relevantes.  
En resumen, en este estudio se observaron cambios significativos en la 
expresión de los receptores de AH en enfermedades inflamatorias que afectan a la 
conjuntiva. En el caso de patologías de base atópica se detectó una expresión 
aumentada de CD44 y RHAMM, mientras que en las patologías inmunes de base 
no atópica se encontró un descenso. Estos resultados indican que los receptores de 
AH, especialmente RHAMM, están implicados en la inflamación ocular y podrían 
incluso ser utilizados como potenciales biomarcadores. 
 
 
ESTUDIO 3 – Función de las células caliciformes conjuntivales: efecto del uso 
de lentes de contacto y citoquinas  
 
 En esta revisión invitada se realizó una búsqueda bibliográfica exhaustiva 
sobre el efecto de las lentes de contacto y de distintas citoquinas en las células 
caliciformes.  
 Primero se llevó a cabo un análisis de las distintas técnicas disponibles para 
identificar las células caliciformes de la conjuntiva: tinción mediante ácido periódico 
de Schiff (PAS), inmunodetección de CK7 y MUC5AC, y tinción con lectinas para 
detectar glicoconjugados.  
 Se revisaron los distintos modelos in vitro existentes para estudiar la función 
de las células caliciformes. A pesar de la dificultad de cultivar este tipo celular, se 
han descrito protocolos de cultivo para las células caliciformes de humano, de rata y 
de ratón, lo que ha permitido avanzar en el conocimiento fisiológico de estas 
células. 
 Las células caliciformes están implicadas en varias enfermedades oculares. 
En el síndrome de ojo seco normalmente hay una disminución en el número y la 
secreción de las células caliciformes, mientras que en las alergias oculares suelen 
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encontrarse mayores densidades de células caliciformes. Además, éstas pueden 
sufrir hiperplasia y presentar mayores tasas de secreción de mucinas. Por último, 
los pacientes con conjuntivitis papilar gigante (GPC) suelen tener también 
hipersecreción mucosa.  
 Hay varios estudios que han intentado analizar el papel de las lentes de 
contacto sobre las células caliciformes. La mayoría de los estudios indican que el 
uso de lentes de contacto puede llevar a un descenso en el número de células 
caliciformes, aunque algunos autores señalan justo lo contrario.  
 A pesar de la relación de las células caliciformes con distintas 
enfermedades en las que las citoquinas son muy estudiadas, el efecto de estas 
últimas sobre dichas células no ha sido ampliamente analizado. En este trabajo se 
llevó a cabo una revisión sobre este tema. Los principales datos encontrados 
indican que el IFN-γ produce apoptosis de células caliciformes y un descenso en la 
secreción, y que citoquinas de tipo Th2, especialmente la IL-13, son capaces de 
aumentar la proliferación y la secreción de las células caliciformes. Estos datos 
podrían ayudar a explicar algunos de los signos observados en pacientes. 
A lo largo de esta revisión se ha podido ver como el estudio de las células 
caliciformes ha ido aumentando en los últimos años. Esto ha permitido confirmar 
que el papel de estas células va más allá de la simple secreción de mucinas, e 
indica que debe continuarse con el estudio de las células caliciformes.  
  
 
ESTUDIO 4 – Interacción del INF-γ con agonistas colinérgicos para modular la 
función de células caliciformes de rata y humanas  
 
 En este trabajó se llevó a cabo un estudio de la interacción del IFN-γ con el 
agonista colinérgico carbacol (Cch) para modular la función de las células 
caliciformes.  
 Las células caliciformes están inervadas por nervios simpáticos. En 
condiciones normales, la acetilcolina es capaz de estimular su secreción mediante 
el aumento de los niveles intracelulares de calcio ([Ca2+]i). En el síndrome de ojo 
seco suele haber una disminución de la secreción mucosa y un descenso en el 
número de las células caliciformes. El IFN-γ es una molécula que se encuentra 
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elevada en esta patología y, por ese motivo, se estudió su interacción con las 
células calciformes.  
 Las células cultivadas se caracterizaron mediante inmunofluorescencia y 
RT-PCR a tiempo real. Además de demostrar que se trataba de células caliciformes 
(puesto que expresaban CK7 y MUC5AC, y se marcaban con lectinas), se demostró 
que estas células expresaban el receptor de IFN-γ. 
Se observó que el IFN-γ era capaz de aumentar los niveles de [Ca2+]i de 
manera dosis dependiente. Lo mismo sucedía con el Cch. Al combinar ambas 
sustancias se observó que el IFN-γ bloqueaba el aumento de [Ca2+]i provocado por 
el Cch y viceversa. Se comprobó que la inhibición que producía el IFN-γ del 
aumento de [Ca2+]i provocado por el Cch era dependiente del tiempo, ya que esta 
inhibición se producía a los 15 minutos, pero no a las 24 horas. 
Para analizar las causas de estos cambios en el tiempo, se llevaron a cabo 
estudios funcionales con y sin [Ca2+] extracelular. Además, se realizaron 
experimentos con tratamientos previos con tapsigargina, una sustancia que 
aumenta los niveles de [Ca2+]i al liberar el Ca2+ almanacenado en el retículo 
endoplasmático, a la vez que impide que esos depósitos intracelulares vuelvan a 
almacenar Ca2+. Los resultados obtenidos parecen indicar que los efectos a corto 
plazo se deben al uso de los mismos depósitos de calcio por parte de IFN-γ y Cch.  
 Además, se observó que el tratamiento durante 24 horas con IFN-γ también 
bloqueaba el incremento en la secreción de mucinas mediado por Cch por parte de 
las células caliciformes.  
 Por último, se demostró que el IFN-γ producía un descenso significativo del 
20% en la proliferación de las células caliciformes. Este dato concuerda con los 
aportados por otros autores que encontraron un incremento de apoptosis en 
presencia de esta citoquina.  
 En resumen, en este estudio se demostró que el IFN-γ afectaba a múltiples 
procesos que controlan la cantidad de mucina producida por las células 
caliciformes. Afecta a la secreción, pero también al número de células caliciformes 
presentes en la conjuntiva. Todo esto podría explicar la deficiencia mucosa que 
suelen sufrir los pacientes con ojo seco, en los que normalmente se detectan 
niveles elevados de IFN-γ.  
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ESTUDIO 5 – Un nuevo modelo de cultivo de células primarias epiteliales de 
conjuntiva humana para estudiar inflamación  
  
En este trabajo se desarrolló y optimizó un protocolo de cultivo de células 
conjuntivales humanas, para poder utilizarlas como modelo de estudio.  
Se aislaron fibroblastos a partir del estroma conjuntival de muestras 
obtenidas de donante cadáver. Los fibroblastos se cultivaron en medio DMEM/F12 
suplementado con antibióticos y un 10% de suero fetal bovino (FBS).  
Las células epiteliales de conjuntiva humana se obtuvieron a partir del tejido 
mediante dos procedimientos: disgregación celular y mediante la técnica de 
explantes. Se observó que mediante los explantes se obtenían más células de una 
forma más fácil y rápida, por lo que fue el método de elección.  
Se consiguió evitar la contaminación de los cultivos epiteliales por 
fibroblastos mediante dos técnicas: pre-sembrado y tripsinización diferencial. Con 
un presembrado de 2 horas se conseguía un cultivo puro de células epiteliales, y lo 
mismo ocurría si se realizaba una tripsinización diferencial durante 5 minutos para 
eliminar los fibroblastos.  
Una vez que se obtuvieron cultivos de células epiteliales sin contaminación 
estromal, se probaron cinco medios de cultivo para lograr optimizar la expansión de 
dichas células. El medio control fue DMEM/F12 suplementado con 10% de FBS, 
2ng/ml de factor de crecimiento epidérmico (EGF), 1 µg/ml insulina, 0,5 µg/ml de 
hidrocortisona, 0,1 µg/ml de toxina colérica, y antibióticos. Además se probó un 
medio enriquecido en EGF (10 ng/ml), un medio con H2O2 (había sido descrito que 
pequeñas cantidades de H2O2 favorecían la adhesión de células de epitelio 
corneal), un medio condicionado por fibroblastos y un medio con 10% de suero 
humano en vez de FBS. Los resultados mostraron que el medio condicionado por 
fibroblastos favorecía la adhesión celular más que ningún otro y era el segundo 
medio con el que se lograron mejores tasas de proliferación celular, siendo 
superado tan solo por el medio con suero humano. Por su parte, el medio con suero 
humano era el que proporcionaba una mayor eficiencia en la formación de colonias. 
No se encontraron cambios en la expresión del marcador de epitelio conjuntival 
CK19 entre los distintos medios. Sin embargo, sí que se observaron diferencias en 
el número de células positivas para el marcador de proliferación Ki67, siendo 
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superiores en el medio condicionado por fibroblastos y en el medio con suero 
humano. Con todos estos resultados se determinó que el medio con suero humano 
era el más adecuado para la expansión in vitro de células epiteliales de conjuntiva 
humana.  
A continuación se realizaron sucesivos pases celulares con el medio de 
elección y se analizaron distintos marcadores específicos de fenotipo epitelial 
conjuntival secretor. Las células epiteliales expresaban los marcadores CK4, CK19 
y CK7 hasta el pase 3. Sin embargo, en los pases 4 y 5 se observaba un descenso 
e incluso desaparición de dichos marcadores epiteliales, así como un aumento en la 
expresión de vimentina, lo que indica transición epitelio-mesenquimal. Las células 
hasta el pase 3 mostraban uniones adherentes (E-cadherina) y uniones estrechas 
(ZO-1), algo que no ocurría en las muestras de pase 5.  
Finalmente, se realizó un pequeño estudio de inflamación celular. Tras 
tratar a células en distintos pases con TNF-α, se observó que éstas secretaban 
mayores niveles de IL-6 que los controles sin tratar. El incremento en la secreción 
de IL-6 tras estimulación con TNF-α ha sido descrito en células epiteliales, por lo 
que este experimento permitió comprobar que las células cultivadas respondían de 
manera normal a este estímulo.  
En este estudio se desarrolló un protocolo completo de aislamiento y cultivo 
de células conjuntivales a partir de muestras de tejido procedentes de donante 
cadáver. Las células epiteliales mantuvieron sus características en cultivo y fueron 
capaces de responder a estímulos inflamatorios. Esto demuestra que los cultivos de 
epitelio conjuntival humano realizados mediante el protocolo descrito pueden ser 
empleados para realizar estudios funcionales.  
 
 
ESTUDIO 6 – Selección del biomaterial adecuado para su uso como andamiaje 
de células conjuntivales  
 
El objetivo de este trabajo era encontrar un biomaterial adecuado para 
elaborar el modelo tridimensional de conjuntiva humana. Para ello, debería permitir 
el crecimiento celular y la adhesión de células epiteliales en su superficie.  
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 Se probaron dos tipos de biomateriales: hidrogeles de gelano/espermidina 
(dos formulaciones distintas) y matrices de fibrina obtenidas a partir de plasma 
humano.  
 Los hidrogeles de gelano/espermidina presentaban un aspecto 
macroscópico homogéneo y transparente. Por el contrario, las matrices de fibrina 
eran más opacas. Sin embargo, el manejo de los hidrogeles de gelano fue más 
difícil que el de las matrices de fibrina, ya que los primeros eran más frágiles y se 
rompían fácilmente al manipularlos con las pinzas.  
 Cuando se añadieron células epiteliales de conjuntiva humana de la línea 
IOBA-NHC sobre los dos biomateriales se observó una mejor adhesión en las 
matrices de fibrina. En ellas, las células eran capaces de adherirse a la superficie y 
proliferar sobre ella. Por el contrario, solo un pequeño porcentaje de células se 
adhirieron a la superficie de los hidrogeles de gelano/espermidina, y al cabo de 
unos días esas células morían. La proliferación celular en ambos biomateriales se 
evaluó mediante el reactivo alamarBlue®. Las células en contacto con los hidrogeles 
de gelano/espermidina presentaban tasas de proliferación muy inferiores a las de 
las células cultivadas sobre plástico (control). Por el contrario, las mayores tasas de 
proliferación se hallaron cuando las células se cultivaron sobre la superfice de las 
matrices de fibrina.  
 Para comprobar si el aparente problema de biocompatibilidad de los 
hidrogeles se debía a un problema de citotoxicidad, se evaluó la viabilidad de las 
células en contacto con los hidrogeles de gelano/espermidina mediante el ensayo 
de toxicidad in vitro basado en el XTT. Los niveles encontrados con los hidrogeles 
fueron similares a los del control positivo de toxicidad empleado (cloruro de 
benzalconio), con porcentajes de viabilidad por debajo del 25%.  
 En resumen, en este trabajo se analizaron dos tipos distintos de 
andamiajes. Mientras que las matrices de fibrina mostraron buenos resultados, los 
datos obtenidos con los hidrogeles de gelano/espermidina desaconsejaron su uso 
con células conjuntivales. En conclusión, las matrices de fibrina fueron el andamiaje 
elegido para continuar con el proyecto de desarrollo de un modelo tridimensional de 
conjuntiva humana.   
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ESTUDIO 7 - Desarrollo de un modelo tridimensional de conjuntiva normal 
humana  
 
 Una vez obtenidas las células y seleccionado el andamio adecuado (las 
matrices de fibrina) se procedió a elaborar el modelo tridimensional de conjuntiva. 
Se usaron matrices de fibrina obtenidas a partir de plasma y a partir de 
crioprecipitado de sangre humana.  
 Las células epiteliales crecidas sobre las matrices de fibrina estratificaban 
en distintas capas a lo largo del tiempo, alcanzando hasta 6 capas a los 14 días de 
cultivo. Además, dichas células mantenían el fenotipo epitelial, corroborado por la 
expresión de CK19. Mediante inmunofluorescencia se comprobó que algunas de 
esas células, normalemente las más superficiales, expresaban también CK7. La 
tinción con la lectina HPA fue también positiva en algunas células. Ambas 
características son indicativas de la presencia de células caliciformes.  
Al analizar la proliferación de las células en las matrices se encontraron 
diferencias entre los distintos tipos celulares. Los fibroblastos incluidos en el interior 
de las matrices de plasma mostraron mejores tasas de proliferación que los que 
estaban en las matrices de crioprecipitado. Por el contrario, las células epiteliales 
crecían más sobre las matrices de crioprecipitado que sobre las de plasma. El 
marcador de proliferación Ki67 también se analizó mediante inmunofluorescencia 
en las células epiteliales, y el porcentaje de células positivas en las distintas 
condiciones corroboró los datos obtenidos mediante alamarBlue®. Las células que 
estaban sobre matrices de crioprecipitado tenían un mayor porcentaje de expresión 
de Ki67 (38,97% a los 3 días y 35,28% a los 7 días) que las que estaban sobre 
plasma (23,13% a los 3 días y 16,13% a los 7 días). 
Al analizar la estructura de las matrices y de las células mediante 
microscopía electrónica de barrido (SEM) se observó como los fibroblastos 
mantenían su morfología fusiforme y se integraban bien en la red de fibras en 
ambos tipos de matrices. Las células epiteliales, por su parte, tapizaban toda la 
superficie de las matrices. Se observaron microvellosidades en la cara superficial de 
las células epiteliales, lo que demuestra en parte que están polarizadas en este 
modelo. Esto es algo que resulta esencial para el desarrollo de sus funciones.  
En resumen, en este estudio se desarrolló un modelo tridimensional de 
conjuntiva humana normal a partir de cultivos primarios y matrices biocompatibles 
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de fibrina. Al ser un modelo de estudio más completo que los descritos hasta el 
momento, se cree que pueda ayudar a avanzar en el estudio de las enfermedades 
inflamatorias de la superficie ocular de una forma más fiable y fidedigna, evitando o 
disminuyendo con ello el uso de animales de experimentación.    
 
 
ESTUDIO 8 – Simulación de enfermedades inflamatorias en el modelo 
tridimensional de conjuntiva humana  
 
 En este trabajo se llevó a cabo una prueba de concepto para comprobar la 
utilidad del modelo tridimensional de conjuntiva humana en estudios in vitro de 
inflamación ocular.  
 Para ello, la construcción elaborada con matrices de fibrina derivadas de 
crioprecipitado y células conjuntivales humanas se expuso a distintas condiciones 
experimentales: control (cultivo en condiciones estándar), cultivo air-lifted (en los 
que las células crecen en la interfase aire-medio de cultivo), desecación (para 
simular algunos de los hallazgos típicos de ojo seco) y tratamiento con IL-13 (para 
simular la condición de alergica ocular). En todos los casos las construcciones se 
mantuvieron en cultivo durante 7 días. En la condición air-lifted, las construcciones 
estuvieron los tres últimos días en cultivo aireado. En la condición de desecación 
las construcciones estuvieron durante 2 horas en la campana de flujo laminar sin 
medio cultivo, de tal forma que el flujo de aire de la propia campana simulaba las 
condiciones adversas. Por último, las construcciones con IL-13 fueron tratadas con 
20 ng/ml de esta citoquina durante 24 horas.  
 Tras 7 días de cultivo las construcciones se fijaron, procesaron y tiñeron 
con hematoxilina/eosina para su evaluación a microscopía óptica. Se observaron 
cambios en las distintas condiciones experimentales comparadas con el control. En 
las construcciones air-lifted se observó un aumento en la estratificiación de las 
capas epiteliales, y en las construcciones tratadas con IL-13 un aumento en el 
grosor de la matriz. Muchos trabajos previos han demostrado que la condición de 
cultivo air-lifted favorece la estratificación, por lo que los resultados obtenidos en 
nuestro modelo de conjuntiva humana corroboran también este hecho.  
 Además, en la condición air-lifted se observó un incremento en el número 
de células de tipo caliciforme teñidas por la lectina HPA, así como en la secreción 
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de MUC5AC. Datos similares han sido descritos por varios autores en cultivos 
tridimensionales de epitelio de mucosas.  
 Para comprobar el estado inflamatorio de las células en las distintas 
condiciones experimentales se midieron los niveles secretados de IL-6. Estos 
niveles estaban muy aumentados en las condiciones air-lifted y desecación en 
comparación con el control.  
 Por último, se utilizó este nuevo modelo tridimensional con las cuatro 
condiciones experimentales para estudiar los receptores de ácido hialurónico. Los 
niveles de CD44 y RHAMM se analizaron mediante inmunofluorescencia, y pudo 
observarse una mayor expresión de ambos en la condición de estimulación con IL-
13. Esto concuerda con los datos obtenidos en el estudio 2, donde se vio que los 
pacientes con enfermedades inmunes de base atópica, en los que la IL-13 suele 
estar elevada, tenían mayores niveles de expresión de CD44 y RHAMM. Por el 
contrario, en la condición de desecación se vio que la expresión de RHAMM 
desaparecía. Este resultado también es compatible con lo observado en el estudio 
2 donde se encontró un descenso en los niveles de RHAMM en pacientes con 
enfermedades inmunes de base no-atópica. Finalmente, se pudo comprobar que 
las células del modelo tridimensional producían sCD44 y que sus niveles eran 
mayores en la condición air-lifted.  
 En resumen, en este estudio se ha demostrado que el modelo 
tridimensional de conjuntiva humana puede ser utilizado para estudiar la 
inflamación de la superficie ocular y que, con las condiciones experimentales 
propuestas, se pueden simular algunos de los efectos más habituales de 
enfermedades inflamatorias tales como el ojo seco y la alergia.  
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CONCLUSIONES 
 
En esta tesis doctoral se ha desarrollado un nuevo modelo tridimensional de 
conjuntiva humana. Además, se presenta una prueba de concepto de su uso para 
el estudio de enfermedades inflamatorias de la superficie ocular. El conocimiento 
adquirido previamente sobre dichas enfermedades, sobre las células conjuntivales 
implicadas y sobre algunas de las moléculas más relevantes permitió orientar el 
desarrollo del nuevo modelo.  
 
Teniendo en cuenta todos los resultados obtenidos en los distintos estudios 
que conforman esta tesis se concluye lo siguiente: 
 
1. Se ha demostrado que los receptores CD44 y RHAMM están implicados en la 
inflamación de la superficie ocular y su expresión varía dependiendo de la 
patología. Esto debería ser tenido en cuenta a la hora de administrar fármacos 
o lágrimas artificiales que contengan ácido hialurónico. Además, el estudio 
comparativo de los receptores de ácido hialurónico en muestras obtenidas de 
pacientes y en líneas celulares ha corroborado una vez más que hay que ser 
cautos con los resultados obtenidos en líneas celulares, puesto que estos 
difieren muy a menudo de los que se obtienen con muestras más directas.  
2. Las distintas citoquinas que se encuentran elevadas en determinadas 
patologías inflamatorias que afectan a la conjuntiva tienen efectos diferenciales 
sobre la función de las células caliciformes. Se ha demostrado que el IFN-γ es 
capaz de interaccionar con agonistas colinérgicos para modular esta función, lo 
que indica que las células caliciformes tienen un papel en la protección de la 
superficie ocular que va más allá de la simple secreción de mucinas. 
3. El tejido conjuntival obtenido de donante cadáver es una fuente adecuada de 
células para desarrollar cultivos primarios de células epiteliales, células 
caliciformes y fibroblastos conjuntivales, algo que no estaba optimizado hasta 
el momento. Esta fuente de material humano puede ayudar a reducir el uso de 
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las líneas celulares que tan a menudo muestran resultados discrepantes con 
los obtenidos directamente de individuos sanos. 
4. Las matrices de fibrina son un buen biomaterial para emplear como andamios 
en cultivos tridimensionales de conjuntiva humana, puesto que permiten la 
adhesión y la proliferación de células epiteliales, caliciformes y no caliciformes, 
y de fibroblastos. 
5. Se han establecido unas condiciones estándar con un único medio de cultivo 
en las que es posible realizar un co-cultivo de fibroblastos, células epiteliales y 
células caliciformes en una matriz tridimensional de fibrina. En estas 
condiciones el crecimiento de cada tipo celular alcanza un equilibrio que 
permite desarrollar un modelo de conjuntiva humana adecuado para llevar a 
cabo estudios de hasta dos semanas. 
6. Se ha podido elaborar y validar un modelo tridimensional de conjuntiva con una 
estructura similar a la conjuntiva humana, con un epitelio estratificado y 
polarizado en el que se encuentran células caliciformes que, además, son 
capaces de secretar MUC5AC de manera diferencial en respuesta a estímulos 
clínicamente relevantes, tales como la desecación o la presencia de citoquinas 
inflamatorias.  
 
 
Estas mismas conclusiones están recogidas en el Epílogo de esta memoria de 
tesis (página 323). 
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“Si tu intención es describir la verdad,  
hazlo con sencillez y la elegancia déjasela al sastre” 
 ------------------------------------------------------------------------- 
“If you are out to describe the truth, 
leave elegance to the tailor” 
 
― Albert Einstein 
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ABSTRACT 
 
 In this Doctoral Thesis report, we have developed a new three-dimensional 
model of human conjunctiva. The development of a new integrative model was 
necessary to overcome the limitations of the available in vitro models and to allow a 
reduction in the number of laboratory animals that are used to study ocular surface 
inflammatory diseases.  
 For this new model, we developed an optimized protocol to expand epithelial 
cells and fibroblasts from conjunctival tissue obtained from human cadaveric donors. 
In addition, some experiments were performed to find an appropriate scaffold within 
which and upon which the conjunctival cells could develop in vitro. Fibrin-based 
matrices showed good results, and that biomaterial was selected as a scaffold for 
this model.  
 Fibroblasts were grown inside the fibrin matrices, and epithelial cells were 
grown on the surface of the scaffold. Epithelial cells became stratified, reaching 5-6 
cell layers at 14 days. In addition, some goblet-like cells were present in the 
constructs. Once the normal conjunctival three-dimensional model was developed, a 
proof-of concept for its use to study ocular surface inflammatory diseases was 
performed. The model was exposed to different conditions such as air-lifted culture, 
desiccation, or cytokine treatments. After that, changes in different cell markers were 
evaluated. The markers and the conditions used were selected based on prior 
knowledge acquired in previous inflammation studies with the different cell types. 
The results obtained in the three-dimensional model were in accordance with the 
data obtained from studies with patients. For example, when the model was 
exposed to interleukin (IL) 13, there was an increase in mucin (MUC) 5AC secretion, 
as occurs in patients with allergic conjunctivitis. When the model was exposed to 
desiccation, there was a reduction in the expression of the hyaluronan receptor 
RHAMM, as seen in patients with Sjögren’s syndrome or rosacea.  
 The results obtained in the different studies that form this Thesis report 
indicated that the newly developed three-dimensional model can be a useful tool to 
perform further studies on conjunctival inflammation.  
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THESIS REPORT STRUCTURE 
 
This Doctoral Thesis report, which is equivalent to a PhD thesis, is elaborated 
as a “compendium of publications” and applies for the International-awarded 
Doctoral Thesis Degree. It has been organized at the University of Valladolid under 
the regulations of the International Doctorate Committee. The joint requirements are 
as follows: 1) a general summary, in which the thematic unit of the work is justified, 
and the objectives, methodology, results, discussion, and conclusions are 
presented, 2) three articles published in scientific journals within the Journal of 
Citations Report, and 3) a doctoral stay of at least three months in duration at a 
research center abroad. The first requirement is fulfilled by the “Summary in 
Spanish” and the “Summary in English” sections. In this thesis eight different studies 
are included. Five of them have resulted in published or accepted papers (Studies 1-
5), thus fulfilling the second requirement.  
The fourth study of this thesis report was performed during my stay at the 
Schepens Eye Research Institute/Massachusetts Eye and Ear Infirmary (Boston, 
MA, USA). Results obtained in Study 4 have been published and are part of this 
doctoral thesis. In this way, this thesis report satisfies the third requirement needed 
to apply for the International-awarded Doctorate Degree. 
After the general synthesis, this report is organized into three thematic 
chapters that present the eight studies (Figure 1).  
Chapter 1: Study of ocular surface inflammation-related relevant 
molecules is composed of four studies. In Study 1, we analyzed the expression of 
CD44 and RHAMM hyaluronan receptors in ocular tissues. We considered this study 
necessary because hyaluronan was, and still is, being used in ocular treatments and 
artificial tears. However, hyaluronan receptors have not been studied in the ocular 
surface, despite their implication in cancer and in inflammatory diseases. We 
demonstrated the presence of CD44 and RHAMM in conjunctival epithelial cells, 
and we showed that the protein and mRNA expression levels in cell lines differed 
from those of cytology samples. In Study 2 we measured hyaluronan receptor 
expression in conjunctival cells obtained by brush cytology from patients with 
inflammatory diseases. We found differential mRNA expression of both CD44 and 
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RHAMM receptors in cells exhibiting different pathologies. Among these, the 
changes in RHAMM receptor were greater than for CD44 receptor. In Study 3 we 
performed a bibliographic review to show the effect of contact lenses and cytokines 
on conjunctival goblet cell function. This review allowed us to select the most 
relevant parameters to be studied in Study 4, in which we showed that the 
interaction between IFN-γ and carbachol modulates rat and human goblet cell 
function.  
 
 
Figure 1. Diagram showing the thesis organization with the three chapters that included the 
eight studies. 
 
Interesting results regarding the role of conjunctival cells in inflammation were 
obtained in the Chapter 1. However, to deepen the knowledge of the conjunctiva in 
inflammatory diseases, such as dry eye or allergy, a good in vitro model is 
necessary. Available models are not complete, and for that reason we considered it 
necessary to develop a new in vitro model of the human conjunctiva that should be 
three-dimensional and made with primary cells. In the next chapter, Chapter 2: 
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Acquiring material resources to build a new 3D model of human conjunctiva, 
focused on the obtention of cells and biomaterials. This chapter includes two 
different studies (Studies 5 and 6 of the thesis). In Study 5, an optimized protocol to 
expand epithelial cells from cadaveric conjunctivas is described. With this protocol, 
the use of cell lines was avoided. Study 6 includes the experiments that were 
carried out with different biomaterials. It concluded with the selection of fibrin 
matrices as the best scaffold for conjunctival tissue engineering. 
Finally, in Chapter 3: Development of a 3D model of human conjunctiva, 
all of the materials previously isolated were put together to engineer a conjunctiva 
that could serve as an in vitro model. In Study 7, complete constructs made of fibrin 
with fibroblasts inside and epithelial cells above were characterized by histological 
processing, immunofluorescent staining, and scanning electron microscopy (SEM). 
In Study 8, the last one of this thesis, the 3D model developed in the previous study 
was put under different conditions to simulate conjunctival inflammatory diseases.  
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INTRODUCTION 
 
1. OCULAR SURFACE AND LACRIMAL FUNCTIONAL UNIT (LFU) 
 
The term “ocular surface” was first introduced by R. A. Thoft (Thoft and 
Friend, 1977) to refer to the anatomical and functional unit formed by cornea, 
conjunctiva, and limbal epithelia, along with the tear film and tissue adnexa. The 
main function of the ocular surface is to preserve sight by protecting the eyeball from 
external agents and maintaining corneal transparency. 
Some years later, M. E. Stern established the term “lacrimal functional unit” 
(LFU) (Stern et al., 1998). It is composed of the corneal, conjunctival, and limbal 
epithelia, and the lacrimal glands and neural interconnections (Figure 2).  
 
 
 
Figure 2. Lacrimal Functional Unit. Picture taken from Beuerman et al. The Lacrimal 
Functional Unit in Dry Eye and Ocular Surface Disorders (Pflugfelder, Beuerman, Stern eds.). 
Marcel-Dekker Inc., New York, NY, USA, 2004, 1004:11-40.  
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2. CONJUNCTIVA 
The conjunctiva is part of the ocular surface and the LFU. It is a 
semitransparent mucous membrane that covers the ocular surface from the eyelids 
to the edge of the cornea. One of its main functions is to produce mucus that 
stabilizes the tear film and keep the cornea wet and protected (Dartt, 2006).  
Anatomically, the conjunctiva is divided in three parts:  
1) The tarsal or palpebral conjunctiva lines the posterior part of the eyelids 
2) The bulbar conjunctiva covers the sclera in the anterior segment of the 
eyeball 
3) The fornix forms the junction between palpebral and bulbar conjunctiva 
 
The conjunctiva is composed of a stratified epithelium and an underlying 
stroma (Figure 3). 
 
 
Figure 3. Microphotograph of a conjunctival section. The stratified squamous 
epithelium contains embedded goblet cells. Image courtesy of Ocular Pathology 
Laboratory, IOBA.  
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2.1. Epithelium 
The conjunctival epithelium is a stratified squamous non-keratinized 
epithelium. It has between 2 and 10 epithelial layers, depending on the part of the 
conjunctiva that is being analyzed (Hoang-Xuan T et al., 2001). Five different types of 
epithelial cells are present in the conjunctiva (Figure 4). The ultrastructural 
characteristics were described by K. P. Steuhl (1989). 
Type I cells are goblet cells. They are a specialized type of epithelial cell that 
secretes mucins (Gipson and Argüeso, 2003). They have mucous granules in their 
cytoplasm, and they usually have a well-differentiated Golgi complex. Goblet cells 
are the only cell type secreting the mucin MUC5AC in the conjunctiva. This mucin is 
one of the most important in tears. Goblet cells express secretory epithelium 
markers (CK7), and their secretory products are stained by lectins that bind high 
molecular weight glycoconjugates (Krenzer and Freddo, 1997).  
Type II cells are epithelial cells with abundant secretory vesicles. They also 
have numerous 60- to 300-nm electron-dense granules. These cells are distributed 
throughout the conjunctiva and are the most common cell type. 
Type III cells are epithelial cells with a well-developed Golgi apparatus. It is 
believed that these cells also contribute to the mucous secretions of the tear film. 
Type IV cells have large amounts of rough endoplasmic reticulum (rER). This 
type of cell frequently occurs in human conjunctiva. A small amount of mitochondria 
and Golgi apparatus is also present in these cells.  
Type V cells are mitochondria-rich epithelial cells.  
  
 
Figure 4. Schematic of the different conjunctival epithelial cell types as described by K. P. 
Steuhl in 1989. 
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Cell types II-V are often grouped as squamous stratified non-goblet cells. 
They constitute approximately 85-90% of all the epithelial cells in the conjunctiva. 
They are in close contact with each other, showing adherens junctions containing E-
cadherin. These cells also have tight junctions, such as the ones formed by zonula 
occludens (ZO) 1 and ZO2. They express cell markers such as cytokeratin (CK) 4 
and CK19 and secrete some mucins, such as MUC1, MUC4, and MUC16. These 
mucins give stability to the tears.  
An essential feature of epithelial differentiation is polarization (Roignot et al., 
2013). Conjunctival epithelial cells, as other mucosal epithelia, have microvilli at the 
apical surface. Microvilli increase the surface area for tear adherence, and are 
involved in cell adhesion, absorption, and secretion. Abnormal conjunctival microvilli 
are present in Sjögren’s syndrome and graft versus host disease, among other 
pathologies (Mancel et al., 1993; Tatematsu et al., 2012). 
 
2.2. Basal Membrane 
The conjunctival basal membrane is a thin layer of connective tissue that 
separates the epithelium from the underlying stroma. It is mainly composed of type 
IV collagen, laminin, nidogen 1 and 2, and thrombospondin-4 (Schlotzer-Schrehardt 
et al., 2007). 
 
2.3. Stroma 
The conjunctival stroma is composed of several molecules, such as collagen, 
laminin, and hyaluronic acid (HA), among others. It also has an important cellular 
component. The most abundant cell type in the stroma is the fibroblast. These cells 
secrete an important amount of the extracellular matrix (ECM) that forms the 
conjunctival stroma.  
The conjunctival stroma has a rich vascular network and abundant 
lymphatics. In addition, the conjunctiva possesses a rich nerve supply. Finally, there 
is a significant presence of conjunctival-associated lymphoid tissue (CALT) (Knop 
and Knop, 2000). Along with the lacrimal drainage-associated lymphoid tissue 
(LDALT), it forms the eye-associated lymphoid tissue (EALT), a component of the 
mucosal-associated lymphoid tissue (MALT). Due to the presence of CALT, innate 
immune defense cells, such as macrophages and mast cells, and specific immune 
response cells, such as lymphocytes, plasma cells, and dendritic cells, populate the 
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conjunctival stroma. The CALT protects the conjunctiva and also the cornea (Knop 
and Knop, 2005). This fact reinforces the idea of the conjunctiva being a protective 
tissue for the entire ocular surface.  
 
 
3. CONJUNCTIVAL ROLE IN INFLAMMATORY DISEASES  
 
3.1. Ocular Surface Diseases 
The conjunctiva, which protects the exposed anterior segment of the eye, is 
involved in several inflammatory diseases that affect the ocular surface (Figure 5). 
Conjunctival epithelial cells are active participants in ocular surface defense, 
secreting different types of molecules, such as cytokines and chemokines 
(Enríquez-de-Salamanca et al., 2008) or antimicrobial peptides like human beta-
defensin 9 (HBD9) (Mohammed et al., 2010). 
Among the large variety of conjunctival diseases, only two of them are 
included in this summary: dry eye disease and ocular allergy.  
 
    
Figure 5. Slit-lamp photographs from a patient with dry eye disease (left) 
and from a patient with allergic conjunctivitis (right). The conjunctival 
damage can be seen in both eyes. Images by courtesy of Prof. M. 
Calonge. 
 
Dry eye syndrome is a multifactorial inflammatory disease of the ocular 
surface and the tear film. It results from disfunction of the LFU (Stern et al., 2004; 
2013). The high prevalence of this disease (Schaumberg et al., 2003; 2009) and its 
high impact in the quality of life of patients (Schiffman et al., 2003) makes dry eye 
disease one of the most studied pathologies in the ocular surface. The typical 
symptoms are itching, pain, blurred vision, and photophobia. The conjunctival 
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epithelium of these patients can be analyzed by impression cytology. This is a 
minimally invasive technique that consists of applying a small filter in the 
conjunctiva. After some seconds, the filter is recovered and the attached cells (one 
or two layers of conjunctival epithelium) are fixed and stained. Morphological 
features such as cell shape or metaplasia, and the number of goblet cells are 
determined. Lower numbers of goblet cells are usually found in impression 
cytologies from dry eye patients (Mantelli et al., 2013; Marko et al., 2013; Kumar et 
al., 2014).  
Allergy is an abnormal and exaggerated immune response to normally 
harmless antigens that do not trigger any reaction in non-allergic patients. 
Conjunctival tissue plays a key role in ocular allergies. There are several types of 
allergies, ranging from mild forms (seasonal of perennial allergic conjunctivitis) to the 
most severe ones (vernal keratoconjunctivitis and atopic keratoconjunctivitis) where 
sight can be seriously compromised because of the potential impairment of the 
cornea (Leonardi, 2013). In all of these allergic disorders, a direct participation of 
conjunctival tissue exists. Specifically, squamous epithelial cells and goblet cells are 
reported to take an active role in the allergic response (Saban et al., 2013). Ocular 
allergies are frequently associated with mucus hyperproduction, and higher 
densities and/or hyperplasia of goblet cells are found in allergic patients.  
 
3.2. Molecules Involved in Conjunctival Diseases 
The number of molecules that are linked to ocular surface inflammation is 
growing continuously and simultaneously with our knowledge of inflammatory 
disease processes. The impossibility of reviewing all of these molecules led us to 
choose only two types to describe here: cytokines and HA receptors.  
 
3.2.1. Cytokines 
Cytokines are small non-structural proteins with a molecular weight ranging 
from 8 to 40,000 Daltons (Dinarello, 2000). They are immunomodulatory agents 
produced by different cell types, including epithelial cells in the ocular surface. In 
fact, every cell except the erythrocyte can produce and respond to cytokines 
(Dinarello, 2007). As regulators of the immune response, some cytokines are 
proinflammatory (Dinarello, 2000), others exert anti-inflammatory actions (Opal y 
DePalo, 2000), and others have both effects.  
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Cytokines can be classified into different subtypes, depending on the type of 
T helper (Th) cell that produces them (Steinman, 2007). The main subtypes are Th1, 
Th2, and Th17 (Figure 6).   
Among Th1 type cytokines, tumor necrosis factor alpha (TNF-α) and 
interferon gamma (IFN-γ) are the most studied. These two cytokines are usually 
present in higher amounts in dry eye patients. Among Th2-type cytokines, 
interleukin (IL) 4, IL-5, and IL-13 have been widely studied in allergy research, 
where elevated levels have been described.  
 
 
Figure 6. Diagram showing the main cytokine subtypes, classified 
according to the Th cell type that produces them. 
 
 
3.2.2. Hyaluronic Acid (HA) and its Receptors 
HA or hyaluronan consists of glycosaminoglycans with different molecular 
weights. They form the ECM of ocular and other tissues. The main functions are to 
retain water and increase the intercellular space, as well as to participate in tissue 
remodeling. One important effect of HA is to stimulate collagen production by 
fibroblasts. For this reason, HAs are broadly used in cosmetics. 
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HA also participates in the inflammatory process, exerting dual actions 
depending on the size of the HA fragments. Low molecular weight HAs have 
proinflammatory effects, whereas high molecular weight HAs help to maintain tissue 
integrity, participate in wound healing, and provide anti-inflammatory actions (Stern 
et al., 2006; Campo et al., 2009). 
To bind cells and exert some of its functions, HAs have two main receptors: 
CD44 and Receptor for Hyaluronic Acid Mediated Motility (RHAMM) (Turley, 1982; 
Entwistle et al., 1996). The role of these receptors in pathological processes has 
been studied for a long time. There is clear evidence regarding their direct 
involvement in oncologic diseases (Giannopoulos et al., 2006; Balla et al., 2009) 
and in inflammatory pathologies such as osteoarthritis (Dunn et al., 2009). CD44 
has a transmembrane form and a soluble part (sCD44) that is produced by shedding 
or alternative splicing. Higher levels of sCD44 are present in the aqueous humor of 
eyes with glaucoma and this fact has been proposed as one of the causes of 
increased intraocular pressure that leads to glaucoma (Nolan et al., 2007; Giovingo 
et al., 2013).  
However, despite the apparent importance of these receptors in several 
pathologies and the continuous use of HA in ocular pharmaceutical formulations, the 
presence of these receptors and their specific role has not been extensively studied 
in conjunctival tissues.  
 
 
4. MODELS TO STUDY THE ROLE OF THE CONJUNCTIVA IN NORMAL AND 
INFLAMMED OCULAR SURFACES  
The physiological importance of the conjunctiva and its implication in several 
pathologies of the LFU makes it essential to study and understand the normal ocular 
surface behavior. Before performing clinical trials to test new drugs, research must 
be done first using in vitro models and then on in vivo models with laboratory 
animals.  
 
4.1. In vivo Models 
In vivo models utilize live experimental animals, such as mice, rats, rabbits, 
etc. Animal models are useful tools in research because, due to the complexity of 
system interactions, the results are more likely to resemble what might be expected 
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in humans. In addition, they yield large amounts of information. However, they 
present several limitations, mainly ethics-related issues, and more practical issues 
such as elevated costs, inexact similarity with human equivalent tissues, and the 
need of specialized and experienced staff and facilities.  
 
4.2. In vitro Models 
Because of the important concerns cited above regarding living animal 
research models, in vitro models allow researchers study and learn from in vitro 
systems, thus reducing the reliance on the use of animal models. Another 
advantage of in vitro models is that several biological parameters can be easily 
controlled at the same time. In addition, the use of these models results in a more 
cost-effective approach to develop pre-clinical studies, as it is possible to test many 
more experimental conditions than with in vivo models. Therefore, the development 
and use of more advanced, sophisticated in vitro models is highly desirable. 
 
4.2.1. Cell Lines and Primary Cultures 
Cell lines are constituted of transformed cells that can undergo an infinite 
number of cell divisions under controlled laboratory conditions. The transformation 
can be spontaneous or artificially induced. As a consequence of the transformation 
process, cell lines lose the property of contact inhibition. Loss of this trait allows 
them to continue growing after confluence in cell culture has been reached. The 
main advantages of cells lines are availability, easy culture technique, and 
homogeneous results. The main disadvantage is that after the transformation that 
makes them cell lines, these cells are in some ways different from the original ones. 
Some of the native characteristics are lost, and they are not as reliable as the 
original cells.  
Primary cultures are established from cells obtained directly from the 
organism under study, usually from biopsy or cadaveric tissue. For this reason, they 
are more similar to the original tissue than cell lines, and results obtained using 
primary cultures are more valuable. However, they have some inconveniences. 
First, human tissue availability is quite limited and subjected to strict regulations to 
guarantee ethical compliance. In addition, it is difficult to culture these cells and their 
in vitro growth is limited.   
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4.2.2. Monolayer Cultures and Three-Dimensional Cultures 
The most common way to grow either cells lines or primary culture cells in the 
laboratory is in a monolayer culture. In monolayer cultures, cells grow attached to a 
specialized culture surface, forming a single layer of cells that covers the entire 
surface, at which point the culture has reached a state of confluence. In contrast, 
three-dimensional cultures approximate the original three-dimensional structure of 
the donor tissues. Such a complex structure would allow better studies of the 
interaction between different cells types or between cells and the ECM. The 
organization of cells in a three-dimensional space and the relation with the 
extracellular environment are the main factors that determine cell phenotype. For 
that reason, research using three dimensional cultures reveals more valuable results 
in terms of the actual similarity with the living in vivo tissue. 
Three-dimensional cultures can be used to study organs or tissues in normal 
or pathological states. The use of these cultures is being increased with the growing 
knowledge of cell-cell and cell-ECM interactions that tissue engineering is providing.  
 
 
5. TISSUE ENGINEERING  
Tissue engineering was described by R. Langer and J. P. Vacanti as “an 
interdisciplinary field that applies the principles of engineering and life sciences to 
the development of biological substitutes that restore, maintain, or improve tissue 
function or a whole organ” (Langer and Vacanti, 1993). Thus, the ultimate goal of 
tissue engineering is the clinical use of the engineered tissues. However, these 
artificial tissues or organs can also be used as complex in vitro models. There are 
two main components in any tissue engineered tissue: cells and scaffolds that 
support cell growth. 
   
5.1. Cells 
Both cell lines and primary cells can be used to engineer a tissue regardless 
of the final use planned for it. Depending on the origin of the cells, these can be 
autologous (from the same patient) or heterologous (from a different donor). The cell 
types used in tissue engineering depend, obviously, on the tissue that is going to be 
engineered. In the conjunctiva, the main cell types are epithelial cells (including 
goblet cells) and stromal cells, mainly fibroblasts.  
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5.2. Scaffolds  
Scaffolds are the acellular component that maintain the formation of the tissue 
in three dimensions. They provide cells with structural support and guide their 
growth. For these reasons scaffolds are an essential part of tissue engineering.  
A good scaffold should be biocompatible, biodegradable, and should favor 
cell adhesion. Also, it can help in nutrient transport and facilitate functional tissue 
formation (Lee et al, 2011). To develop an artificial tissue as similar to the native 
tissue as possible, the scaffold should also be similar to the native ECM.  
Both natural and synthetic biomaterials can be used to elaborate scaffolds. 
The main advantages of natural biomaterials are their biocompatibility and their 
greater resemblance to the native ECM. Some of the most frequently used natural 
biomaterials are amniotic membrane, collagen, chitosan, fibrin, and HA (Rosso et 
al., 2005), whereas the most frequent synthetic biomaterials are poly-lactic acid 
(PLA), poly-lactic-co-glycolic acid (PLGA), and polycaprolactone (PCL) (Saltzman, 
1999; Putman, 2001). 
 
5.3. Ocular Surface Approaches 
Several studies applying tissue engineering resources into the ocular surface 
field have been published. Some of them are focused on developing an artificial 
cornea to substitute for conventional corneal grafts (Griffith et al., 2009) in patients 
suffering from limbal stem cell deficiency (Xu et al., 2012). With this purpose, the 
transplant of limbal epithelial cells (Pellegrini et al., 2014), oral epithelial cells 
(Utheim, 2015), and conjunctival equivalents (Tanioka et al., 2006; Di Girolamo et 
al., 2009) have also been proposed. Several studies report the huge potential of 
using conjunctival cells for treating blindness, and specifically limbal stem cell 
deficiency (Di Giralomo et al., 2009; Jeon et al., 2013). 
Alaminos and collaborators (Alaminos et al., 2006) recently developed a 
complete rabbit corneal substitute to be used as an in vitro model. To develop this 
model they used the three main corneal cell types: endothelial cells, fibroblasts, and 
epithelial cells. Fibrin and agarose matrices were used as scaffolds for this model. 
They constructed an organotypic cornea model that resembles the ultrastructure of 
a normal native cornea. This study is a good example of how tissue engineering can 
also be used for research purposes.  
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In 2007, Chung and collaborators (Chung et al., 2007) reported the 
development of a three-dimensional model of human conjunctiva that secreted 
MUC5AC. The lack of MUC5AC production in vitro, probably due to the difficulty of 
culturing goblet cells, is the main limitation of several conjunctival models reported 
so far. However, in the model described by Chung et al., this limitation was 
overcome. Starting from small conjunctival biopsies, Chung and colleagues cultured 
human goblet cells that were later seeded in Transwell-clear 3450 culture inserts 
with a polyester membrane. Using an air-lifted culture technique, these cells became 
stratified in different layers, reaching 6-8 layers after two weeks. In these conditions 
they observed MUC5AC secretion. This research provides a good model to study 
conjunctival epithelium, but not the whole conjunctiva because the stroma was not 
present.  
Despite the progress made with conjunctival tissue equivalents, a complete 
three-dimensional conjunctival model has not been described until now. Thus, there 
remains a need for a good human model to increase our understanding of normal 
and pathological conjunctival physiology and to test new treatments. 
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MOTIVATION 
 
Although the conjunctiva is less often studied than the cornea, it is the main 
tissue implicated in some prevalent and potentially sight-threatening ocular surface 
diseases, such as dry eye or ocular allergy. To make progress in the study of the 
pathophysiological processes affecting the conjunctiva and to find new therapies to 
treat those diseases, it is mandatory to have good in vitro models.  
We understand that currently available models for conjunctiva are not 
adequate because they are oversimplified. Usually they consist only of cell 
monolayers formed by transformed cell lines that are no longer similar to the actual 
progenitor tissue. Therefore, caution should be taken when conclusions are drawn 
from results obtained with these models.  
One of the main functions of the conjunctiva is to secrete mucins that lubricate 
and protect the ocular surface. This function is usually altered in inflammation. Most 
conjunctival epithelial cells are able to secret mucins, but the main secretory cell is 
the goblet cell, which is the only cell type in the conjunctiva that secretes MUC5AC, 
one of the most important mucins in the tear film. Hence, the study of goblet cell 
function becomes especially relevant.  
Bearing all this in mind, we feel a new, more complex and integrative 
conjunctival model is necessary. To overcome the limitations of existing models, the 
new model should be derived from primary cells and not from cell lines. In addition, 
the model should recapitulate the three-dimensional structure of the conjunctiva, 
with at least a stroma populated with fibroblasts and an epithelium containing mucin-
secreting goblet cells.   
To test the efficacy of this model in the study of inflammatory diseases, the 
different types of cells that participate in the inflammatory process should have 
already been identified. In this way, the most relevant findings can be simulated in 
the three-dimensional model.   
This doctoral thesis was developed in the context of this framework. The main 
aim was to develop a three-dimensional in vitro model of human conjunctiva that 
allows researchers to deepen the knowledge of conjunctival inflammatory diseases 
while minimizing the use of animals.  
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To face this challenge, a multidisciplinary team was needed. The Ocular 
Surface Group from IOBA has provided leadership in the study of inflammatory 
diseases for a long time. The team relies on medical experts that provide the clinical 
point of view to understand the pathological processes. Additionally, the team is led 
by Dr. Y. Diebold who has expertise in cell culture techniques and an established 
career in the field of nanomedicine. Effectiveness of the team relies in part on 
collaborations in the biomaterials field, such as researchers from the Department of 
Pharmacy and Pharmaceutical Technology from the University of Santiago de 
Compostela (Spain) and the Tissue Establishment San Francisco Clinic Foundation 
from León (Spain). Several competitive national joint grants support these 
collaborations.  
Therefore, the need for further pathophysiological study of the conjunctiva 
and the need to test new therapeutic strategies that are being developed by the 
nanomedicine team support the idea of developing a three-dimensional model of 
human conjunctiva. The career path within the Ocular Surface Group from IOBA is a 
guarantee of achieving these goals and making progress in this challenging thesis 
project. 
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HYPOTHESES  
 
It is possible to develop a three-dimensional model of human conjunctival 
tissue containing stromal and epithelial cells, and this model can incorporate goblet-
like cells able to secrete mucins.  
 
This in vitro model would be capable of responding to external stimuli, and 
would be suitable to study inflammatory processes affecting the conjunctiva.  
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OBJECTIVES 
 
General Objective 
 
To develop a three-dimensional model of human conjunctiva composed of 
three cell types: fibroblasts, epithelial cells, and goblet cells. The model should be 
developed in a biocompatible matrix and allow reliable studies related to 
inflammation. 
 
 
Specific Objectives 
 
1. To determine the role of the HA receptor in ocular surface inflammatory 
diseases (Studies 1 and 2). 
2. To determine the role of cytokines expressed in ocular surface diseases on 
goblet cell function (Studies 3 and 4). 
3. To establish primary cultures from human conjunctival epithelial and stromal 
cells (Study 5). 
4. To select an appropriate biomaterial to be used as a scaffold in the 
development of a three-dimensional model (Study 6). 
5. To develop a three-dimensional co-culture of human conjunctival goblet, 
non-goblet epithelial cells, and fibroblasts (Study 7). 
6. To simulate ocular surface inflammatory diseases in the three-dimensional 
model by the application of different stimuli (Study 8). 
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METHODOLOGY 
 
Detailed descriptions for the methodologies used in the experiments are 
included in each study. For that reason only general techniques are summarized in 
this section. 
 
1. SAMPLES 
Human conjunctival tissues to prepare primary cultures were obtained post-
mortem from cadaveric donors. These samples were from Barraquer Eye Bank 
(Barcelona, Spain), Heartland Lions Eye Bank (Kansas City, MO, USA), and 
Michigan Eye Bank (Ann Arbor, MI, USA), in all cases with valid agreements and 
approval from Institutional Boards.  
Conjunctival and corneal samples for the analyses performed in Studies 1 
and 2 were obtained from living individuals. Prior approval from the Clinical 
Research Ethics Committee was obtained, and each patient signed an informed 
consent. All the experiments were in accordance to the Tenets of the Declaration of 
Helsinki and to the Spanish regulations in biomedicine and biological samples.  
Rat goblet cells were obtained from Sprague-Dawley rat conjunctivas. 
Experiments were performed in accordance with the ARVO Declaration for Use of 
Animals in Research (http://www.arvo.org/About_ARVO/Policies/Statement_for_the 
_Use_of_Animals_in_Ophthalmic_and_Visual_Research/). 
 
1.1. Cell Lines 
The human corneal epithelial (HCE) cell line (Araki-Sasaki et al., 1995) and 
the normal human conjunctival (IOBA-NHC) epithelial cell line (Diebold et al., 2003) 
were used in Study 1 for comparison purposes. 
 
1.2. Primary Cultures 
Primary cultures from fibroblasts, epithelial, and goblet cells were stablished 
in Studies 4, 5, 7, and 8 from the human conjunctival tissue (Figure 7) following the 
explant technique. In addition, goblet cells were also cultured from Sprague-Dawley 
rats in Study 4.   
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Figure 7. Cell expansion from cadaveric conjunctiva. The conjunctival tissue was isolated 
from corneoscleral rims (left). Small pieces (explants) were placed in the surface of 12-well 
plates (middle left, middle right). Cell growth from the explants was observed after 1-2 days 
(right). 
 
1.3. Freshly Collected Samples 
Conjunctival epithelial cells used in Studies 1 and 2 were collected by brush 
cytology from patients with active ocular surface inflammatory diseases and from 
healthy volunteers. Corneal epithelial cells analyzed in Study 1 were obtained from 
patients undergoing refractive surgery.  
 
 
2. CELL PARAMETER MEASUREMENTS 
 
2.1. Cell Proliferation Measurement with the Cell Proliferation Assay Reagent 
alamarBlue®  
Cell proliferation was determined in Studies 5, 6, and 7 with the colorimetric 
assay alamarBlue® (AbD Serotec, Oxford, UK). alamarBlue® dye was applied to 
cultured cells and after 4-6 h incubation, and the fluorescence was read at 590 nm. 
Fluorescence levels were related to cell proliferation.  
 
2.2. Goblet Cell Proliferation Measurement with Cell Counting Kit-8 
Cell proliferation of conjunctival rat goblet cells was determined in Study 4 
with Cell Counting Kit-8 (Dojindo Molecular Technologies, Gaithersburg, MD, USA). 
Tetrazolium salt WST-8 included in the kit was diluted in culture medium and added 
to cultured cells. Absorbance was read at 450 nm after 45 min incubation. The 
absorbance values obtained were proportional to cell proliferation.  
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2.3. Cell Viability Measurement with In Vitro Toxicology Assay kit, XTT based 
Cell viability was determined in Study 6 with the In Vitro Toxicology Assay kit, 
XTT based (Sigma-Aldrich, St. Louis, MO, USA) to evaluate potential cytotoxicity of 
gellan gum hydrogels. As in the other proliferation assays, the XTT assay was 
based on a tetrazolium salt that becomes reduced by mitochondrial dehydrogenases 
in viable cells. XTT was added to the cells and incubated for 17 hours. The 
absorbance, which is proportional to cell viability, was read at 450 nm.  
 
 
3. PROTEIN ANALYSIS 
 
3.1. Immunofluorescence Detection 
Immunofluorescence staining is based on antigen-antibody reactions. A 
primary antibody binds the protein and, later, a secondary antibody with a 
fluorescent label binds the primary antibody. A list of all the different primary 
antibodies used in this thesis is found in Table 1. This technique was routinely used 
in Studies 1, 4, 5, 7, and 8. 
 
3.2. Electrophoresis and Western Blotting 
Western blotting is a method for identification of proteins that have been 
previously separated according to their molecular weight by electrophoresis in a 
polyacrylamide gel. Proteins are then transferred from the gel to a membrane, 
where they are subsequently detected using specific antibodies. This technique was 
used to detect different proteins in Studies 1 and 5. A list of the primary antibodies 
used and their working dilutions is presented in Table 1.  
 
3.3. Enzyme-Linked Immunosorbent Assay (ELISA)  
ELISA is a biochemical assay used to detect an antigen that is present in a 
liquid phase and is based on the antigen-antibody reaction. Secreted proteins, such 
as IL-6 (Studies 5 and 8), sCD44 (Studies 1 and 8), and MUC5AC (Study 8) were 
measured by ELISA following the assay manufacturer’s instructions (Diaclone, 
Besançon, France, for IL-6 ELISA; eBioscience, Vienna, Austria, for sCD44 Instant 
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ELISA; Shanghai Yehua Biological Technology Co., Ltd., Shanghai, China, for 
MUC5AC ELISA).  
 
Table 1. Primary antibodies and lectins used in the different studies  
Antibody/Lectin Reference IF dilution WB dilution Study 
CD44 Calbiochem-Merck 1:100 1:500 1 
RHAMM Santa Cruz Biotechnology 1:50 1:500 1 
CK4 Abcam 1:100 - 4 
CK7 Abcam 1:100 - 4 
MUC5AC Abcam 1:100 - 4 
IFN-γ-R1 Novus Biologicals 1:100 - 4 
CK19 Dako 1:50 1:1000 5, 7, 8 
CK4 Sigma-Aldrich - 1:250 5 
CK7 ThermoScientific 1:100 1:200 5, 7, 8 
MUC5AC EMD Millipore Corp. 1:500 1:500 5, 7, 8 
Vimentin Santa Cruz Biotechnology 1:500 1:200 5 
FSP-1 Abcam 1:100 - 5 
Ki67 Dako 1:50 - 5, 7, 8 
E-cadherin BD Bioscience 1:100 1:1000 5, 7 
ZO-1 Invitrogen 1:50 1:250 5 
UEA-1 lectin Sigma Aldrich 1:500 - 4 
HPA lectin Sigma Aldrich 1:500 - 3, 4, 7, 8 
IF: immunofluorescence; WB: Western blotting 
 
 
4. GENETIC ANALYSIS 
 
4.1. Conventional Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR) and Electrophoresis in Agarose Gel 
To determine genetic expression levels, RT-PCR followed by electrophoresis 
in agarose gel was performed in Studies 1 and 4. Previously, mRNA was isolated 
with RNeasy Mini Kit (Qiagen, Valencia, CA, USA). The primers used are listed in 
Table 2. Specific conditions for each primer are detailed in the corresponding 
studies.  
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4.2. Real Time RT-PCR 
This technique is a technological advance of conventional RT-PCR. It 
provides some advantages such as speed, reproducibility, and low contamination 
risk. In this thesis, a semiquantitative variant was performed in Studies 1, 2, and 4. 
The isolated mRNA was reversed transcribed to cDNA that was then mixed with 
primers (Table 2) and SYBR Green PCR Master Mix (Applied Biosystems, Carlsbad, 
CA, USA). Data was analyzed with the 2-ΔΔCt semiquantitative method (Livak y 
Schmittgen, 2001). 
 
       Table 2. Primers used in different studies 
Primer Reference Base pairs Study 
CD44 SABioscience-Qiagen 106 1, 2 
RHAMM SABioscience-Qiagen 108 1, 2 
GAPDH Sigma 250 1, 2, 4 
P53 SABioscience-Qiagen 188 2 
MUC5AC Sigma-Aldrich 85 4 
Human IFN-γ-R1 OriGene Technologies Inc. 169 4 
Rat IFN-γ-R1 Qiagen 169 4 
 
 
5. SPECIAL TECHNIQUES 
 
5.1. Intracellular Calcium Measurement 
 In Study 4, intracellular calcium levels [Ca2+]i were measured in cultured rat 
and human goblet cells stimulated with IFN-γ and carbachol. Cells were incubated 
with Krebs-Ringer bicarbonate (KRB) buffer (120 mM NaCl, 25 mM NaHCO3, 10 mM 
HEPES, 4.8 mM KCl, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 1 mM CaCl2) with 0.5% 
bovine serum albumin (BSA), 8 µM F127 pluronic acid, 250 µM sulfynpirazone, and 
0.5 µM Fura-2/AM for 1 hour at 37ºC. After incubation, the cells were rinsed in KRB 
buffer with sulfinpyrazone and under the microscope with the calcium visualizing 
system InCyt Im2 (Intracellular Imaging, Cincinnati, OH, USA). At least 10 individual 
cells in each assay were selected for analysis. The peak change in [Ca2+]i was 
recorded.  
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5.2. Fibrin Matrices Preparation  
Fibrin-based matrices were prepared from either human fresh frozen plasma 
(Studies 6 and 7) or cryoprecipitates (Studies 7 and 8), obtained from CHEMCYL 
(Valladolid, Spain). Matrices were produced by mixing plasma (400 µl/ml) or 
cryoprecipitate (333 µl/ml) with 40 µl/ml tranexamic acid (Rottapharm, Valencia, 
Spain) and 40 µl/ml calcium chloride (Braun, Barcelona, Spain), all diluted in 
DMEM/F12 culture medium (Invitrogen-GIBCO, Inchinnan, UK). In matrices where 
fibroblasts were incorporated, 100,000 cells/ml were added to the matrix mix before 
polymerization. When epithelial cells were cultured on the surface of the matrices, 
100,000 cells/cm2 were added 24 hours after matrix formation.  
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SUMMARY OF RESULTS 
 
Chapter 1: Study of Ocular Surface Inflammation-Related Relevant Molecules  
• Hyaluronan receptors are expressed in the ocular surface. CD44 expression 
was constant for the entire ocular surface epithelium, whereas higher levels 
of RHAMM were found in the conjunctival tissue compared to the corneal 
tissue. This was the first study reporting the presence of RHAMM in the 
conjunctiva. In addition, we demonstrated that sCD44 was present in normal 
human tears.  
• CD44 and RHAMM were implicated in conjunctival inflammation. Higher 
levels of CD44 and even higher levels of RHAMM were present in patients 
with immune-atopic diseases such as vernal and atopic keratoconjuntivitis. 
In contrast, lower levels of RHAMM were detected in patients with immune 
non-atopic diseases such as rosacea or Sjögren’s syndrome.  
• Several proinflammatory and anti-inflammatory cytokines interact with goblet 
cells in different situations. It has been described that IFN-γ and TNF-α that 
are usually found in higher levels in dry eye patients with decreased goblet 
cell proliferation and secretion. In contrast, IL-4, IL-5, and IL-13 were 
increased in ocular allergy and induced goblet cell differentiation, 
proliferation, and increased secretion.  
• IFN-γ affected rat and human cultured goblet cell proliferation and secretion. 
In addition, IFN-γ interacted with carbachol to modulate goblet cell function, 
each blocking the effect of the other.  
 
 
Chapter 2: Acquiring Material Resources to Build a New Three-Dimensional 
Model of Human Conjunctiva 
• We developed a protocol to expand epithelial cells from cadaveric 
conjunctival tissue. Standard culture medium supplemented with human 
serum provided the best proliferation rates. Cells expressed epithelial and 
goblet cell markers such as CK4, CK7, CK19, E-cadherin, and MUC5AC.  
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• Gellan gum/spermidin hydrogels and fibrin matrices were tested as scaffolds 
for human conjunctival cells. Gellan gum hydrogels were not compatible 
with the studied cells. In contrast, fibrin-based matrices made from fresh 
frozen plasma allowed conjunctival epithelial cell growth on the surface of 
the matrix and inside the matrix.  
 
 
Chapter 3: Development of a Three-Dimensional Model of Human Conjunctiva 
• We developed a three-dimensional conjunctival model with human primary 
cells derived from conjunctival tissues and fibrin matrices made from plasma 
and cryoprecipitates. Fibroblasts were grown inside the matrices and 
epithelial cells on the surface of them. Epithelial cells became stratified on 
the surface of the matrices, reaching 5-6 layers at 14 days, and they 
maintained the conjunctival epithelial cell phenotype. Cell proliferation rates 
varied depending on the specific matrix composition. Epithelial cells grew 
better in cryoprecipitate matrices, whereas fibroblasts showed higher 
proliferation rates inside plasma matrices. The presence of mucin-secreting 
cells was observed 3 days after establishing the cultures and were no longer 
present after the seventh day of culture.  
• The three-dimensional model was exposed to different conditions to mimic 
inflammatory diseases, such as dry eye or allergic conjunctivitis. When the 
model was exposed to desiccation, RHAMM expression was decreased, 
similarly to what happened in patients with immune non-atopic disease. In 
contrast, when IL-13 was added, there was an increase in MUC5AC 
secretion. This is one of the main clinical findings in allergic diseases. Thus, 
this model reacts differentially to the analyzed stimuli, and the responses 
were in accordance to what occurs in the inflammation-related studies 
included in Chapter 1 of this Thesis.  
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CONCLUSIONS 
 
In this Doctoral Thesis report the development of a new three-dimensional 
model of human conjunctiva is presented. Also, proof-of-concept of its use to study 
ocular surface inflammatory diseases is provided. The existing knowledge of the 
diseases, including the cells and molecules implicated in the pathophysiology, 
allowed us to focus the development of this model upon the most relevant findings. 
 
Bearing in mind all of the results obtained in the different studies 
accomplished, we conclude the following: 
 
1. We demonstrated that CD44 and RHAMM hyaluronan receptors are implicated 
in ocular surface inflammation. Expression of the hyaluronan receptors 
changed depending on the etiology of the disease. This should be taken into 
account when artificial tears or drugs containing HA are prescribed to patients. 
In addition, comparison of the results based on cell lines and on fresh samples 
obtained from patients highlighted once again the caution that researchers 
should exert when extrapolating results obtained from cell lines.  
2. Cytokines that are altered in several ocular surface inflammatory diseases, 
such as dry eye and ocular allergy, had differential effects on goblet cells. We 
showed that IFN-γ interacts with cholinergic agonists to modulate goblet cell 
function in terms of proliferation and secretion, indicating that goblet cells have 
a protective role beyond mucin secretion. 
3. Conjunctival tissue obtained from cadaveric donors, a resource that has been 
neglected for a long time, provided suitable conjunctival epithelial cells and 
fibroblasts to construct the conjunctival models. This source of human tissue 
can help to reduce the use of human cell lines, which can drift far from the 
originating healthy human tissues in terms of marker expression. 
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4. Fibrin-based matrices were a good biomaterial to develop a three-dimensional 
scaffold for human conjunctival cells. The properties of these matrices likely 
facilitated cell adhesion and allowed the proliferation of different cell types.  
5. We established standard conditions with a specific culture medium to co-culture 
conjunctival fibroblasts, epithelial cells, and goblet cells. In these conditions, the 
performance of each cell type reached an equilibrium that allowed development 
of an appropriate three-dimensional model suitable to perform different 
laboratory studies up to two weeks.  
6. We designed, constructed, and validated an in vitro three-dimensional 
conjunctival model with a structure similar to that of the native human 
conjunctival tissue. The model included a stratified and polarized epithelium 
containing goblet cells that secreted mucins in response to relevant stimuli, 
such as desiccation or cytokine exposure.  
 
 
These conclusions are also included in the Epilogue of this Thesis report 
(page 325). 
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STUDY OF OCULAR SURFACE 
INFLAMMATION-RELATED 
RELEVANT MOLECULES  
 
 
 
 
 
 
 
“A veces no es suficiente saber lo que significan las cosas,  
a veces hay que saber lo que no significan” 
---------------------------------------------------------------------------------- 
“Sometimes it’s not enough to know what things mean,  
sometimes you have to know what things don’t mean” 
 
― Bob Dylan 
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Abstract The purpose of this study was to demonstrate
the presence of the receptor for hyaluronan-mediated
motility (RHAMM) in human conjunctival epithelium and
in two widely used cell lines from human corneal (HCE)
and conjunctival (IOBA-NHC) epithelia. We compared the
distribution of RHAMM proteins and mRNAs in human
ocular surface tissues (corneal, limbal and conjunctival),
HCE and IOBA-NHC cell lines, and corneal and con-
junctival epithelia primary samples from healthy donors
with the previously identified hyaluronan receptor CD44.
We also aimed to determine if soluble CD44 (sCD44) was
present in human tears, as it could have a role in the
interaction of the tear fluid with hyaluronan. Protein
expression was evaluated by Western blots and immuno-
fluorescence microscopy. mRNA expression was evaluated
by RT-PCR and Q-PCR. sCD44 was analyzed by ELISA in
culture supernatants and in human tears. We describe the
expression of RHAMM in human healthy conjunctiva and
in HCE and IOBA-NHC cells at both protein and mRNA
levels, and the presence of sCD44 in human tears.
Furthermore, we detected CD44 and sCD44 expression
variations in in vitro inflammatory conditions. This study
also focused on the necessary caution with which the
conclusions extracted from cell lines should be made, and
in the great value of using primary samples as often as
possible.
Keywords RHAMM ! Hyaluronan receptors ! CD44 !
Ocular surface ! Conjunctiva ! Epithelial cells !
Inflammation ! Eye
Introduction
Interactions between epithelial cells and the extracellular
matrix are essential for the maintenance of tissue archi-
tecture. An abundant component of the extracellular matrix
is hyaluronan (HA), a glycosaminoglycan that is implicated
in development, tissue remodeling, creation of cell-free
spaces, and disease processes like inflammation and
tumorigenesis (Sherman et al. 1994; Turley et al. 1991).
For these reasons it has been deeply analyzed in many
organs, including the eye. The way in which HA exerts its
functions is by interacting with cell-surface receptor pro-
teins. Although others exist, there are two main receptors,
CD44 and the receptor for HA-mediated motility
(RHAMM), that have been characterized and cloned
(Entwistle et al. 1996).
CD44 is reported to be the main HA receptor (Aruffo
et al. 1990). It is a transmembrane glycoprotein found in a
wide variety of cell types, including leukocytes, fibroblasts,
keratinocytes, and epithelial cells (Isacke and Yarwood
2002). It has a variety of functions such as cellular adhe-
sion, HA degradation, lymphocyte activation, lymph node
homing, myelopoiesis and lymphopoiesis, angiogenesis,
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ESTUDIO 1 
 
El ácido hialurónico fue descubierto por primera vez en el vítreo del ojo. 
Desde entonces, y debido a sus propiedades, su uso se ha ido extendiendo hasta 
estar presente en muchos de los productos que usamos a diario, desde la 
cosmética a los fármacos.  
En el ojo, el ácido hialurónico se ha usado en lágrimas artificiales y también 
en el desarrollo de nuevas plataformas terapéuticas de liberación controlada. Sin 
embargo, sus receptores no han sido apenas estudiados en la superficie ocular. Y 
eso, a pesar de su demostrada importancia en otras patologías sistémicas como el 
cáncer.  
En este estudio se analiza la expresión de los receptores de ácido hialurónico 
en tejidos de la superficie ocular, en líneas celulares de la córnea y de la conjuntiva, 
y también en muestras epiteliales de los mismos tejidos recién recogidas de 
pacientes, así como en lágrima.  
 
 
STUDY 1 
 
Hyaluronic acid or hyaluronan was first discovered in the vitreous of the eye. 
Since then, its use has been extended and now it is present in many of the products 
we use everyday, from cosmetics to drugs.  
In the eye, hyaluronic acid is included in different artificial tear formulations. 
Also, it is an important component of drug delivery systems used to obtain a 
controlled release of different ocular drugs. Although its receptors are implicated in 
several systemic diseases, they have not been deeply studied in the ocular surface.  
This study assesses the expression of hyaluronan receptors in corneal and 
conjunctival epitelial cell lines, in ocular surface tissues, as well as in freshly 
collected epitelial cells and tear samples from patients.  
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Hyaluronan Receptors in the Human Ocular Surface: a Descriptive and 
Comparative Study of RHAMM and CD44 in Tissues, Cell Lines and Freshly 
Collected Samples 
 
ABSTRACT 
The purpose of this study was to demonstrate the presence of the receptor 
for hyaluronan-mediated motility (RHAMM) in human conjunctival epithelium and in 
two widely used cell lines from human corneal (HCE) and conjunctival (IOBA-NHC) 
epithelia. We compared the distribution of RHAMM proteins and mRNAs in human 
ocular surface tissues (corneal, limbal and conjunctival), HCE and IOBA-NHC cell 
lines, and corneal and conjunctival epithelia primary samples from healthy donors 
with the previously identified hyaluronan receptor CD44. We also aimed to 
determine if soluble CD44 (sCD44) was present in human tears, as it could have a 
role in the interaction of the tear fluid with hyaluronan. Protein expression was 
evaluated by Western blots and immunofluorescence microscopy. mRNA 
expression was evaluated by RT-PCR and Q-PCR. sCD44 was analyzed by ELISA 
in culture supernatants and in human tears. We describe the expression of RHAMM 
in human healthy conjunctiva and in HCE and IOBA-NHC cells at both protein and 
mRNA levels, and the presence of sCD44 in human tears. Furthermore, we detected 
CD44 and sCD44 expression variations in in vitro inflammatory conditions. This 
study also focused on the necessary caution with which the conclusions extracted 
from cell lines should be made, and in the great value of using primary samples as 
often as possible. 
 
Keywords: RHAMM; Hyaluronan receptors; CD44; Ocular surface; Conjunctiva ; 
Epithelial cells; Inflammation; Eye 
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INTRODUCTION 
Interactions between epithelial cells and the extracellular matrix are 
essential for the maintenance of tissue architecture. An abundant component of the 
extracellular matrix is hyaluronan (HA), a glycosaminoglycan that is implicated in 
development, tissue remodeling, creation of cell-free spaces, and disease 
processes like inflammation and tumorigenesis (Sherman et al. 1994; Turley et al. 
1991). For these reasons it has been deeply analyzed in many organs, including the 
eye. The way in which HA exerts its functions is by interacting with cell-surface 
receptor proteins. Although others exist, there are two main receptors, CD44 and the 
receptor for HA-mediated motility (RHAMM) that have been characterized and 
cloned (Entwistle et al. 1996). 
CD44 is reported to be the main HA receptor (Aruffo et al. 1990). It is a 
transmembrane glycoprotein found in a wide variety of cell types, including 
leukocytes, fibroblasts, keratinocytes, and epithelial cells (Isacke and Yarwood 
2002). It has a variety of functions such as cellular adhesion, HA degradation, 
lymphocyte activation, lymph node homing, myelopoiesis and lymphopoiesis, 
angiogenesis, and release of cytokines (Sneath and Mangham 1998). Through 
alternative splicing, the CD44 gene can give rise to different isoforms, all highly 
glycosylated (Naor et al. 1997). In the cornea, CD44 plays an important role in 
wound healing (Yu et al. 1998). A soluble form of CD44 (sCD44) has been detected 
in circulation and in other body fluids (Cichy and Puré 2003). In the eye, this form 
has been studied in the aqueous humor, and suggested as a potential protein 
marker for primary open-angle glaucoma (Budak et al. 2009). However, to our 
knowledge, it has not been studied in the tear film. 
RHAMM (Hardwick et al. 1992; Turley 1982) is part of a multimeric cell 
surface-bound complex, termed the HA receptor complex (HARC), present in the 
cell surface or secreted into the media. The capability of HARC to bind HA, however, 
has been exclusively attributed to the RHAMM protein (Abetamann et al. 1996). The 
interaction between HA and RHAMM triggers a phosphorylation cascade implicated 
in cell signaling, cell migration, and proliferation, along with being involved in 
modulation of acute and chronic inflammation (Turley et al. 2002). RHAMM has 
neither a signal peptide nor a membrane domain, despite which it is present not only 
as an intracellular protein in the nucleus, but also in the cell membrane (Turley et al. 
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2002). It is thought to be linked to the plasma membrane by either a 
glycosylphosphatidylinositol anchor or by a so far unidentified linker protein 
(Assmann et al. 1999). As a result of alternative splicing and posttranscriptional 
modifications (mainly glycosylations), a remarkable heterogeneity of RHAMM 
proteins exists, with molecular masses ranging from 52 to 125 kDa. RHAMM forms 
are not highly expressed in most normal mammalian cell types, such as fibroblasts, 
endothelial cells, macrophages, immature thymocytes, or B-cell lineages, but are 
commonly overexpressed in many advanced cancers (Gust et al. 2009; Hamilton et 
al. 2007).  
Due to the implications of these receptors in several diseases, they have 
been carefully studied in many tissues. However, this is not the case of the ocular 
surface, which comprises the cornea, the conjunctiva and the sclerocorneal limbus. 
Many severe problems in the ocular surface, mainly in the corneal and conjunctival 
epithelia, eventually cause blindness. It is important to know which molecules are 
involved in these diseases, to find good biomarkers or target proteins for new 
therapies. One of those could be the HA receptors, but they are not very well 
defined. In fact, there are no processes describing the expression and distribution of 
these receptors in the ocular surface. A great part of the studies are carried out in 
cell lines. CD44 is present in human ocular surface tissues, such as cornea (Zhu et 
al. 1997), limbus (Lerner et al. 1998), and conjunctiva (Hughes et al. 2006). It is also 
present in the human corneal epithelial (HCE) cell line (Hornof et al. 2008) and in 
the normal human conjunctival (IOBA-NHC) cell line (De la Fuente et al. 2008). 
Ahmad et al. (2008) reported the presence of RHAMM in corneal and limbal 
epithelial cells. As far as we know, there is no evidence of RHAMM presence in 
human conjunctiva or in the HCE and IOBA-NHC cell lines.  
Therefore, this study was aimed, firstly, to determine whether or not 
epithelial cells from human conjunctiva express RHAMM. Secondly, by comparing 
the CD44 and RHAMM expressions in corneal and conjunctival tissues with that in 
HCE and IOBA-NHC cell lines, we could gain insight regarding the suitability of 
using cell lines as models for in vitro processes. We also aimed at determining 
whether sCD44 is present in tear fluid, and if it is detectable. Finally, we wanted to 
show some preliminary data indicative of the possible implication of these receptors 
in ocular surface inflammation. 
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MATERIALS AND METHODS 
 
Materials 
All materials used were purchased from Sigma-Aldrich (St. Louis, MO, USA) 
unless otherwise indicated. DMEM/F12, fetal bovine serum (FBS), penicillin and 
streptomycin were from Invitrogen-GIBCO (Inchinnan, UK). Human epidermal 
growth factor (EGF) and bovine insulin were from Invitrogen (Eugene, OR, USA). 
Cholera toxin was purchased from Gentaur (Brussels, Belgium). Eight-well 
multichamber Permanox® slides were from Nunc (Roskilde, Denmark) and Optimal 
Cutting Temperature (OCT) compound was from Sakura (Tokyo, Japan). BCA assay 
was from Pierce (Rockford, IL, USA). HeLa cell extract and mouse brain extract 
came from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). All the cytokines 
used for the in vitro inflammation model were from PeproTech (London, UK). Rat 
anti-CD44 monoclonal and goat anti-RHAMM polyclonal antibodies (Abs) were from 
Calbiochem-Merck (Darmstad, Germany) and Santa Cruz Biotechnology Inc., 
respectively. The secondary Abs for Western blotting were purchased from Jackson 
Immuno-Research Laboratories, Inc. (West Grove, PA, USA), and those for 
immunofluorescence assays were from Invitrogen. Acrylamide and Tris buffered 
saline (TBS) used in Western blotting experiments were from Bio-Rad Laboratories 
(Hercules, CA, USA). Vectashield® mounting media was from Vector Laboratories 
(Burlingame, CA, USA). Human sCD44std Instant ELISA was from eBioscience 
(Vienna, Austria). The buffer used to recover tears was Assay Buffer (Millipore 
Corporation, Billerica, MA, USA). Kits for RNA isolation were from Qiagen (Valencia, 
CA, USA), and Quant-iTTM RNA assay and SuperScript Vilo cDNA kit were from 
Invitrogen. All reagents for reverse transcription polymerase chain reaction (RT-
PCR) were from Biotools B&M Labs S.A. (Madrid, Spain), except Blue JuiceTM Gel 
Loading Buffer 109 (Invitrogen). CD44 and RHAMM primers were purchased from 
SABioscience-Qiagen (Frederick, MD, USA), and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) primers were from Sigma. SYBR Green PCR Master Mix 
was from Applied Biosystems (Carlsbad, CA, USA). The ChemiDoc® gel 
documentation system (Bio-Rad Laboratories) was used to visualize the acrylamide 
and agarose gels, and the Quantity One software was used to analyze the resulting 
images. A Leica DMI 6000B fluorescence microscope (Leica Microsystems, Wetzlar, 
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Germany) was used to visualize immunofluorescence preparations and LAS AF Lite 
software (Leica Microsystems) was used to analyze them. 
 
Human tissues 
Human corneal, limbal and conjunctival tissues were obtained from 
cadaveric donors and used as controls. Tonsil tissues from cadaveric donors were 
used as positive controls. Human corneal and conjunctival epithelial cells, and tear 
samples from healthy donors were collected and used as described below. This 
study followed the tenets of the Declaration of Helsinki and had the approval of the 
Institutional Review Board of the University of Valladolid. Informed consent was 
obtained from every donor.  
Corneal epithelial cells were obtained from healthy donors (n = 8; mean age 
± standard error of the mean: 34.6 ± 2.8 years) undergoing photorefractive 
keratectomy. From four of the donors, the corneal epithelial cells obtained after 
refractive surgery (CERS samples) were recovered in 1 ml of culture medium for 
immunofluorescence microscopy. These samples were washed with phosphate 
buffered saline (PBS) and incubated with 0.05%trypsin-ethylenediaminetetraacetic 
acid for 15 min to dissociate cells. For the other four donors, the CERS samples 
were recovered in 700 µl of lysis buffer for RNA extraction. 
Conjunctival epithelial cells were obtained by brush cytology (BC) from 
healthy volunteers (n = 8; 25.4 ± 1.9 years). Donors had no ocular or systemic 
disease or topical treatment within the previous 6 months. BC was performed on the 
upper tarsal conjunctiva of one eye of each donor. Topical double anesthetic 
Colircusí (Alcon Cusí S.A., Barcelona, Spain) was applied. The conjunctiva was 
brushed twice in the same spot with the Cytobrush Plus GT (Medscand AB, Malmö, 
Sweden). After sampling, the epithelial cells were immediately detached from the 
brush by gentle rotation for 30 s in an Eppendorf tube containing 1.4 ml of culture 
medium (DMEM/F12 supplemented with 10% FBS) for immunofluorescence assays. 
For RNA extraction, the epithelial cells were detached into 700 µl of RLT lysis buffer 
(from RNA isolation Qiagen kit) plus 14.5 M b-mercaptoethanol.  
Tear samples were obtained from healthy donors (n = 28, 20–50 years old, 
11 males and 17 females) who were not under ocular or systemic medications. Tear 
collection was performed as previously described (Enriquezde-Salamanca et al. 
2010). Briefly, 8 µl of tears were collected (4 µl from each eye) using glass capillary 
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micropipettes. Each sample was then diluted 1:2.5 in a sterile collection tube 
containing Assay Buffer. 
 
Cell lines and culture conditions 
HCE cells (Araki-Sasaki et al. 1995) from passages 42 to 52 were cultured 
in DMEM/F-12 supplemented with 15% FBS, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 10 ng/ml EGF, 0.5%dimethylsulfoxide, 5 µg/ml insulin, and 0.1 l µg/ml 
cholera toxin.  
IOBA-NHC conjunctival cells (Diebold et al. 2003) from passages 71 to 87 
were grown in DMEM/F-12 supplemented with 10% FBS, 5,000 U/ml penicillin, 5 
mg/ml streptomycin, 2.5 µg/ml fungizone, 2 ng/ml human EGF, 1 µg/ml bovine 
insulin, 0.1 µg/ml cholera toxin, and 0.5 µg/ml hydrocortisone.  
Both cell lines were cultured at 37º C in a 5% CO2–95% air atmosphere. The 
medium was changed every other day, and the cultures were observed daily by 
phase contrast microscopy. 
 
In vitro inflammation model 
HCE and IOBA-NHC cells were seeded in 24-well plates and grown until 
confluence. Then, cells were maintained for 24 h in serum free medium, before 
treating them with TGFβ (10 ng/ml), TNFα (25 ng/ml) or IL13 (20 ng/ml) for 48 h. 
Controls were untreated cells. The cytokines and their concentrations were selected 
according to the in vitro inflammation model previously described (Enriquezde-
Salamanca et al. 2008). 
 
Electrophoresis and Western blot analysis 
Cadaveric tissues from the cornea, conjunctiva, and limbus, and HCE and 
IOBA-NHC cells were separately homogenized in ice-cold radioimmunoprecipitation 
assay (RIPA) buffer with a cocktail of proteases inhibitors (100 µl/ml 
phenylmethylsulfonyl fluoride, 6 µl/ml aprotinin, and 100 nM sodium orthovanadate). 
Cadaveric tonsil, included as control for CD44 and RHAMM, was treated similarly. 
Also, HeLa cell extract and mouse brain extract were used as controls for CD44 and 
RHAMM, respectively. The controls were selected as recommended by the 
manufacturer. After incubation on ice for 30 min, the samples were centrifuged at 
14,000 rpm for 30 min at 4º C. To isolate proteins from the membrane fraction of 
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IOBA-NHC cells, an additional step was performed. After the centrifugation, the 
supernatant was collected and centrifuged at 35,000 rpm for 1 h at 4º C. Then, the 
pellet containing the membrane fraction was resuspended in 250 µl of RIPA buffer, 
mixed with sample buffer, boiled and stored until used. The protein concentration 
was measured by BCA assay. 
Proteins in each sample were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis on 10% acrylamide gels according to the method 
of Laemmli (1970). Proteins were then transferred to nitrocellulose membranes, 
according to Towbin et al. (1979), and blocked for 1 h in TBS containing 0.05% 
Tween-20, 5% milk, and 4% FBS. Membranes were incubated with primary Abs 
(Table 1) for 2 h, then washed in TBS, and incubated with horseradish peroxidase-
conjugated secondary Abs (Table 1) at room temperature (RT) for 1 h. 
Immunoreactive bands were visualized by a chemiluminescence method using the 
ChemiDoc® gel documentation system and images were analyzed with the Quantity 
One software.Equal loading was proved by GAPDH detection.  
 
Immunofluorescence assays 
Corneal, conjunctival, limbal, and tonsil tissues from cadaveric donors were 
rinsed in 30% sucrose in PBS, placed in 30% sucrose at 4º C overnight, embedded 
in OCT compound, and frozen. Cryostat sections (7 µm) were collected in poly-L-
lysine-treated slides and kept at -80º C until used. HCE and IOBA-NHC cells were 
seeded onto eight-well multichamber PermanoxTM slides and grown until confluence 
was reached. CERS cells (n = 4) and conjunctival epithelial cells obtained by BC (n 
= 4) were fixed on slides by cytocentrifugation with a Shandon Cytospin (Southern 
Products, Cheshire, UK) at 800 rpm for 5 min. 
Tissue cryosections, HCE cells, IOBA-NHC cells, CERS samples, and BC 
samples were fixed in ice-cold methanol, washed in PBS, and blocked in PBS 
containing 4% goat or donkey serum, 0.3% Triton® X-100, and 1% bovine serum 
albumin, at RT for 1 h. The slides were then incubated with primary Abs (Table 1) at 
4º C overnight. Alexa Fluor®-conjugated secondary Abs (Table 1) were used for 1 h 
at RT. Cell nuclei were counterstained with Hoechst dye. The preparations were 
coverslipped, mounted, and viewed under an epifluorescence microscope (Leica 
DMI 6000B). Negative controls included the omission of primary Abs. The specificity 
of anti-CD44 and anti-RHAMM was previously tested by blocking them with an 
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excess of HA. Image fluorescence was quantitatively evaluated by the mean 
grayscale value determined by the microscope’s software. The background of the 
negative controls was also quantified, and this value was subtracted from that of the 
experimental samples. This allowed making a relative comparison between different 
images. 
 
Table 1: Antibody (Ab) concentrations (µg/ml) used in Western blotting and in 
immunofluorescence assays 
  Species Western blotting 
Immunofluorescence 
assays 
CD44 
1st Ab Rat 1.25 10 
2nd Ab Goat 0.15 6 
RHAMM 
1st Ab Goat 0.4 4 
2nd Ab Donkey 60 6 
 
 
sCD44 instant enzyme-linked immunosorbent assay (ELISA) 
An instant ELISA was developed to determine the levels of sCD44 in cell 
culture supernatants from HCE and IOBA-NHC cells exposed to proinflammatory 
cytokines (TGFβ, TNFα and IL13), and in tear samples from healthy donors (n = 28). 
The assay was performed according to the manufacturer’s protocol. Culture medium 
and Assay Buffer used to collect the tear samples were used as negative controls. 
 
Reverse transcription polymerase chain reaction (RT-PCR) and real-time RT-
PCR (Q-PCR)  
Total RNA from control tissues, HCE cells, IOBA-NHC cells, CERS samples 
(n = 4) and BC samples (n = 4), was isolated using the RNeasy Mini Kit. 
Contaminating DNA was eliminated by digestion with RNase-Free DNase Set. 
Total RNA concentration was measured with the QuantiT TM RNA assay. The 
extracted RNA was reverse-transcribed to cDNA with the SuperScript Vilo cDNA kit 
following the manufacturer’s protocol.  
RT-PCR was conducted on aliquots of cDNA samples using the 
Mastercycler Personal Thermocycler (Eppendorf, Hamburg, Germany). Each 
reaction contained 1 µl of gene-specific primer pairs (Table 2), 50 ng of cDNA, 5 µl 
of PCR buffer 109, 1 µl dNTPs, and 1 µl Taq polymerase in a final volume of 50 µl. 
 
CHAPTER 1                    Study 1. Hyaluronan receptors in the human ocular surface 
	   125 
Negative controls with omission of cDNA were included for all RT-PCR experiments. 
The level of GAPDH mRNA for each sample was used as an endogenous control. 
Thermocycling conditions were 95º C for 2 min, followed by 39 cycles of 95º C for 20 
s, 60º C (primer-specific annealing temperature) for 30 s, 72º C for 40 s and a final 
cycle of 72º C for 10 min. RT-PCR products and the 100 base pair (bp) ladder 
markers were mixed with 2 µl of Blue JuiceTM Gel Loading Buffer 109 and were 
resolved on 2% agarose gels. Gel images were captured with the ChemiDoc® gel 
documentation system and analyzed with the Quantity One software.  
 
Table 2: Primers for reverse transcription PCR 
Primer Primer sequence Size product 
GAPDH Sense: 5’-GAACGTGAAGGTCGGAGTCAAC-3’ Antisense: 5’-CGTGAAGATGGTGATGGGATTTC-3’ 250 bp 
CD44 Unknown: Ref. PPH00114A 106 bp 
RHAMM Unknown: Ref. PPH09857A 108 bp 
bp, base pair 
 
The Q-PCR reaction was performed with 10 ng cDNA, 1 µl primers and 10 
µl SYBR Green PCR Master Mix in a final volume of 20 µl. The PCR reaction was 
run under the following conditions: denaturation at 95º C for 10 min, followed by 40 
cycles of 95º C for 15 s and 60º C for 60 s, and a final cycle of 95º C for 90 s. All 
reactions were performed in duplicate. The levels of GAPDH for each sample were 
used as endogenous controls and a non-template control was included to detect 
DNA contamination. To assure the specificity of the PCR products, a melting curve 
analysis was performed. Relative mRNA expression levels were determined using 
the 2-ΔΔCt method (Livak and Schmittgen 2001). 
 
Statistical analysis 
Statistical analysis was done using Statistical Procedures for the Social 
Sciences software (SPSS 15.0, SPSS Inc, Chicago, IL, USA). Data were expressed 
as means ± standard error of the means. A Levene’s test was performed to assure 
the equality of variance, and after that, a one-way ANOVA was done. Then, pairwise 
comparisons (Tukey test) were performed. When there was no equality of variance, 
a robust test was performed (Brown–Forsythe test). After that, pairwise comparisons 
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were done with Games–Howell test. Differences were considered to be significant 
when p ≤ 0.05. 
 
 
RESULTS 
 
HA receptors in human ocular surface tissues  
Different isoforms of CD44 and RHAMM were detected by Western blot 
analysis in protein extracts of the cadaveric corneal, conjunctival, and limbal tissues, 
as well as tonsil, the positive control (Fig. 1a, b). In all cases, major bands of 58 kDa 
for CD44 and of 57 kDa for RHAMM were identified. Volumetric analysis of the 
immunoreactive bands showed similar levels of CD44 expression in all ocular 
tissues (Fig. 1c; Table 3). RHAMM expression was higher in the conjunctival and 
limbal extracts compared to the corneal extracts (p = 0.016 and 0.017, respectively). 
For cornea, there was no difference in the expression of CD44 and RHAMM; 
however, for conjunctiva and limbus, the RHAMM levels were significantly higher 
than the CD44 levels (p = 0.014 and 0.007, respectively, Table 3). 
 
Fig. 1 Western blot analysis of CD44 (a) and RHAMM (b) expression in human tissues. M 
molecular weight marker, 1 Cornea, 2 Conjunctiva, 3 Limbus, 4 Tonsil. c Volumetric analysis 
of immunoreactive bands (n = 3). Higher levels of RHAMM than of CD44 were detected in 
human conjunctiva and limbus. *p B 0.05; **p B 0.01 
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  Table 3: Summary of hyaluronan receptors expression levels in all samples studied 
  Protein  mRNA 
  CD44 RHAMM  CD44 RHAMM 
TISSUES 
 
Cornea + +  +++ + 
Limbus + ++  N/D N/D 
Conjunctiva 
 
+ 
 
++ 
 
 +++ 
 
+ 
 
CELL LINES 
 
HCE ++ +++  ++ ++ 
IOBA-NHC 
 
+ 
 
+++ 
 
 ++ 
 
++ 
 
PRIMARY 
SAMPLESa 
CERS samples ++ +++  +++ + 
BC samples + ++  +++ + 
Protein levels were determined by Western blotting or immunofluorescencea, and mRNA 
levels were determined by RT-PCR. CERS samples: corneal epithelial cells obtained after 
refractive surgery; BC samples: conjunctival epithelial cells obtained by brush cytology. 
Expression intensity was arbitrarily estimated as: (+) weak, if expression levels were in the 
first third of intensity range; (++) medium, if expression levels were in the second third; (+++) 
strong, if expression levels were in the upper third of intensity range. N/D: Not determined 
 
 
We studied the distribution of both HA receptors in cadaveric corneal, limbal, 
and conjunctival tissues by immunofluorescence microscopy. No fluorescent signal 
was detected in negative controls, as expected (data not shown). Primary antibodies 
against CD44 (Fig. 2a–c) and RHAMM (Fig. 2d–f), detected by the 
immunofluorescent signal, were distributed mainly in the epithelium of all of the 
ocular surface tissues. In the corneal epithelium, the staining of CD44 was 
somewhat more pronounced in the deeper layers (Fig. 2a), whereas in the limbus, it 
had stronger intensity in the suprabasal layers compared to the basal ones (Fig. 2b). 
RHAMM was not expressed in either corneal or limbal stromas (Fig. 2d, e), but it 
was detected in conjunctival stroma (Fig. 2f).  
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Fig. 2 Expression of HA receptors in cadaveric ocular surface tissues. CD44 (a–c) and 
RHAMM (d–f) expression (red) was evident in all tissues. Nuclei were counterstained with 
Hoechst dye (blue). Representative images of three independent experiments. Scale bars a–
f: 50 lm 
 
Both CD44 and RHAMM mRNAs were detected in corneal and conjunctival 
tissues by RT-PCR (Fig. 3a). For conjunctiva, the levels of CD44 mRNA, measured 
by Q-PCR, were significantly higher than that of RHAMM (p = 0.017, Fig. 3b; Table 
3). 
 
 
Fig. 3 RT-PCR analysis a of 
CD44 and RHAMM mRNA 
expression in human ocular 
surface tissues. 1 Cornea, 2 
Conjunctiva, NTC 
Nontemplate control. b 
Analysis of Q-PCR (n = 3). 
Expression of the CD44 gene 
was higher than expression of 
the RHAMM gene in human 
conjunctiva. *p ≤  0.05 	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HA receptors in corneal and conjunctival cell lines 
Major CD44 (Fig. 4a) and RHAMM (Fig. 4b) bands were detected in 
Western blots of corneal and conjunctival cell lines. Isoforms of both receptors were 
also in the membrane fraction of the IOBA-NHC cells, where the immunoreactivity 
was the strongest in the 57 kDa form of CD44. Weaker immunoreactive bands were 
also detected for RHAMM at higher (100–200 kDa) molecular masses. RHAMM 
levels were higher than CD44 levels in IOBA-NHC cells (p = 0.044), as determined 
by the volumetric analysis (Fig. 4c; Table 3). 
 
Fig. 4 Western blotting analysis of CD44 (a) and RHAMM (b) expression in human cell lines. 
M molecular weight markers, 1 HCE, 2 IOBA-NHC, 3 IOBA-NHC membrane fraction, 4 
Positive controls: HeLa cell extract for CD44 and mouse brain extract for RHAMM. c 
Volumetric analysis of immunoreactive bands (n = 3). *p B 0.05 
 
Negative controls for immunofluorescence assays did not show any signal 
(data not shown). Immunofluorescent signals for both CD44 and RHAMM were also 
detected in HCE and IOBA-NHC cells (Fig. 5). In both cell lines, CD44 was evenly 
distributed among the cells, and CD44 and RHAMM were localized to the plasma 
membrane, with less intensity also being present in the cytosol. 
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By RT-PCR, CD44 and RHAMM mRNAs were detected in HCE and IOBA-
NHC cells (Fig. 6a). According to Q-PCR results, both cell lines had higher levels of 
CD44 that those of RHAMM (p = 0.015 for HCE and p = 0.007 for IOBA-NHC). HCE 
cells had higher levels of RHAMM than IOBA-NHC (p = 0.047, Fig. 6b). Both cell 
lines had significantly higher mRNA levels of RHAMM than did any of the other 
tissues or primary samples taken by CERS or BC. 
 
Fig. 6 RT-PCR analysis (a) of 
CD44 and RHAMM gene 
expression in human ocular 
surface cell lines. 1, HCE; 2, 
IOBA-NHC; NTC, non-template 
control. (b) Analysis of Q-PCR 
(n=3), showing higher levels of 
CD44 than of RHAMM in both 
cell lines, and higher RHAMM 
levels in HCE than in IOBA-
NHC cells. *p≤0.05; **p≤0.01 	  
Fig. 5 Expression of HA 
receptors in ocular surface 
cell lines. CD44 (a-b) and 
RHAMM (c-d) were present 
(red) in HCE (a, c) and 
IOBA-NHC cell lines (b, d). 
Nuclei were counterstained 
with Hoechst dye (blue). 
Representative images of 3 
independent experiments. 
(Magnification, x40) 
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HA receptors expression in CERS, BC and tears samples 
CD44 and RHAMM were detected by immunofluorescence microscopy in 
the CERS samples and in the BC samples from healthy donors (Fig. 7). As 
expected, in negative controls no fluorescent signal was detected (data not shown). 
The CD44 signal was predominantly membrane-associated in both CERS and BC 
samples (Fig. 7a, b). RHAMM had a high intensity in the plasma membrane in 
CERS samples (Fig. 7c), whereas in BC samples it was more diffuse, with some 
expression in the plasma membrane, but also in cytosol and nucleus (Fig. 7d). 
Quantitative evaluation of the fluorescence in both CERS and BCsamples showed 
significantly higher intensity of RHAMM than CD44 (p = 0.029 and p = 0.006, 
respectively; Table 3).  
 
 
Fig. 7 CD44 (a-b) and RHAMM (c-d) immunofluorescence. In these representative images, 
both HA receptors (red) were expressed in corneal epithelial cells obtained after refractive 
surgery (CERS samples) and in the conjunctival epithelial cells obtained by brush cytology 
(BC samples). The fluorescence intensity for RHAMM receptors was higher than that for 
CD44 receptors. Representative images of 4 independent experiments (Magnification, x40)  
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Both CD44 and RHAMM mRNAs were detected in all of the CERS and BC 
samples (Fig. 8a). For each of the primary samples, the CD44 mRNA level was 
higher than that for RHAMM (p = 0.010 for CERS and p < 0.001 for BC). Both HCE 
and IOBA-NHC cells had higher levels of RHAMM than CERS and BC samples, 
respectively (p = 0.030 and p = 0.010, respectively).  
 
 
 
The sCD44 was detected in 32% of all the tear samples (29.4% in male 
samples and 36.36% in female samples) with a concentration of 1.72 ± 0.38 ng/ml, 
showing that this molecule is present in tears. No sCD44 was detected in the 
negative control.  
 
HA receptors expression in inflammatory conditions 
 The expression of both CD44 (Fig. 9a) and RHAMM (Fig. 9b) was studied 
by Q-PCR in HCE and IOBA-NHC cells exposed to cytokines to simulate 
inflammatory conditions. We found significantly higher levels of CD44 mRNA in HCE 
cells exposed to TGFβ (p < 0 0.001), TNFα (p = 0.048) or IL13 (p = 0.047). 
We also studied the secretion of sCD44 by cytokine exposed cells (Fig. 9c) 
to culture medium, and found a significant reduction when IOBA-NHC cells were 
exposed to IL13 (p < 0.001), while no significant changes were observed after TFGβ 
or TNFα exposure. No sCD44 was detected in the negative control, as expected. 
Fig. 8 RT-PCR analysis (a) of 
CD44 and RHAMM gene 
expression in corneal epithelial 
cells obtained after refractive 
surgery (CERS samples) and in 
conjunctival epithelial cells 
obtained by brush cytology (BC 
samples). 1, CERS samples; 2, 
BC samples; NTC, non-template 
control. (b) Analysis of Q-PCR 
(n=3). **p≤0.01;***p≤0.005 
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Fig. 9 Analysis of HA receptors in inflammatory conditions. Q-PCR analysis of 
CD44 (a) and RHAMM (b) gene expression in HCE and IOBA-NHC cells 
exposed to TGFβ, TNFα and IL13 (n=3). There were higher levels of CD44 in 
HCE cells exposed to the cytokines compared with the unexposed control. (c) 
sCD44 levels in cell culture supernatants of HCE and IOBA-NHC cells 
exposed to TGFβ, TNFα and IL13 (n=3). There were lower levels of sCD44 in 
IOBA-NHC cells exposed to IL13. *p≤0.05; **p≤0.01; ***p≤0.005 
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DISCUSSION 
We report the presence and cellular distribution of RHAMM in conjunctival 
epithelial cells of healthy human donors, and the presence of sCD44 in normal 
human tears. We also compared the presence of RHAMM with another HA receptor, 
CD44, in freshly collected corneal and conjunctival cells as well as with HCE and 
IOBA-NHC cell lines. 
Our previous work with nanoparticles made of HA and other biopolymers 
showed slightly higher internalization rates in HCE cells than in IOBA-NHC cells 
(Contreras-Ruiz et al. 2011). Moreover, when doing preliminary studies in the cell 
lines in our laboratory, we have noticed variations in the mRNA levels of these 
receptors, when those cell lines are stimulated with different cytokines. These data 
point out a possible relevance of these receptors in pathological conditions affecting 
the ocular surface. 
For these reasons we are interested in a complete study and 
characterization of these important molecules in the normal and healthy ocular 
surface. To determine if these cell lines are a good in vitro model for this kind of 
assay, we characterized HA receptors in ocular surface epithelia and the only 
available soluble form in tears (sCD44). We wanted to know if the expression of 
these receptors in the cell lines was similar to that of human ocular surface tissues 
and freshly collected samples. 
CD44 has been described in human corneal and conjunctival cells (Hughes 
et al. 2006; Lerner et al. 1998; Zhu et al. 1997). However, to our knowledge, a 
comparison of its expression levels between different tissues has not been reported. 
In this study we determined that CD44 expression is rather constant for the entire 
ocular surface epithelium, with no significant differences in either the protein or 
mRNA levels. Additionally, CD44 is present in the human corneal and conjunctival 
cell lines used in this work (de la Fuente et al. 2008; Hornof et al. 2008).  
Interestingly, we have been able to detect sCD44 in 9 out of 28 tear samples 
(32% of all the tear samples). The reason why sCD44 was not detected in the 
remaining 68% of tear samples may be related with the detection limit of the kit 
used; however, it is the most sensitive commercially available kit to measure sCD44. 
Another limitation that may explain the observed differences is the small amount of 
tear sample that one can collect without stimulating reflex tear production (4 µl/eye). 
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Baseline sCD44 levels have been detected in several body fluids, such as serum, 
lymph or saliva, which may support our hypothesis of baseline levels also in human 
tears, where sCD44 could have a physiological role. Also, detected tear levels are 
similar to those measured in saliva (Franzmann et al. 2005). More experiments with 
a larger study group are warranted to extract stronger conclusions. 
No reports describe the presence of RHAMM in conjunctiva and just one 
indicates its presence in corneal and limbal suprabasal cells but not basal cells 
(Ahmad et al. 2008). Our data showed that RHAMM is present throughout the 
conjunctival epithelium and confirm its presence in corneal and limbal tissues. 
However, we observed a different distribution pattern in the limbus from that 
reported by Ahmad et al. (2008). We found that RHAMM expression was present 
throughout the entire limbal epithelium, with no differences between basal and 
suprabasal layers. We also described RHAMM expression in both corneal and 
conjunctival cell lines studied.  
Moreover, RHAMM, as well as CD44, was clearly detected in CERS and BC 
samples from healthy donors. BC is a minimally invasive technique that enabled us 
to obtain small amounts of human conjunctival cells, with a minimum of discomfort 
for the donor. Even with the small amount of tissue collected, it was enough to 
accomplish the study of HA receptor mRNAs. Our results in this respect contrast 
with those of Fujihara et al. (1997), who could not detect CD44 expression in their 
BC samples and concluded that CD44 was not expressed in normal human 
conjunctival epithelial cells. However, subsequent works from different groups 
confirmed its presence (De Saint et al. 2004; Hughes et al. 2006), as substantiated 
by our results.  
Western blot assays showed different isoforms of CD44 and RHAMM in 
ocular surface tissues and cells. The results obtained in whole cell extracts and 
membrane fractions of IOBA-NHC cells indicated a relatively high expression of the 
non-membrane-associated RHAMM forms, in contrast to CD44. This is supported in 
the literature where intracellular RHAMM is described (Maxwell et al. 2008; Slevin et 
al. 2007). 
Interestingly, we found differences among the cell lines, tissues, and BC 
samples. Both HCE and the IOBA-NHC cell lines had higher RHAMM mRNA levels 
than did the tissues or the primary samples. Moreover, the lines also had higher 
protein levels of RHAMM than did the corneal or conjunctival tissues. That 
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overexpression may be related to the fact that the cell lines are immortalized, and 
RHAMM is implicated in malignant transformation and proliferation (Maxwell et al. 
2008; Pilarski et al. 1994; Sohr and Engeland 2008). Also, both cell lines had lower 
protein levels of CD44 compared to RHAMM. This can be explained by the concept 
of molecular redundancy, as suggested for these HA receptors (Nedvetzki et al. 
2004). Accordingly, in the absence of CD44, RHAMM supports some of its functions, 
which could explain the reduced levels of CD44 when RHAMM is overexpressed.  
Additionally, some of the differences found between protein and mRNA 
expression levels could be due to posttranslational modifications. CD44 and 
RHAMM are strongly glycosylated (Sherman et al. 1994; Underhill 1992), which can 
mask epitopes and consequently make protein immunodetection difficult. Post-
translational modifications can also affect protein stability. Discrepancies in RHAMM 
expression levels could be also partially attributed to differences in cell cycle phase. 
Several studies confirm that RHAMM is cell cycle-regulated and that there can be 
discrepancies between RHAMM mRNA levels and protein levels (Buganim and 
Rotter 2008; Sohr and Engeland 2008). 
RHAMM protein levels were higher in conjunctiva than in cornea. Although 
CD44 is postulated as the main HA receptor, our results suggest an unexpected role 
of RHAMM in conjunctiva because its levels are similar to or even higher than those 
of CD44. The actual physiological relevance of this HA receptor remains to be 
determined.  
Our results in the in vitro inflammation model showed some variations in the 
expression of CD44 in cells stimulated with inflammatory cytokines compared with 
the unstimulated controls. That points at a possible implication of CD44 in ocular 
surface inflammation. In contrast, we did not see differences in the expression of 
RHAMM between different conditions. The fact that RHAMM is overexpressed in 
these cell lines could explain why its mRNA levels are not increased as CD44 levels 
are. Additionally, we detected some differences in the levels of sCD44 in the cell 
culture supernatants of IOBA-NHC cells exposed to IL13. Taking these data all 
together, it seems that there could be changes in the HA receptors in the ocular 
surface when an inflammatory process is underway. 
It is important to know these receptors in normal and pathological 
conditions, because several topical formulations with HA are being used in 
ophthalmology. For this reason, our finding about the presence of sCD44 in human 
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tears is especially important, as it could be very relevant to the interaction with eye 
drops. In fact, artificial tears with HA are widely used in some inflammatory 
processes, like dry eye disease, and they could be exerting some unknown actions, 
since the interaction with HA receptors has not been studied. 
 
 
CONCLUSIONS 
In light of these results, we conclude that human ocular surface tissues 
express both CD44 and RHAMM receptors for HA. This is the first work that 
describes RHAMM presence in conjunctiva and confirms RHAMM expression in the 
cornea and limbus. We also show that sCD44 is present in human tears. 
Furthermore, this study reveals that HCE and IOBA-NHC cells express these 
receptors in a similar, but not identical, way to corneal and conjunctival tissues, 
respectively. This means that conclusions based on HA receptor assays in those cell 
lines need to be made with caution. Finally, we show that the expression of these 
receptors is somehow altered in inflammatory conditions, what could implicate that 
they could play a role in ocular surface inflammation. 
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Abstract
Background CD44 and RHAMM hyaluronan (HA) receptors
have been studied in several systemic diseases such as osteo-
arthritis and cancer. However, not too much is known about
their role in ocular surface disorders. The purpose of this
research was to determine if CD44 and RHAMM are impli-
cated in human ocular surface inflammation.
Methods Upper tarsal conjunctival epithelial samples from
patients with active ocular surface inflammation (n=17) and
healthy controls (n=14) were recovered by brush cytology.
Patients were evaluated by an ophthalmologist and classified
in different groups according to the etiology (immune atopic
diseases or immune non-atopic diseases) and inflammation
intensity (mild/moderate or severe). CD44, RHAMM, and
p53 mRNAs were measured using real-time PCR.
Results CD44, RHAMM, and p53 mRNAs were detected in
all samples. In immune atopic diseases, higher levels of CD44
and RHAMM mRNAs were present, reaching a 300 % in-
crease for RHAMM in severe inflammation (p<0.001). In
contrast, in immune non-atopic diseases, the HA receptors
were downregulated. CD44 tended to decrease up to 30 %
in severe patients (p=0.06), and RHAMM decreased 40 % in
severe inflammation (p=0.021).
Conclusions RHAMM may be implicated in severe ocular
surface inflammation affecting the upper tarsal conjunctiva.
Keywords Hyaluronan receptors .RHAMM .CD44 .Ocular
surface . Inflammation
Introduction
Ocular surface inflammation can be due to different factors
such as infection, autoimmunity, and external injuries among
others. In all of these pathological conditions, epithelial cells
and the extracellular matrix (ECM) undergo changes in pro-
tein composition and levels. ECM proteins provide not only
structural support to cells but also function as signalling
molecules for inflammatory cells [1]. In fact, the ECM be-
comes altered in different pathologies affecting the eye [2, 3].
An abundant component of the ECM is hyaluronan (HA), a
crucial glycosaminoglycan in many cellular processes, includ-
ing tissue remodelling, tumorigenesis, inflammation, and im-
mune regulation [4]. To trigger a response, HAmust bind cells
through cell-surface receptors. Two of the most studied HA
receptors are CD44 and the receptor for HA-mediated motility
(RHAMM) [5]. CD44 plays an important role in different
events occurring during the inflammatory process, such as
leukocyte recruitment, cell–matrix interactions, and HA deg-
radation [6]. RHAMMhas both intracellular functions such as
control of cell cycle, and extracellular functions such as loco-
motion [7, 8]. The main RHAMM repressor is p53, a tumour
suppressor protein implicated in apoptosis [9, 10].
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ESTUDIO 2 
 
En el estudio anterior se demostró la presencia de los receptores de ácido 
hialurónico en la superficie ocular. También se vieron variaciones en la expresión 
de uno de esos receptores (RHAMM) en la línea celular de conjuntiva tratada con 
distintas citoquinas para simular condiciones inflamatorias. Sin embargo, se observó 
también que las líneas celulares no expresaban estos receptores de la misma 
manera que las muestras recién recogidas de pacientes, por lo que esos datos 
deben ser corroborados.  
Con esos antecedentes, se decidió llevar a cabo un estudio piloto en un 
grupo reducido de pacientes con distintas enfermedades inflamatorias con 
afectación conjuntival. De esta forma, en este estudio se pretende mostrar la 
implicación de estos receptores, especialmente RHAMM, en las patologías 
inflamatorias de la superficie ocular. 
 
 
STUDY 2 
 
The previous study  established the presence of hyaluronan receptors in the 
ocular surface. Variations in the levels of RHAMM were found in the conjunctival cell 
line treated with inflammatory cytokines. However, changes in the expression of 
these receptors between cell lines and primary cells were also observed. For that 
reason, those data should be corroborated.  
To address this issue, a pilot study with a reduced number of patients with 
inflammatory diseases was accomplished. Thus, the aim of this study was to show 
the involvement of hyaluronan receptors, especially RHAMM, in inflammatory 
diseases of the ocular surface.  
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CD44 and RHAMM Hyaluronan Receptors in Human Ocular Surface 
Inflammation  
 
 
ABSTRACT  
 
Background: CD44 and RHAMM hyaluronan (HA) receptors have been studied in 
several systemic diseases such as osteoarthritis and cancer. However, not too much 
is known about their role in ocular surface disorders. The purpose of this research 
was to determine if CD44 and RHAMM are implicated in human ocular surface 
inflammation. 
Methods: Upper tarsal conjunctival epithelial samples from patients with active 
ocular surface inflammation (n = 17) and healthy controls (n = 14) were recovered 
by brush cytology. Patients were evaluated by an ophthalmologist and classified in 
different groups according to the etiology (immune atopic diseases or immune non-
atopic diseases) and inflammation intensity (mild/moderate or severe). CD44, 
RHAMM, and p53 mRNAs were measured using Real-Time PCR. 
Results: CD44, RHAMM, and p53 mRNAs were detected in all samples. In immune 
atopic diseases, higher levels of CD44 and RHAMM mRNAs were present, reaching 
a 300% increase for RHAMM in severe inflammation (p < 0.001). In contrast, in 
immune non-atopic diseases, the HA receptors were downregulated. CD44 tended 
to decrease up to 30% in severe patients (p = 0.06), and RHAMM decreased 40% in 
severe inflammation (p = 0.021).  
Conclusions: RHAMM may be implicated in severe ocular surface inflammation 
affecting the upper tarsal conjunctiva. 
 
Keywords: hyaluronan receptors, RHAMM, CD44, ocular surface, inflammation 
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INTRODUCTION 
 
Ocular surface inflammation can be due to different factors such as 
infection, autoimmunity, and external injuries among others. In all of these 
pathological conditions, epithelial cells and the extracellular matrix (ECM) undergo 
changes in protein composition and levels. ECM proteins provide not only structural 
support to cells but also function as signalling molecules for inflammatory cells [1]. In 
fact, the ECM becomes altered in different pathologies affecting the eye [2, 3]. 
An abundant component of the ECM is hyaluronan (HA), a crucial 
glycosaminoglycan in many cellular processes, including tissue remodelling, 
tumorigenesis, inflammation, and immune regulation [4]. To trigger a response, HA 
must bind cells through cell-surface receptors. Two of the most studied HA receptors 
are CD44 and the receptor for HA-mediated motility (RHAMM) [5]. CD44 plays an 
important role in different events occurring during the inflammatory process, such as 
leukocyte recruitment, cell-matrix interactions, and HA degradation [6]. RHAMM has 
both intracellular functions such as control of cell cycle, and extracellular functions 
such as locomotion [7, 8]. The main RHAMM repressor is p53, a tumour suppressor 
protein implicated in apoptosis [9, 10]. 
The presence of CD44 has been described in cornea, limbus, and 
conjunctiva [11, 12], whereas little is known about RHAMM expression in the ocular 
surface [13]. Abnormal levels of both CD44 and RHAMM receptors have been 
described in some diseases, such as leukemia [14], osteoarthritis [15], and 
retinoblastoma [16], but little has been published regarding the ocular surface. 
Recently, we have reported the expression of RHAMM in human conjunctiva (cell 
lines of normal human conjunctival epithelium, fixed tissues, and brush cytology 
samples), as well as changes in both HA receptors in human ocular cell lines when 
exposed to several inflammatory cytokines [17]. To further determine a possible 
involvement of CD44 and RHAMM in inflammation, we analysed their mRNA 
expression in human ocular surface inflammatory diseases. The purpose of this 
study was to determine if gene expression for these receptors was altered in 
pathological inflammatory states.  
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METHODS 
 
Subjects 
This study followed the tenets of the Declaration of Helsinki and had the 
approval of the Ethics Committee of the University of Valladolid, Valladolid, Spain. 
Seventeen Caucasian patients and 14 Caucasian healthy control subjects were 
recruited. Patients were recruited at the Ocular Immunology Unit of the Institute for 
Applied Ophthalmobiology (IOBA, Valladolid, Spain). An informed consent was 
signed by each donor after the procedure was fully explained.  
Inclusion criteria for the patients were 10-70 years of age, a well-established 
diagnosis of chronic ocular inflammatory disease, and a clear etiology. Exclusion 
criteria for both patients and healthy controls were pregnant or nursing women, use 
of contact lenses, any ocular disease in control subjects, any other ocular surface 
disease other than the one responsible for the current inflammatory state in patients, 
use of HA-based artificial tears, or any systemic disease such as leukemia and 
osteoarthritis known to alter levels of HA receptors. Additional exclusion criteria for 
healthy control subjects were systemic disease or medications of any kind, ocular 
topical medications of any kind (including any artificial tear use). Allergies, even 
mild, were excluded.  
The clinical phenotype, i.e., specific diagnosis and degree of inflammation, 
of the recruited patients was assessed by an ophthalmologist who specialized in 
ocular surface diseases (author MC). Patients were classified in different groups 
according to the etiology and the inflammation intensity according to Efron Grading 
Scale [18]. 
 
Sample collection and processing 
One brush cytology (BC) sample was taken from the upper tarsal 
conjunctiva of patients and healthy subjects for RNA extraction as previously 
reported by our group [19, 20]. In patients with both eyes affected, the most inflamed 
eye was the one chosen to perform the BC. Briefly, after topical application of the 
double anesthetic Colircusí® (Alcon Cusí S.A., Barcelona, Spain), the conjunctiva 
was scraped twice in the same spot with the Cytobrush Plus GT (Medscand AB, 
Malmö, Sweden). The cells were detached in an Eppendorf tube containing 700 µl 
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of RLT lysis buffer (Qiagen, Valencia, CA, USA) containing 14.5 M β-
mercaptoethanol.  
 
Real Time polymerase chain reaction (RT-PCR) 
Messenger RNA (mRNA) from BC samples was isolated using the RNeasy 
Mini Kit (Qiagen), and contaminating DNA was eliminated by digestion with RNase-
Free DNase Set (Qiagen). Total RNA concentration was measured with the Quant-
iT RNA assay (Invitrogen, Inchinnan, UK). The extracted RNA was reverse-
transcribed to cDNA with the SuperScript Vilo cDNA kit (Invitrogen) following the 
manufacturer’s protocol.  
The RT-PCR reaction was performed as previously described [17] using the 
following primers: CD44 (Ref. PPH00114A), RHAMM (Ref. PPH09857A), and p53 
(Ref. PPH00213E), all from SABiosciences-Qiagen (Frederick, MD, USA), and 
glyceraldehyde phosphate dehydrogenase (GAPDH) from Sigma (St. Louis, MO, 
USA). All reactions were performed in duplicate. The levels of GAPDH for each 
sample were used as endogenous controls, and a non-template control was 
included to detect DNA contamination. To assure the specificity of the PCR 
products, a melting curve analysis was performed. Relative mRNA expression levels 
were determined using the 2-ΔΔCt method [21]. 
 
Statistical analysis 
Statistical analysis was done using the Statistical Package for the Social 
Sciences software (SPSS 15.0, SPSS Inc., Chicago, IL, USA). Data were calculated 
as means ± standard error of the mean (SEM). To compare two groups a Student’s 
t-test was done. For more than two groups a one-way analysis of variance (ANOVA) 
was done after assuring equality of variance (Levene’s test). After that, pairwise 
comparisons (Tukey test) were performed. In the absence of variance equality, a 
robust test was performed (Welch test), and the Games-Howell test was used for 
pairwise comparisons. Differences were considered to be significant when p ≤ 0.05.  
 
RESULTS 
Clinical characteristics of patients and controls 
Thirty-one subjects were recruited for this pilot study: 17 patients with 
inflammatory diseases affecting the ocular surface (41.5 ± 4.9 years; 8 males and 9 
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females), and 14 healthy volunteers (30.1 ± 3.0 years; 6 males and 8 females). 
There was no statistically significant difference in the age between the patients and 
healthy subjects. The individual characteristics of each patient are shown in Table 1.  
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By etiological group, 8 patients had immune atopic diseases and 9 had 
immune non-atopic diseases (Table 2). 
 
 
CD44 and RHAMM gene expression 
In the RT-PCR studies, mRNA for both receptors was detected in all 
samples. There were no significant differences in mean CD44 or RHAMM mRNA 
levels when all of the patients, regardless of disease etiology or intensity, were 
collectively compared to the healthy controls; however, the variability of expression 
was much higher in the patients. No relationship was found between age of healthy 
controls and expression levels of either CD44 or RHAMM mRNA. However, men (n 
= 6) expressed 20% less CD44 mRNA than women (n = 8) (p = 0.019, Student’s t-
test, data not shown).  
When we studied the expression of CD44 and RHAMM mRNAs by etiology, 
there were no significant differences in CD44 gene expression between normal and 
inflamed eyes. However, RHAMM gene expression was significantly lower in eyes 
with immune non-atopic inflammatory disease than in healthy eyes (p = 0.026, 
Games-Howell test). There was also a tendency toward higher levels of RHAMM in 
immune atopic patients compared to healthy controls (p = 0.067).  
 
Table 2. Pathological groups under study with individual diseases 
included in each one  
Group 
(n; mean age) 
Disease n Mean age 
 
Immune atopic 
(8; 27.4 ± 6.3) 
 
AKC 
 
4 
 
39.0 ± 9.4 
VKC 4 15.7 ± 2.5 
    
Immune non-atopic 
(9; 54.0 ± 4.4) 
Rosacea 5 59.0 ± 4.6 
GVHD 2 60.5 ± 8.5 
SJS 1 39 
SS 1 59 
AKC: Atopic keratoconjunctivitis; VKC: Vernal keratoconjunctivitis; 
GVHD: Graft versus host disease;  SJS: Stevens-Johnson’s syndrome;  
SS: Sjögren’s syndrome 
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To know if the expression of HA receptor mRNAs was influenced by the severity of 
the current inflammatory flare-up, patients with mild/moderate inflammation (degrees 
1 and 2) and severe inflammation (degrees 3 and 4) within each etiology group 
(atopic diseases and immune-based diseases)  were compared, as follows.  
 
Immune atopic diseases 
For immune atopic patients with moderate inflammation, there was no 
significant difference in the expression of CD44 mRNA compared to healthy control 
subjects (Figure 1a, left). However, for immune atopic patients with severe 
inflammation, the expression of CD44 mRNA was significantly higher (p = 0.05, 
Games-Howell test). 
Bigger differences were found in the expression of RHAMM mRNA (Figure 1a, 
right). While the expression of RHAMM mRNA in patients with moderate 
inflammation was not significantly higher than in healthy controls, patients with 
severe inflammation had a 3-fold increase compared to the controls (p < 0.001, 
Tukey test). The levels in the severely affected patients were also significantly 
higher than in those with moderate inflammation (p < 0.001, Tukey test). In 
summary, an increase of HA receptor mRNAs was present in atopic diseases.  
 
Immune non-atopic diseases 
Immune non-atopic patients with severe inflammation had a tendency for 
lower levels of CD44 mRNA than healthy controls (p = 0.06, Tukey test, Figure 1b, 
left). For RHAMM, this decreased expression in severe patients was more 
pronounced (40%) and statistically significant (p = 0.021, Tukey test, Figure 1b, 
right). In summary, HA receptor mRNA levels were lower in patients with immune 
non-atopic diseases compared to healthy control subjects.  
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Figure 1. Inflammation intensity-associated hyaluronan receptor expression in immune atopic 
and immune non-atopic disease groups. a) CD44 and RHAMM were significantly 
overexpressed in atopic patients with severe inflammation. b) In immune non-atopic diseases, 
there was a tendency toward lower levels of CD44. RHAMM expression was significantly 
decreased in the severely affected group. * p ≤ 0.05; ***  p ≤ 0.005 
 
p53 gene expression 
p53 mRNA levels were measured to determine if it was overexpressed and 
possibly acting as a repressor for RHAMM. p53 mRNA was detected in all samples. 
Patients with inflammation expressed lower levels of p53 than healthy controls (p = 
0.012, Student’s t test). In immune atopic patients there were no significant 
differences in p53 gene expression compared to healthy subjects (Figure 2a). 
However, patients with immune non-atopic diseases expressed lower levels of p53 
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than healthy controls (p = 0.005, Tukey test). The levels in mild/moderate immune-
based inflammation were significantly lower than in healthy controls (p = 0.009, 
Tukey test, Figure 2b). In summary, inflamed eyes expressed lower p53 levels than 
healthy eyes, especially in immune non-atopic diseases.  
 
 
 
 
DISCUSSION 
In the present study we showed that CD44 and RHAMM HA receptor 
mRNAs are expressed in human conjunctival cells harvested by BC from healthy 
subjects and from patients with ocular surface inflammation. While BC is a minimally 
invasive technique, patients with conjunctival inflammation may suffer some pain 
from it. For this reason, it is not ethically acceptable to perform several BCs on the 
same patient. Additionally, cells recovered from different BC samples may not be 
Figure 2. Inflammation intensity-
associated p53 mRNA expression. 
a) There were no significant 
differences in the expression of p53 
in either mild/moderate or severely 
affected patients with atopic 
diseases. b) p53 expression was 
significantly decreased in 
mild/moderate patients with immune 
non-atopic diseases. ** p ≤ 0.01	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the same because the most differentiated cells are found in the external layers. 
These will be recovered only with the first brush [19]. Due to this limitation, we were 
limited to performing only a single type of analysis, the RT-PCR for HA receptor 
gene expression. The amount of recovered cells was not enough to study protein 
expression by Western blotting, and it is difficult to quantify differences in expression 
by immunofluorescence microscopy. Therefore, we studied only mRNA expression, 
due to the great accuracy of the RT-PCR technique.  
The expression levels of RHAMM receptor mRNA varied more among the 
different groups than did those of CD44. In general, RHAMM receptor mRNA 
expression levels were higher in immune atopic patients than in healthy control 
subjects or in those with immune non-atopic diseases. Further, the expression was 
higher in the more severe cases. This may implicate RHAMM in inflammatory 
conditions affecting the upper tarsal conjunctiva.  
Our results showed that CD44 and RHAMM mRNA levels did not vary 
among different ages, but higher levels of CD44 were measured in healthy women 
than in men. This difference could be due to hormonal factors. Dave et al. [22] 
showed an increase in CD44 levels in rats with higher levels of progesterone 
receptor-A, which indicates a relationship between progesterone and CD44. Durst et 
al. [23] reported that estradiol increased CD44 expression in human cell lines. Both 
progesterone and estradiol levels are higher in females than in males, which 
supports our results.  
The classification of patients according to their etiology revealed some 
striking differences in the expression of RHAMM mRNA versus healthy controls. For 
instance, there was a 200% increase in immune atopic patients and a 25% 
decrease in immune non-atopic diseases. This suggests an involvement of RHAMM 
in ocular surface inflammation.  
However, the most relevant results are those obtained when we grouped our 
samples according to not only the etiology but also the intensity of the inflammation. 
Both severe groups showed significantly different levels of RHAMM when compared 
to healthy subjects. It is noteworthy that the variations were completely different 
depending on the etiology group, ranging from a 300% increase in severe atopic 
patients to a 40% decrease in immune-non atopic states.  
We now propose a hypothetical molecular model to explain these results 
(Figure 3). Some inflammatory cytokines that are overexpressed in atopic 
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inflammation promote HA production in a variety of cell types [24]. Interestingly, we 
have reported a significant increase in CD44 mRNA expression in corneal epithelial 
cells exposed to some of these cytokines [17]. HA has a higher affinity for CD44 
than for RHAMM [25]. For that reason one can assume that most of the HA present 
in the ECM is bound to CD44 under normal conditions. However, when there is an 
increase in HA level, it probably binds RHAMM as well. The HA/RHAMM complex 
triggers a signal transduction cascade that leads to increased RHAMM mRNA 
production and protein overexpression, which then moves to cell surface [26]. The 
result is higher levels of RHAMM that will bind the abnormally high levels of HA. 
However, the high levels of HA/RHAMM complex may also increase CD44 levels 
[27]. Then, CD44 will preferentially bind HA, inducing phagocytosis to eliminate HA 
and intracellular signals to stop ECM overproduction [28]. Inflammation due to this 
signalling cascade would end when both receptors reached equilibrium.  
 
Figure 3. Hypothetical model. Proposed mechanism of RHAMM 
upregulation in immune atopic inflammation and downregulation in immune 
non-atopic inflammation. 
 
In contrast to patients with atopic inflammatory disease, we found a 
decrease of CD44 and RHAMM mRNA levels in immune non-atopic disease 
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patients with severe inflammation. In several diseases included in this group, e.g., 
rosacea and Sjögren syndrome, ECM degradation and remodelling has been 
reported as a cause or as a consequence of the pathology [29, 30]. A degraded 
ECM could mean lower HA levels than in normal conditions, and this in turn could 
lead to a downregulation of HA receptors (Figure 3). 
The main RHAMM repressor is p53 [9]. This protein controls cell cycle, and 
it is implicated in apoptosis. The reported higher levels of apoptosis in several ocular 
surface diseases [20] could be due to higher levels of p53. This correlates with the 
lower RHAMM mRNA levels, which could be due to p53-mediated downregulation 
(Figure 3). Our proposed explanation of HA receptor regulation in ocular 
inflammatory diseases deserves further study.  
Currently, artificial tears containing HA are being used in patients with ocular 
surface inflammation, particularly in patients with moderate-to-severe dry eye 
disease. However, the interaction of the instilled HA with the HA receptors present in 
the ocular surface are not known. Our findings show that there is a need for 
determining if these compounds are beneficial, harmful, or neither. 
In summary, by sampling the upper tarsal conjunctiva, we have shown that 
RHAMM mRNA expression levels vary with inflammatory conditions affecting the 
ocular surface. These variations are dependent on the etiology and severity of the 
inflammation, which suggests that the underlying mechanisms implicated in each 
group are completely different. We have detected the highest variations in RHAMM 
mRNA when the inflammation was severe, but similar changes, although lower in 
intensity, were present in mild/moderate cases. This study provides an overview of 
HA receptor expression in different inflammatory diseases affecting the human 
ocular surface and suggests that RHAMM may be implicated in upper tarsal 
conjunctiva severe inflammation. Since there was no information about the 
expression of RHAMM in any ocular surface disease, we considered necessary to 
first accomplish a pilot study like this one. The main limitation of this research is the 
small sample size. However, even with a low number of patients, several statistically 
significant differences have been found. Now, we consider that our results should 
stimulate and guide further research. The potential usefulness of RHAMM as a 
biomarker of and/or therapeutic target for ocular surface inflammation is worth 
exploring.  
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REVIEW
Conjunctival Goblet Cell Function: Effect of Contact Lens Wear
and Cytokines
Laura García-Posadas, M.Sc., Laura Contreras-Ruiz, Ph.D., Laura Soriano-Romaní, M.Sc.,
Darlene A. Dartt, Ph.D., and Yolanda Diebold, Ph.D.
Abstract: This review focuses on conjunctival goblet cells and their
essential function in the maintenance of eye health. The main function of
goblet cells is to produce and secrete mucins that lubricate the ocular
surface. An excess or a defect in those mucins leads to several alterations
that makes goblet cells central players in maintaining the proper mucin
balance and ensuring the correct function of ocular surface tissues. A typical
pathology that occurs with mucous deﬁciency is dry eye disease, whereas
the classical example of mucous hyperproduction is allergic conjunctivitis.
In this review, we analyze how goblet cell number and function can be
altered in these diseases and in contact lens (CL) wearers. We found that
most published studies focused exclusively on the goblet cell number.
However, recent advances have demonstrated that, along with mucin
secretion, goblet cells are also able to secrete cytokines and respond to
them. We describe the effect of different cytokines on goblet cell
proliferation and secretion. We conclude that it is important to further
explore the effect of CL wear and cytokines on conjunctival goblet cell
function.
Key Words: Goblet cell—Contact lens—Cytokines—Dry eye—Giant
papillary conjunctivitis.
(Eye & Contact Lens 2015;0: 1–8)
G oblet cells are highly specialized epithelial cells present inmucosal tissues along the body. The main function of these
cells is to produce and secrete mucins, which hydrate and lubricate
mucosal surfaces.1 Under nonpathologic conditions in the eye,
goblet cells are conﬁned to the conjunctival epithelium.
Along with the corneal epithelium and the tear ﬁlm, the
conjunctival epithelium is part of the ocular surface.2 Both corneal
and conjunctival epithelial cells produce different mucins, but the
main mucin-secreting cells are conjunctival goblet cells.
Mucins are highly glycosylated glycoproteins, consisting of
a protein core and multiple side chains.3 In the human, up to 20
mucin genes have been identiﬁed. Mucins are classiﬁed into two
different types: membrane-spanning mucins and secretory mucins.4
One of the most studied mucins is MUC5AC, a large gel-forming
secretory mucin found in the conjunctiva. MUC5AC or a similar
mucin MUC5B is located in airway mucosa and the gastrointestinal
tract.5 Conjunctival goblet cells are the only cells secreting
MUC5AC onto the ocular surface, and therefore, MUC5AC is
one of the best markers for goblet cell identiﬁcation.
In this review, we analyzed what techniques have been
developed to identify goblet cells and analyze their changes in
different conditions. We focused on dry eye and allergic conjunc-
tivitis because of the high prevalence of these diseases. In addition,
we reviewed the literature studying goblet cell variations in contact
lens (CL) wearers, with special attention to patients with giant
papillary conjunctivitis (GPC). Unfortunately, conjunctival goblet
cells have not been studied as much as goblet cells in other
mucosal tissues. Therefore, we summarized the effect that several
cytokines have on either conjunctival or nonconjunctival goblet
cells. Cytokines are immunomodulatory agents that are altered in
immune diseases. Altered levels of these molecules in ocular
diseases and in CL wearers have been broadly studied. Hence, we
aimed at drawing a global picture of the main effects exerted by
cytokines in goblet cells. Bearing all these in mind, and knowing
which cytokines are altered in which conditions, we hope this
review will guide further research.
IDENTIFICATION OF GOBLET CELLS
Because of the impact of goblet cell alteration on ocular surface
diseases, several techniques to identify these cells have been
developed. Goblet cells are usually identiﬁed in biopsies or
cytologies (mainly, conjunctival impression cytology6) using a clas-
sical chemical staining that interacts with mucopolysaccharides,
namely periodic acid–Schiff (PAS) staining (Fig. 1a). With this
method, ﬁlled goblet cells are identiﬁed, but since the staining is
based on the reaction with their mucous content, it is not possible
to detect the cells that have already released their products.
Goblet cells release their products in an apocrine manner. When
they receive the appropriate stimuli, they secrete all the contents of
their secretory granules at once. As a consequence, cells that have
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ESTUDIO 3 
 
Las células caliciformes conjuntivales son esenciales para mantener una 
superficie ocular sana. Se sabe que el número de células caliciformes se encuentra 
aumentado o disminuido en algunas enfermedades, lo que implica cambios en la 
secreción de mucinas que afectan significativamente a la salud de la superficie 
ocular. Sin embargo, no hay muchos estudios que vayan más allá del cambio en las 
densidades de células caliciformes y que analicen en profundidad su interacción 
con estímulos inflamatorios.  
En este estudio se lleva a cabo una revisión bibliográfica de los últimos 30 
años sobre el efecto que tienen sobre las células caliciformes el uso de lentes de 
contacto, así como la presencia de distintas citoquinas. 
 
 
STUDY 3 
 
Conjunctival goblet cells are essential to maintain a healthy ocular surface. 
Goblet cell numbers are increased or decreased in several pathologies, what leads 
to changes in mucin secretion that alter ocular surface health. However, most 
studies are just focused on the number of goblet cells, but they do not analyze in 
detail their interaction with inflammatory stimuli.  
In this study we have reviewed published literature in the last 30 years to write 
a revision about the effects of contact lens wear and inflammatory cytokines on 
conjunctival goblet cell function.  
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Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines 
 
ABSTRACT 
 
This review focuses on conjunctival goblet cells and their essential function 
in the maintenance of eye health. The main function of goblet cells is to produce and 
secrete mucins that lubricate the ocular surface. An excess or a defect in those 
mucins leads to several alterations that makes goblet cells central players in 
maintaining the proper mucin balance and ensuring the correct function of ocular 
surface tissues. A typical pathology that occurs with mucous deficiency is dry eye 
disease, whereas the classical example of mucous hyperproduction is allergic 
conjunctivitis. In this review we analyze how goblet cell number and function can be 
altered in these diseases and in contact lens wearers. We found that most published 
studies focused exclusively on goblet cell number. However, recent advances have 
demonstrated that, along with mucin secretion, goblet cells are also able to secrete 
cytokines and respond to them. We describe the effect of different cytokines on 
goblet cell proliferation and secretion. We conclude that it is important to further 
explore the effect of contact lens wear and cytokines on conjunctival goblet cell 
function. 
 
Keywords 
goblet cell; contact lens; cytokines; dry eye; giant papillary conjunctivitis 
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INTRODUCTION 
Goblet cells are highly specialized epithelial cells, present in mucosal 
tissues along the body. The main function of these cells is to produce and secrete 
mucins, which hydrate and lubricate mucosal surfaces.1 Under non-pathologic 
conditions in the eye, goblet cells are confined to the conjunctival epithelium. 
Along with the corneal epithelium and the tear film, the conjunctival 
epithelium is part of the ocular surface.2 Both corneal and conjunctival epithelial cells 
produce different mucins, but the main mucin-secreting cells are conjunctival goblet 
cells.  
Mucins are highly glycosylated glycoproteins, consisting on a protein core 
and multiple side chains.3 In the human, up to 20 mucin genes have been identified. 
Mucins are classified into two different types: membrane-spanning mucins and 
secretory mucins.4 One of the most studied mucins is MUC5AC, a large gel-forming 
secretory mucin found in conjunctiva. MUC5AC or a similar mucin MUC5B are 
located in airway mucosa and the gastrointestinal tract.5 Conjunctival goblet cells 
are the only cells secreting MUC5AC onto the ocular surface, and for that reason, 
MUC5AC is one of the best markers for goblet cell identification. 
In this review we analyzed what techniques have been developed to identify 
goblet cells and analyze their changes in different conditions. We focused on dry 
eye and allergic conjunctivitis due to the high prevalence of these diseases. In 
addition, we reviewed literature studying goblet cell variations in contact lens 
wearers, with special attention to patients suffering giant papillary conjunctivitis 
(GPC). Unfortunately, conjunctival goblet cells have not been studied as much as 
goblet cells in other mucosal tissues. For that reason, we summarized the effect that 
several cytokines have on either conjunctival or nonconjunctival goblet cells. 
Cytokines are immunomodulatory agents that are altered in immune diseases. 
Altered levels of these molecules in ocular diseases and in contact lens wearers 
have been broadly studied. For that reason, we aimed at drawing a global picture of 
the main effects exerted by cytokines in goblet cells. Bearing all this in mind, and 
knowing which cytokines are altered in which conditions, we hope this review will 
guide further research. 
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IDENTIFICATION OF GOBLET CELLS 
Because of the impact of goblet cell alteration in ocular surface diseases, 
several techniques to identify these cells have been developed. Goblet cells are 
usually identified in biopsies or cytologies (mainly, conjunctival impression cytology6) 
using a classical chemical staining that interacts with mucopolysaccharides, namely 
periodic acid-Schiff (PAS) staining (Figure 1a). With this method, filled goblet cells 
are identified, but since the staining is based in the reaction with their mucous 
content, it is not possible to detect those cells that have already released their 
products. 
Goblet cells release their products in an apocrine manner. When they 
receive the appropriate stimuli, they secrete all the contents of their secretory 
granules at once. As a consequence, those cells that have secreted their mucins are 
completely empty and, remain invisible to the PAS staining. The same problem 
remains if MUC5AC or lectins such as UEA-1 or HPA are used to identify goblet 
cells. In 1997, Krenzer and Freddo described that cytokeratin (CK) 7 stained the cell 
body of goblet cells,7 allowing the identification of all goblet cells, regardless whether 
they had already secreted their contents or not. Thus, it is possible to identify the 
total number of goblet cells, filled and empty, using co-immunolocalization with CK7 
and HPA or MUC5AC8 (Figure 1b). 
Another technique to identify goblet cells is in vivo laser scanning confocal 
microscopy.9 This technique allows evaluation of tissue structure by in vivo 
identification of goblet cells10 (Figure 1c). The main advantage compared to 
conjunctival impression cytology, is that confocal microscopy is not invasive at all, 
whereas cytology is a minimally invasive method. Furthermore, cytologies or 
biopsies need histological processing that can introduce artifacts, what can 
invalidate the study or diagnosis; whereas in vivo confocal microscopy does not. 
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IN VITRO MODELS TO STUDY CONJUNCTIVAL GOBLET CELL FUNCTION 
A generally accepted theory some decades ago was that the only function of 
goblet cells was to secrete mucins and that those mucins acted only in lubricating 
the ocular surface. Recent studies have demonstrated that goblet cells have more 
functions, and that they also produce more substances apart from mucins. Cytokine 
secretion has been described and an immunomodulatory function of conjunctival 
goblet cells has been identified based on their ability to modulate dendritic cell 
phenotype.11 Moreover, it has recently been proven that intestinal goblet cells play a 
role in presenting food antigens to dendritic cells12 which opens a new field of 
Figure 1. Goblet cell 
identification by several 
techniques. (a) PAS staining 
in a human conjunctiva. (b) 
Goblet cells identified by 
cytokeratin 7 (red) 
immunostaining and HPA 
lectin binding (green). (c) In 
vivo laser scanning confocal 
microscopy image showing 
possible goblet cells, 
identified by its rounded 
shape and brightness (black 
arrows). 	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potential treatments against inflammatory bowel disease or celiac disease. Thus, we 
now know that goblet cells are much more than just mucin-secretory cells and that 
their mucins have more important functions than simply lubrication.  
In fact, the ocular surface depends in part on the levels of mucins present in 
the tear film to keep its integrity, and in turn, this surface depends largely on goblet 
cell number and their rate of production and secretion of mucins. These mucins 
protect the ocular surface against desiccation, but also against pathogen access. 
Thus, conjunctival goblet cells are one of the first lines of defense of the ocular 
surface and the entire eye.13 
Recent discoveries of unexpected functions of goblet cells makes it 
imperative to study further the physiology of these cells in both health and disease. 
However, goblet cells are slow-cycling cells, so it is difficult to culture and expand 
them in vitro. For that reason, few in vitro studies were performed until 10 years ago. 
In 2001, Shatos et al. published a method to culture primary goblet cells from rat 
conjunctiva.14 Later, in 2003, this technique was developed for human cells.15 Since 
then, the number of reported in vitro studies using goblet cell cultures has 
experienced a significant increase.  
The lack of human tissue sometimes makes it difficult to advance the study 
of goblet cell pathophysiology. However, parallel studies using both rat and human 
cultured goblet cells have demonstrated that rat cells are a good model for the 
human ones.16,17 The main difference between rat and human goblet cells is 
distribution within the conjunctiva. Human goblet cells usually occur as single cells, 
mainly in the external layers of the epithelium, whereas rat cells are often associated 
in clusters. Regarding signaling pathways and celular functions, results in the 
species are similar. 
 
 
ROLE OF GOBLET CELLS IN OCULAR SURFACE DISEASE 
As previously mentioned, goblet cells are altered in several diseases (Figure 
2). While their specific role in pathologies affecting the gastrointestinal tract or the 
airway mucosa has been widely studied, the study of their function in ocular surface 
diseases is at an earlier stage. 
Ocular surface diseases are often associated with inflammation.18,19 Several 
cell types are involved in the inflammatory reaction. An important cellular participant 
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is the T helper (Th) cell. Depending on the pattern of signals these cells receive, 
different types of Th cells develop, the most studied being Th1, Th2, Th17, and 
regulatory cells (Treg).20,21 Each Th cell subtype produces a specific profile of 
molecules that modulate the immune response. Cytokines are one of these 
immunomodulatory molecules, and are also classified as Th1, Th2, or Th17 
cytokines, among others. The predominant Th response pattern varies between 
diseases.  
From the wide range of pathologies affecting the ocular surface, the role of 
goblet cells has been most extensively studied in two main conditions dry eye and 
ocular allergy. These two diseases have been classically associated with different 
Th responses. Dry eye is a predominantly Th1-mediated disease22 and allergic 
diseases are typically Th2 inflammatory responses.23 
 
 
Figure 2. Conjunctival impression 
cytologies (CIC) obtained from different 
patients and stained with PAS. (a) CIC from 
a patient with no alterations in the 
conjunctiva. Goblet cells can be identified 
by the PAS staining and are distributed 
along all the cytology. (b) CIC from a 
patient with dry eye disease. No goblet 
cells were found in the CIC. (c) CIC from a 
patient with allergic conjunctivitis showing 
goblet cell hyperplasia. 	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Dry Eye Disease 
Dry eye affects millions of people worldwide.24,25 In this inflammatory 
disease the lacrimal functional unit is altered.26 Increased levels of several 
cytokines, such as IFN-γ, TNF-α, or IL-6, along with goblet cell loss have been 
reported in this disease (Figure 2b). In fact, the lack of goblet cells has been the 
topic of numerous studies on dry eye.27–31 
 
Ocular Allergic Diseases 
Allergic diseases of the cornea and conjunctiva are typically associated with 
mucus hypersecretion. Higher goblet cell densities and/or hyperplasia are usually 
found in this type of disease (Figure 2c). Allergy has been classically associated with 
the presence of Th2 cytokines. They are not the only type of cytokines involved in 
these diseases, but Th2 cytokines, such as IL-4 or IL-13, are especially important in 
allergy. There are four types of allergic diseases affecting the eye, namely allergic 
conjunctivitis (seasonal or perennial), vernal keratoconjunctivitis (VKC), atopic 
keratoconjunctivitis (AKC), and giant papillary conjunctivitis (GPC).32 The inclusion 
of GPC in this group of allergic diseases is controversial because the 
pathophysiological features are quite different from the other diseases. For that 
reason, and because of its special relation with contact lenses, we will comment 
separately on this disease. 
 
Giant Papillary Conjunctivitis 
GPC is an adverse ocular reaction to contact lenses, and can occur with 
both soft and rigid contact lenses.33,34 Although it is predominantly associated with 
contact lenses, additional etiologies such as sutures, corneal foreign bodies, or 
prostheses have been reported.33,34 Common symptoms usually reported by GPC 
patients are decrease comfortable CL wearing time, excessive lens movement, 
foreign body sensation, and blurred vision.  
The inclusion of GPC in the group of ocular surface allergy is controversial 
because this disease is a non-IgE mediated hypersensivity.35 The incorrect inclusion 
of GPC as an allergic disease was also pointed out by the mechanical theory that 
suggested an irritative and mechanical etiology for GPC, rather than an allergic 
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etiology.36,37 This hypothesis is also supported by reported cases due to sutures or 
foreign bodies. For these reasons, GPC is now included in the group of non-allergic 
hypersensivity disorders.38 However, for many years, GPC was considered an 
allergic disease. This mistake was probably due to the clinical symptoms that are 
similar to those observed in allergic diseases: itching, tearing, mucous 
hyperproduction, and an increase of symptoms during spring pollen season.39 In 
addition, higher levels of IL-4 and IL-13 have also been found in this pathology. GPC 
is characterized by papillae on the upper tarsal conjunctiva. There is also a 
significantly greater number of inflammatory cells in the conjunctiva of these 
patients, especially in the epithelium.34 
In summary, GPC is an ocular surface disease, presumably induced by 
contact lens wear, with mucous hyperproduction as one of its main symptoms. As 
we previously explained, the main mucous-producers cells in the ocular surface are 
goblet cells, so GPC links contact lens with goblet cell function. 
 
 
CONTACT LENS WEAR AND GOBLET CELL FUNCTION 
The influence that contact lenses have on the ocular surface mucous 
system started to be explored in the 1980s. The Allansmith group published several 
studies regarding non-goblet epithelial cells in human conjunctiva, and concluded 
that there were more secretory vesicles in non-goblet epithelial cells in contact lens 
users.40–42 
An extensive review about contact lens wear and goblet cells was published 
in 2011 by Doughty.43 In that review, the author highlighted the contradictory results 
found in the literature regarding the effect of contact lens wear on conjunctival goblet 
cells. The majority of authors found a large decrease in goblet cell numbers in 
contact lens users,44,45 several others described the opposite,46,47 and two studies 
found no differences in goblet cell density.48,49 As Doughty explains in his review, the 
reason for this variability could be inconsistency in the methodologies used. 
More recently, the Tear Film and Ocular Surface society (TFOS) 
International Workshop on Contact Lens Discomfort also summarized the changes 
found in goblet cell density induced by contact lens wear.50 As well as Doughty, they 
also remarked on the variations in the methodology as the potential cause for the 
diversity of results. Another possibility for the diverse results is that the number of 
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goblet cells per unit area varies with location on the conjunctiva.51,52 If goblet cells 
are not sampled from the same area in each study participant, the results of a study 
are not valid. In addition, since the contact lens interacts differently with each area of 
the conjunctiva, if studies use different areas of the conjunctiva they could obtain 
diverse results. In fact, the TFOS study concluded that the location at which the 
cytology sample is obtained is likely the main reason of the variations in study 
results. 
However, all the studies described in the previous paragraph focused on the 
effect of contact lens wear on goblet cell density, but not on other possible 
influences on goblet cell function. Surprisingly, the authors have not yet explained 
the reason for changes in goblet cell density. Interestingly, several recent studies 
have shown the effect of a variety of cytokines on goblet cells, and changes in 
cytokine levels (mainly increased or decreased) have been reported in contact lens 
wearers.53–57 Research investigating the effect of contact lens wear on goblet cell 
function is critically needed. 
 
 
CYTOKINES AND CONJUNCTIVAL GOBLET CELL FUNCTION 
Cytokines are immunomodulatory agents that are secreted by different types 
of cells. Every cell, except the red blood cell, can produce and respond to 
cytokines.58 In addition there is a wide range of cytokines, with different biochemical 
characteristics and biologic functions. However, all of them play an important role in 
cell signaling. As regulators of the immune response cytokines can exert pro-
inflammatory actions, anti-inflammatory actions, or both. These compounds can be 
classified into different subtypes, depending on the type of T helper (Th) cell that 
produces them.20 The main subtypes are: Th1, Th2, and Th17.59 
 
Th1-derived cytokines 
Interferon gamma (IFN-γ ) 
IFN-γ is a key cytokine coordinating immune defense.60 It is probably the 
most studied cytokine in relation to conjunctival goblet cell function. The main 
reason for this focus is the clear implication of IFN-γ in dry eye disease, as well as 
the extensive interest in understanding this quality of life-threatening condition. 
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Increased levels of IFN-γ in tears of dry eye patients have been reported by several 
authors.61,62 
IFN-γ binds to its receptor IFN-γ-R to trigger a cell signaling cascade.60,63 
The presence of IFN-γRs in goblet cells has been confirmed in C57/BL6 mice,64,65 
and we have recently described it in cultured rat and human goblet cells (manuscript 
under review). The main signaling pathway used by IFN-γ is the JAK-STAT 
cascade. However, some other alternative pathways have been described.66 
IFN-γ has an apoptotic effect on goblet cells.30,64,65 This would explain the 
loss of goblet cells typically found in dry eye patients. In addition to finding a 
decrease in goblet cell proliferation by IFN-γ, we have also demonstrated that the 
secretion of the remaining cells is also altered in the presence of IFN-γ when rat 
cells were investigated. We showed that this cytokine by itself induced an increase 
in [Ca2+]i, which relates to high molecular weight glycoconjugate secretion. In 
addition to increasing [Ca2+]i, IFN-γ blocked the effect of a cholinergic agonist on 
inducing goblet cell secretion in rat goblet cells.67 Similar results were obtained in 
cultured mouse goblet cells.65 
 
Tumor Necrosis Factor alpha (TNF-α) 
TNF-α is another Th1 cytokine that is also involved in dry eye disease. This 
cytokine is upregulated in conjunctival epithelial cells of patients with Sjögren’s 
syndrome-associated aqueous-deficient dry eye, but not in those with non-Sjögren’s 
syndrome.68 Due to its central role in the inflammatory state of dry eye disease, 
TNF-α blockers have been proposed as a treatment for dry eye disease.69 
The effect of TNF-α on conjunctival goblet cells has not been extensively 
explored, but it has been shown that TNF-α inhibits MUC5AC secretion induced by 
cholinergic agonists and increases goblet cell apoptosis.65 These effects are similar 
to the ones exert by IFN-γ. 
 
Th2-derived cytokines 
Th2 cells are characterized by the production of IL-4, IL-5, and IL-13.70 
These cytokines have a critical role in allergic diseases affecting the mucosa, such 
as asthma or allergic conjunctivitis. 
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Interleukin 4 
The presence of IL-4 is essential for a naïve Th cell to become a Th2 cell. 
IL-4 is necessary for Th2 lymphocyte differentiation and it is later secreted by these 
Th2 cells.71 This pleiotropic cytokine binds to IL-4 receptors to activate signal 
transduction, mainly through Jak1 and Jak2 kinases. We have demonstrated the 
presence of IL-4 receptor in cultured human goblet cells.72 
The effect of IL-4 on goblet cells has been studied in the airway epithelium.73 
These authors showed that IL-4 induced the differentiation of epithelial cells into 
mucous-producing goblet cells, and that after IL-4 exposure there was an increase 
in glycoconjugate secretion. These experiments were performed in vitro with a 
human pulmonary mucoepidermoid cell line and in vivo with BALB/c mice. We 
showed results consistent with those of Dabbagh K. et al in rat cultured conjunctival 
goblet cells.67 We found that IL-4 increased conjunctival goblet cell proliferation by 
1.94 fold over basal. In addition, intracellular [Ca2+] was also increased by IL-4 
exposure. Intracellular [Ca2+] measurement after different stimuli is especially 
relevant in goblet cells, since it is directly related with mucin secretion.74,75 
  
Interleukin 13 
Interleukin 13 is, along with IFN-γ, the most extensively studied cytokine in 
relation to conjunctival goblet cells. IL-13 is a small glycoprotein with a broad 
spectrum of actions, such as promotion of eosinophil migration, upregulation of 
adhesion molecules, and goblet cell differentiation and mucous hypersecretion. IL-
13 induces mucin synthesis and hyperplasia in airway goblet cells.76 The role of this 
cytokine in asthma is well known, where it is a critical mediator in the pathology of 
this disease.77 In fact, a vaccine that neutralized endogenous IL-13 has been 
proposed as a therapy to attenuate allergic inflammation in asthma.78 
In the eye, it has been demonstrated that IL-13 promotes conjunctival goblet 
cell differentiation and proliferation.65,79 These authors confirmed the expression of 
IL-13 receptor in mouse goblet cells, and we have done the same in human cultured 
goblet cells.72 
  
Interleukin 5 
Interleukin 5 is an important cytokine in allergic processes. Its main role is to 
enhance eosinophilic accumulation and activation during allergen-induced 
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inflammation.80 Although it has been extensively studied in allergy, where it is found 
elevated, the interaction of IL-5 with goblet cells is not clear. Lee et al. stated that IL-
5 expression in the lung epithelium of mice leads to several pulmonary changes, 
including goblet cell hyperplasia.81 However, it is unclear if this hyperplasia is 
produced directly by IL-5, or if it is eosinophils-mediated.82,83 
  
Th17-derived cytokines 
The Th17 cell subtype was described in 2005.59,84–86 These cells act as 
regulators of the immune response and produce IL-17, IL-6, IL-21, or IL-22, among 
other cytokines.87 
 
Interleukin 17 
The prototypic member of the IL-17 family is IL-17A, a cytokine with high 
homology among mouse, rat, and human.88 It has been associated with ocular 
inflammatory diseases, such as uveitis, scleritis, and dry eye syndrome.89 IL-17 
along with IL-6 is able to increase MUC5AC levels in primary human 
tracheobronquial epithelial cells.90 Regarding the conjunctiva, Contreras-Ruiz et al. 
Have recently shown an increase in proliferation of cultured goblet cells when cells 
were exposed to IL-17A.65 
 
Interleukin 6 
Interleukin 6 is another well studied Th17-type cytokine. IL-6 acts as an 
activator of the immune system, and is elevated in most inflammatory states.91 This 
cytokine is secreted mainly by monocytes/macrophages and epithelial cells, 
including conjunctival epithelial cells.92,93 Several authors have determined levels of 
IL-6 in tears.57,94,95 Boehm et al. described a 2.1 fold increase of IL-6 levels in dry 
eye patients compared to healthy controls. Others have studied expression levels of 
this cytokine on conjunctival epitelial cells.92,96 However, in most of these studies, 
goblet cells have not been analyzed. 
  
Other cytokines 
Recently, interest in the study of IL-22 and IL-33 in mucosal pathologies has 
increased.97–99 Turner et al. suggested a key role for IL-22 in intestinal goblet cells, 
showing IL-22-induced mucin secretion and goblet cell activation.99 Luzina et al. 
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reported that full-length IL-33 isoforms induced goblet cell hyperplasia in lungs97 and 
Tanabe et al. showed that IL-33 acts directly on goblet cells stimulating IL-8 
secretion, what may maintain mucus hypersecretion in asthma patients.98 However, 
the effect of these cytokines on conjunctival goblet cells is still unexplored. The 
similarity previously found in goblet cells among different mucosa suggests that IL-
33 would probably play an important role in the ocular surface that still needs to be 
discovered. 
 
 
Figure 3. Schematic illustrating the effect of cytokines on goblet cells in dry eye disease and 
ocular allergy. 
 
 
SUMMARY 
Goblet cells have been studied in several diseases due to their mucin-
secreting capacity. It is known that the number of these cells is lower in dry eye 
diseases, and that higher goblet cell densities are found in allergic diseases (Figure 
3). The cytokine balances in these two diseases is also opposite. While a Th1 profile 
predominates in dry eye disease with special involvement of the Th1-cytokine IFN-γ, 
a Th2 profile predominates in allergic diseases that are associated with mucous 
hyperproduction. Recent findings on the effect of cytokines on goblet cells have 
shown that Th1 cytokines have pro-apoptotic effects on goblet cells, whereas Th2 
cytokines promote goblet cell proliferation. A summary of the effect that cytokines 
have on conjunctival goblet cells is shown in Table 1. 
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Interestingly, several authors have studied goblet cell density in contact lens 
wearers. Most of studies have found a decrease in goblet cell number in these 
patients. However, the biological processes that lead to this decrease are not fully 
understood. 
 
TABLE 1. Summary of cytokines effect on conjunctival goblet cells 
Cytokine Effect Specie Authors 
IFN-γ ↑ apoptosis Mouse Zhang et al. (2011, 2014)
30, 64,; 
Contreras-Ruiz et al. (2013)65 
 ↓ proliferation Rat García-Posadas et al. (ARVO 2013)67 
 ↑ secretion Rat García-Posadas et al. (ARVO 2013) 67 
TNF-α ↑ apoptosis Mouse Contreras-Ruiz et al. (2013) 65 
IL-4 ↑ proliferation Rat; Human 
García-Posadas et al. (ARVO 2013, 
2014)67, 72 
 ↑ secretion Rat; Human 
García-Posadas et al. (ARVO 2013, 
2014) 67, 72 
IL-13 ↑ proliferation Mouse De Paiva et al. (2011)
79; Contreras-
Ruiz et al. (2013) 65 
 ↑GC differentiation Mouse De Paiva et al. (2011) 79 
IL-17 ↑ proliferation Mouse Contreras-Ruiz et al. (2013) 65 
IL-6 ↑ proliferation Mouse Contreras-Ruiz et al. (2013) 65 
 
 
CONCLUSIONS 
Recent studies about the influence of cytokines on goblet cells open a new 
field of research. It is important to observe how different types of Th cytokines seem 
to have opposite effects on conjunctival goblet cells, especially when comparing Th1 
versus Th2-derived cytokines. 
Goblet cells are becoming increasingly more important in the study of all 
types of pathologies affecting the ocular surface, from dry eye to allergies. It is 
surprising that, until now, most clinical studies regarding goblet cells were only 
focused on goblet cell number, but not on goblet cell function. The latest advances 
in this area are revealing previously unknown functions of these important cells and 
we know now that it is not only an issue of numbers. 
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ESTUDIO 4 
 
Tal y como se vio en el estudio anterior, las células caliciformes pueden 
responder a varios estímulos, tales como lentes de contacto o la presencia de 
distintas moléculas.  
En este estudio se lleva a cabo un análisis detallado del efecto del IFN-γ en 
las células caliciformes. Esta citoquina está elevada en distintas enfermedades y es 
especialmente relevante en el síndrome de ojo seco. Además, se estudia la 
interacción del IFN-γ con agonistas colinérgicos y cómo dicha interacción es capaz 
de modular la función de las células caliciformes en la secreción de mucinas.  
 
 
STUDY 4 
 
In the previous study we reviewed the goblet cell response to several stimuli 
such as contact lens or cytokines.  
In this study, we further investigate the effect of IFN-γ on goblet cell function. 
This cytokine is elevated in several ocular surface inflammatory diseases, including 
in dry eye. In addition, we study the interaction of IFN-γ with cholinergic agonists 
and how this interaction modulates goblet cell function in terms of mucin secretion.  
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Interaction of IFN-γ with Cholinergic Agonists to Modulate Rat and Human 
Goblet Cell Function 
 
 
ABSTRACT  
Goblet cells populate wet-surfaced mucosa including the conjunctiva of the 
eye, intestine, and nose, among others. These cells function as part of the innate 
immune system by secreting high molecular weight mucins that interact with 
environmental constituents including pathogens, allergens, and particulate 
pollutants. Herein we determined whether IFN-γ, a Th1 cytokine increased in dry 
eye, alters goblet cell function. Goblet cells from rat and human conjunctiva were 
cultured. Changes in intracellular [Ca2+] ([Ca2+]i), high molecular weight 
glycoconjugate secretion, and proliferation were measured after stimulation with 
IFN-γ with or without the cholinergic agonist carbachol. IFN-γ itself increased [Ca2+]i 
in rat and human goblet cells and prevented the increase in [Ca2+]i caused by 
carbachol. Carbachol prevented IFN-γ-mediated increase in [Ca2+]i. This cross-talk 
between IFN-γ and muscarinic receptors may be partially due to use of the same 
Ca2+i reservoirs, but also from interaction of signaling pathways proximal to the 
increase in [Ca2+]i. IFN-γ blocked carbachol-induced high molecular weight 
glycoconjugate secretion and reduced goblet cell proliferation. We conclude that 
increased levels of IFN-γ in dry eye disease could explain the lack of goblet cells 
and mucin deficiency typically found in this pathology. IFN-γ could also function 
similarly in respiratory and gastrointestinal tracts.  
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INTRODUCTION 
 
 The wet-surfaced mucosa including the conjunctiva of the eye, the intestine, 
colon, nose, bronchioles, Eustachian tube, and vagina contain goblet cells. These 
cells function as part of the innate immune system by secreting high molecular 
weight mucins that directly interact with environmental constituents including 
pathogens, allergens, and particulate pollutants. Substantial experimental evidence 
demonstrates that goblet cells function in mucosal epithelial protection and disease 
pathogenesis in respiratory and gastrointestinal tracts. 1,2 
 In the ocular surface goblet cells are found in the epithelial layer of the 
conjunctiva, the mucous membrane that surrounds the cornea and lines the eyelids. 
These goblet cells are specialized cells that produce and secrete mucins, most 
notably the mucin (MUC) MUC5AC that lubricates and protects the ocular surface, 
maintaining its health. 3,4 Goblet cells are also integral participants in diseases of the 
ocular surface including allergic conjunctivitis, bacterial keratitis and conjunctivitis, 
and dry eye. 
 MUC5AC is a high molecular weight glycoconjugate that forms the mucous 
layer of the tear film. 5 The amount of MUC5AC found in the ocular surface is tightly 
controlled by goblet cell number, MUC5AC synthesis, and MUC5AC secretion. In 
inflammatory disorders such as dry eye, Sjögren’s syndrome or ocular cicatricial 
pemphigoid goblet cells die or are non-functional. 6-8 On the other hand, in diseases 
such as allergic conjunctivitis, higher goblet cell numbers are found. As early as in 
1992, Lemp 9 suggested that either an increase or a decrease in the number of filled 
goblet cells was associated with ocular surface pathology.  
Under normal conditions, goblet cell secretion is under neural control by the 
efferent parasympathetic nervous system. Cholinergic, muscarinic mediators that 
are analogs of the parasympathetic neurotransmitter acetylcholine are major stimuli. 
10 Cholinergic agonists transmit their signal by activating the G protein Gαq/11 that 
activates phospholipase C, which breaks down phosphatidylinositol 4,5 
bisphosphate (PIP2) producing inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. 
The increase in IP3 binds to its receptor in the endoplasmic reticulum to release Ca2+ 
from intracellular stores thereby elevating the intracellular Ca2+ concentration 
([Ca2+]i). 11 The increase in [Ca2+]i leads to activation of extracellular regulated kinase 
(ERK)1/2 (also known as p44, p42 mitogen activated protein kinase (MAPK)), and 
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secretion of high molecular weight glycoconjugates including MUC5AC. 12 In airway 
epithelium, mucin secretion is dependent upon the calcium sensors Munc13-2 and 
synaptotagmin2.13 These proteins have not yet been identified in the conjunctiva. 
Cholinergic agonists mediate goblet cell secretory responses to environmental 
changes under normal conditions. When inflammation develops in the ocular 
surface as occurs in dry eye, these responses may be altered. This alteration would 
lead to a change in goblet cell mucin production. In early disease mucus production 
can be increased as a protective response, but later in the disease goblet cell mucin 
production can be decreased leading to ocular surface pathology.  
 Interferon gamma (IFN-γ) is the major Th1-derived cytokine. This cytokine is 
implicated in several different immune responses, such as inflammation or graft 
rejection. IFN-γ is secreted by cytotoxic T cells, Th1 cells, and natural killer cells. 14 It 
binds to its receptor, IFN-γ-R, that is ubiquitously expressed at the cell surface on all 
cells except erythrocytes. 15 The main signaling pathway induced by IFN-γ is through 
the JAK-STAT intracellular signal transduction pathway leading to activation of 
STAT-1 target genes. 16,17 IFN-γ-R can also recruit and activate phosphatidylinositol-
3 kinase (PI-3K), Src, or MyD88, that initiate signaling cascades involving ERK1/2, 
Akt or NF-κB.13 
 In the conjunctival epithelium, IFN-γ induces squamous metaplasia, which 
leads to progressive goblet cell loss. Both changes are related to dry eye disease. 
Recently Zhang et al. 18 showed that IFN-γ caused goblet cell apoptosis in a mouse 
model of dry eye. However, the signaling pathways activated by this cytokine and its 
role regulating in goblet cell function remain unclear.  
The purpose of this study was to determine if IFN-γ, a mediator of dry eye, 
directly regulates mucin production in rat and human conjunctival goblet cells. Thus, 
presence of IFN-γ-R-1, as well as effect on intracellular Ca2+ signaling, mucin 
secretion, and goblet cell proliferation were measured after stimulation with IFN-γ 
alone or in the presence of a normal stimulus of secretion, a cholinergic agonist. We 
found that IFN-γ blocked the cholinergic agonist-stimulated increase in [Ca2+]i, mucin 
secretion, and decreased goblet cell proliferation. Thus, IFN-γ leads to decreased 
goblet cell mucous production and contributes to the mucin deficiency found in dry 
eye disease.  
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RESULTS 
 
Goblet Cell Characterization 
 Identity of cells cultured from both rat and human conjunctiva was confirmed 
by immunofluorescence microscopy using the following markers: cytokeratins (CK) 4 
(specific for stratified squamous non-goblet epithelial cells) and 7 (goblet cell specific 
keratin), 19,20 and lectins from Ulex europaeus agglutinin type 1 (UEA-1) (rat) or Helix 
pomatia agglutinin (HPA) (human). Lectins identify high molecular weight 
glycoconjugates including MUC5AC synthesized and secreted by goblet cells. 
The majority of rat cells in culture were positive for both lectin UEA-1 (green) 
and CK7 (red) as shown in Figure 1a. To assure that lectins were identifying goblet 
cells, immunocytochemistry against UEA-1 and MUC5AC was performed in cultured 
cells (Figure 1b). We observed that UEA-1 and MUC5AC staining co-localized, 
showing that there were identifying the same mucous products. Human cultured 
cells were positive for lectin HPA (red) and CK7 (green), as shown in Figure 1c, and 
positive for MUC5AC (Figure 1d). Cultured cells did not express CK4 (data not 
shown). Additionally, the expression of MUC5AC in these cells and in conjunctival 
tissue from rat and human was confirmed by semi-quantitative real time RT-PCR 
(Figure 1e). MUC5AC was detected in both rat (left) and human (right) conjunctival 
tissue and in cultured goblet cells. MUC5AC mRNA levels were 277.7 times higher 
in cultured rat goblet cells that in rat conjunctiva, and 170.7 times higher in human 
goblet cells than in human conjunctiva. Therefore the overwhelming majority of cells 
in culture were goblet cells. 
 
CHAPTER 1                             Study 4. Interaction of IFN-γ with cholinergic agonists 
	   201 
 
Figure 1. Cultured cells are goblet cells as they contain CK7, lectin binding domains, 
and MUC5AC. Representative images of rat (a-b) and human (c-d) cultured goblet 
cells. Nuclei were stained in blue with DAPI. Cells expressed CK7 (a, c) lectins UEA-
1 (rat cells, a) and HPA (human cells, c), and MUC5AC (b, d) as seen in merged 
images. Magnification X100 for a, X400 for b and d, and X200 for c. MUC5AC mRNA 
expression was measured by Real Time RT-PCR (e). Values are expressed as mean 
+ SEM (n=2). CK, cytokeratin; DAPI, 6-diamidino-2-phenylindole; HPA, Helix pomatia 
agglutinin; MUC, mucin; RT-PCR, reverse transcription polymerase chain reaction; 
UEA-1, Ulex europaeus agglutinin type 1; Conj., conjunctiva; GC, goblet cells. 
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Goblet Cells Express IFN-γ-R1 
To determine if conjunctival goblet cells were able to directly respond to IFN-
γ, the presence of IFN-γ-R1, the receptor for this cytokine, was determined by 
immunofluorescence microscopy and by real time RT-PCR. IFN-γ-R1 protein 
expression was identified in both rat and human cultured cells (Figure 2a-b). In 
addition, IFN-γ-R1 was detected in conjunctival tissue and cultured goblet cells 
(Figure 2c). We confirmed that both rat and human cultured cells expressed the 
receptor needed for IFN-γ to be effective. 
 
Figure 2. Conjunctival goblet cells express the IFN-γ receptor. Images of rat (a) 
and human (b) cultured goblet cells, where IFN-γ-R is stained in red. Nuclei 
were stained in blue with DAPI. IFN-γ-R mRNA expression was analyzed by 
Real Time RT-PCR (c). Values are expressed as mean + SEM (n=2). DAPI, 6-
diamidino-2-phenylindole; IFN-γ, interferon-gamma; RT-PCR, reverse 
transcription polymerase chain reaction; Conj., conjunctiva; GC, goblet cells. 
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IFN-γ Increases [Ca2+]i in Goblet Cells 
 Due to its role in goblet cell signaling, [Ca2+]i was measured in cultured cells 
after addition of different stimuli. The effect of IFN-γ was compared with the 
cholinergic agonist carbachol, an agonist of parasympathetic nerve mediated 
responses, that are known to increase [Ca2+]i in conjunctival goblet cells. 21 
Concentration-dependency assays were first performed in cultured rat cells to select 
optimal concentrations for IFN-γ and carbachol. IFN-γ caused a rapid increase in 
[Ca2+]i to a peak value that was maintained at a lower plateau level over time 
(Figure 3a). IFN-γ at 0.1, 1.0, and 3.0 ng/ml significantly increased the peak [Ca2+]i 
in a concentration dependent manner to 68.8 ± 29.6, 115.6 ± 37.3, and 239.5 ± 52.3 
(n=6), respectively  (Figure 3b). The highest concentration of IFN-γ 10 ng/ml did not 
produce any change. Thus IFN-γ itself increases [Ca2+]i. IFN-γ at 3 ng/ml was 
chosen as the maximal concentration for use in subsequent experiments. 
When three different concentrations (10-6 M, 10-5 M, and 10-4 M) of 
carbachol were used, all these concentrations significantly increased [Ca2+]i over 
time with a peak response followed by an elevated plateau (Figure 3c). When peak 
values were analyzed, the highest response of 271.4 ± 64.2 nM (n=4) was obtained 
at 10-4 M carbachol (Figure 3d). This result is in agreement with previous studies, 22 
that found the plateau for carbachol was at 10-4 M. Therefore, carbachol at 10-4 M 
was chosen as the concentration to be used in subsequent experiments. 
Comparison of carbachol and IFN-γ responses shows that IFN-γ caused a Ca2+i 
response comparable to that induced by the cholinergic agonist. 
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Figure 3. Caption on next page. 
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Figure 3. IFN-γ and Cch cause a concentration dependent increase in intracellular [Ca2+] and 
desensitize each others Ca2+ response in cultured conjunctival goblet cells.  Concentration 
dependency of IFN-γ (a-b) and Cch (c-d) of [Ca2+]i in rat conjunctival goblet cells. Mean 
intracellular Ca2+ response over time after addition of increasing concentrations of IFN-γ from 
0.1 to 10 ng/ml (n=6) (a) and of Cch from 10-6 -10-4 M (n=5) (c). Peak [Ca2+]i over basal is 
shown in (b) and (d) for IFN-γ and Cch, respectively. Mean intracellular Ca2+ response over 
time (e) or peak value over basal (f) in response to Cch at 10-4 M alone or the effect of 
addition of increasing concentrations of IFN-γ (indicated by first arrow) on the Cch response 
15 min (indicated by second arrow) after IFN-γ addition (n=5). Mean intracellular Ca2+ 
response over time (g) or peak value over basal (h) in response to IFN-γ (3 ng/ml) alone or 
the effect of increasing concentrations of Cch (indicated by first arrow) on the IFN-γ response 
15 min (indicated by second arrow) after Cch addition (n=4). * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 
0.005. Cch, carbachol; IFN-γ, interferon-gamma. 
 
 
IFN-γ and a Cholinergic Agonist Block Each Others’ Increase in [Ca2+]i in  
Goblet Cells 
The effect of a 15 min pretreatment with IFN-γ on the carbachol Ca2+i 
response was next studied. Carbachol 10-4 M significantly increased [Ca2+]i to 232.0 
± 52.1 nM (n=5) (Figure 3e and f). IFN-γ at 0.1, 1.0, 3.0, and 10 ng/ml significantly 
inhibited the carbachol-stimulated peak [Ca2+]i response decreasing it to 18.4 ± 15.6, 
17.1 ± 7.1, 43.2 ± 24.0, and 24.2 ± 11.9 nM (n=5), respectively. This was a 92.07%, 
92.63%, 81.36%, and 89.57% inhibition, respectively. All four IFN-γ concentrations 
blocked the carbachol-induced increase in [Ca2+]i (Figure 3f). 
Conversely, the effect of 15 min pretreatment with carbachol on the IFN-γ 
response was also studied. IFN-γ (3ng/ml) significantly increased peak [Ca2+]i to 
886.4 ± 326.7 nM (n=4). Carbachol at 10-6 M and at 10-4 M significantly decreased 
IFN-γ stimulated [Ca2+]i response to 27.3 ± 10.9 and 91.6 ± 19.0 nM (n=4), 
respectively, with 96.92 and 89.67 % inhibition (Figure 3g and h). Although not a 
significant decrease, carbachol at 10-5 M decreased the IFN-γ response by 88.6 %. 
IFN-γ and the cholinergic agonist carbachol each block the intracellular Ca2+i 
response of the other agonist.  
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IFN-γ Causes a Time-dependent Inhibition of a Cholinergic Agonist-Induced 
Increase in [Ca2+]i in  Goblet Cells  
The effect of IFN-γ on carbachol-induced increase in [Ca2+]i was evaluated 
at two different incubation times. The first time, 15 min, is a short treatment that 
indicates the immediate effect on intracellular Ca2+ levels and the use of the different 
cellular Ca2+ pools. The effect of a 15-min treatment was shown in Figure 3 and is 
used as a control in Figure 4. The second time, 24 h, is used to study longer term 
activation of cytokine dependent signaling pathways probably involving synthesis of 
signaling mediators. In rat goblet cells, IFN-γ (3 ng/ml) increased peak [Ca2+]i to a 
mean of 240.4 ± 52.0 nM (n=5) (p = 0.009, Figure 4 a-c). IFN-γ treatment for 15 min 
significantly reduced the effect of carbachol (10-4 M) from 304.5 ± 64.7 nM to 43.2 ± 
23.9 nM (p = 0.009), whereas with the 24 h treatment no statistically significant 
difference was found when comparing the carbachol response before with the 
response after IFN-γ (p = 0.06, Figure 4a-c). 
In human cells, IFN-γ (3 ng/ml) also induced a significant increase in peak 
[Ca2+]i (Figure 4 d-f), to an average of 110.7 ± 40.8 nM compared to basal (n=7) (p 
= 0.019; Figure 4f). The 15 min treatment with IFN-γ blocked carbachol-induced 
increase from 395.3 ± 199.8 nM to 76.9 ± 9.0 nM (p = 0.009, Figure 4f). In contrast, 
the 24 h treatment with IFN- γ showed no significant effect on the carbachol-induced 
[Ca2+]i response before compared to after IFN-γ.   
 
Figure 4 (next page). A fifteen minutes, but not a 24 h incubation with IFN-γ blocks the 
increase in [Ca2+]i stimulated by Cch in rat and human conjunctival goblet cells. A pseudo 
color image of [Ca2+]i from fura-2 loaded single goblet cells in rat (a) and human (d) shows the 
increase in [Ca2+]I under basal conditions, after stimulation with Cch (10-4 M), or Cch after 15 
min or 24 h incubation with IFN-γ.  Shown in rat (b) and human (e) goblet cells is the mean 
intracellular Ca2+ response over time, after addition of Cch (Cch- arrow black line), IFN-γ (first 
arrow red line), Cch (second arrow red line) after a 15 min treatment with IFN-γ or Cch (first 
arrow green line) after a 24 h treatment with IFN-γ. Peak [Ca2+]i over basal for each condition 
is shown in (c) and (f) and is expressed as mean ± SEM (n=5) in rat cells (b and c) and (n=7) 
in human cells (e and f). * indicates statistical significance compared to basal values, and # is 
compared to Cch values. * or # p ≤ 0.05; ** or ## p ≤ 0.01; *** or ### p ≤ 0.005. Cch, carbachol; 
IFN-γ, interferon-gamma. 
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Figure 4. Caption on previous page. 
 
CHAPTER 1                             Study 4. Interaction of IFN-γ with cholinergic agonists 
	   208 
Effect of Extracellular and Intracellular Ca2+ Store Depletion on IFN-γ and 
Cholinergic Agonist Ca2+i Responses in Goblet Cells 
We explored the cellular Ca2+ pools used by IFN-γ and carbachol to 
increase [Ca2+]i.. To determine the role of extracellular Ca2+ (Ca2+o) we removed 
Ca2+o for 3 min before adding 3 ng/ml IFN-γ or 10-4 M carbachol. In rat goblet cells, 
IFN-γ increased [Ca2+]i to 368.1 ± 109.4 nM (n=6) (Figure 5 a and c). In the 
absence of Ca2+o this response was significantly decreased to 92.6 ± 41.8 nm. 
When Ca2+o was re-added, a significant increase in [Ca2+]i to 531.9 ± 123.2 nM was 
observed showing that the intracellular Ca2+ stores were not altered in these 
experiments.  Similar results were obtained with carbachol (Figure 5 a and c). 
Carbachol increased [Ca2+]i to 1061.2 ± 356.1 nM (n=6), which was significantly 
decreased to 258.7 ± 57.7 nM in the absence of Ca2+o. Re-addition of Ca2+o 
increased the carbachol [Ca2+]i response to 618.9 ± 200.7 nM.  
A similar experiment was conducted using human goblet cells (Figure 5 b 
and d). In the presence of extracellular Ca2+, IFN-γ increased Ca2+ to 398.6 ± 222.7 
nM (n=5), and that increase was reduced to 21.2 ± 10.6 nM in the absence of Ca2+o. 
When Ca2+o was re-added, [Ca2+]i increased to 380.5 ± 225.0. Carbachol increased 
[Ca2+]i to 394.4 ± 77.9 nM, and in the absence of Ca2+o  it was decreased to 100.7 ± 
34.8 nM. Re-addition of Ca2+o increased [Ca2+]i to 284.2 ± 215.4 nM.    
 To explore the role of intracellular Ca2+ stores, rat goblet cells were treated 
for 15 min with 10-5 M thapsigargin or for 30 min with 10-5 M 2-amino-
ethoxydiphenylborane (2-APB). Thapsigargin depletes intracellular Ca2+ stores and 
2-APB blocks store-operated calcium release. 23 After treatment, cells were 
stimulated with 3 ng/ml IFN-γ or 10-4 M carbachol (Figure 5 e-h). IFN-γ increased 
[Ca2+]i to 961.4 ± 308.1 nM (n=6) (Figure 5 e and g). The IFN-γ-induced increase in 
[Ca2+]i after treatment with thapsigargin was significantly reduced to 110.5 ± 66.6 
and with 2-APB was decreased to 303.3 ± 146.7 nM. Carbachol increased [Ca2+]i to 
1128.9 ± 348.6 nM (n=6) (Figure 5 f and h). After treatment with thapsigargin the 
carbachol increase in [Ca2+]i was significantly depressed to 212.1 ± 131.2 and after 
2-APB was decreased to 422.5 ± 217.5 nM.  
 Both IFN-γ and carbachol responses were significantly lowered with prior 
treatment with thapsigargin. 2-APB also blocked both IFN-γ and carbachol 
responses, but the decrease was not statistically significant. IFN-γ and cholinergic 
agonists use similar cellular Ca2+ stores in goblet cells. These stores have both 
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intracellular and extracellular components as previously demonstrated for 
cholinergic agonists. 24 
 
Figure 5. The IFN-γ and Cch stimulated increases in [Ca2+]i are dependent upon both 
extracellular Ca2+ and intracellular Ca2+ stores in rat and human conjunctival goblet cells. The 
mean [Ca2+]i over time is shown for 3 ng/ml IFN-γ or 10-4 M Cch in the presence or absence 
of extracellular calcium (first arrow), or the re-addition of extracellular Ca2+ (second arrow) 
was studied in rat (a) and human (b) goblet cells in (n=6 in rat cells) or (n=5 in human cells). 
Peak [Ca2+]i over basal for each condition is shown in (c) and (d) and is expressed as mean ± 
SEM. The [Ca2+]i over time is shown for 3 ng/ml IFN-γ (e) or 10-4 M Cch (f) alone (first arrow) 
or after a 15 min treatment with thapsigargin (10-5 M) (second arrow) or 30 min after addition 
of 2-APB (10-5 M) in rat goblet cells (n=6). Peak [Ca2+]i over basal for each condition is shown 
in (g) and (h) and is expressed as mean ± SEM. * p ≤ 0.05; ** p ≤ 0.01. 2-APB, 2-amino-
ethoxydiphenylborane; Cch, carbachol; IFN-γ, interferon-gamma. 
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Effect of Inhibition of PI-3K and ERK1/2 on IFN-γ- and Cholinergic Agonist-
Stimulated Increase in [Ca2+]I in Goblet Cells 
Phosphoinositide-3 kinase (PI-3K) and mitogen-activated protein kinase 
kinase (MEK) 1/2 form part of an alternative IFN-γ signaling cascade compared to 
STAT-1.13 Rat goblet cells were preincubated with the PI-3K inhibitor LY294002 or 
the MEK1/2 inhibitor U0126 at 10-5 M (prevents activation of ERK1/2) for 30 min and 
then stimulated with IFN-γ (3 ng/ml) or carbachol (10-4 M).  
IFN-γ increased [Ca2+]i to 453.7 ± 82.9 nM (n=5) (Fig 6a and b). Addition of 
LY294002 before IFN-γ decreased [Ca2+]i to 259.3 ± 130.3 nM, but the effect was 
not significant. When U0126 was added, goblet cell response to IFN-γ was 
significantly reduced to 133.9 ± 68.5 nM. This is a 70.49 % inhibition.  
Carbachol increased [Ca2+]i to 942.9 ± 253.4 nM (n=5) (Fig 6 c and d). After 
pretreatment with LY294002, the response to carbachol was significantly decreased 
to 114.3 ± 10.7 nM, an 87.88% inhibition. In contrast, preincubation with U0126 did 
not significantly inhibit carbachol-mediated increase in [Ca2+]i, which was 309.0 ± 
197.4 nM. 
 These data suggest that in goblet cells IFN-γ induces ERK1/2, but not PI-3K 
to increase [Ca2+]i. In contrast, cholinergic agonists activate PI-3K, but not ERK1/2 to 
increase [Ca2+]i. These results confirm results from a previous study. 25 
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Figure 6. Blockage of PI-3K or ERK1/2 differentially inhibits IFN-γ and Cch stimulation of 
[Ca2+]i. The mean [Ca2+]i over time is shown for 3 ng/ml IFN-γ (a) or 10-4 M Cch (c) alone or 
after a 30 min treatment with the PI-3K inhibitor LY294002 (10-5 M) or the MEK inhibitor 
U0126 (10-5 M) in rat goblet cells (n=3). Arrow indicates addition of agonist. Peak [Ca2+]i over 
basal for each condition is shown in (b) and (d) and is expressed as mean ± SEM. * p ≤ 0.05. 
Cch, carbachol; ERK, extracellular regulated kinase; IFN-γ, interferon-gamma; MEK, mitogen-
activated protein kinase kinase; PI-3K, phosphatidylinositol-3 kinase. 
 
 
IFN-γ Induces Mucin Secretion and Blocks Cholinergic Agonist-Stimulated 
Mucin Secretion from Goblet Cells 
 Goblet cell secretion was evaluated after stimulation with 3 ng/ml IFN-γ or 
10-4 M carbachol. IFN-γ by itself did not have a significant effect on rat goblet cell 
secretion, and did not stimulate secretion from human cells (n=3) (Figure 7a and d).  
As a positive control carbachol induced high molecular weight glycoconjugate 
secretion from both rat and human goblet cells to 1.60 ± 0.08 and 2.01 ± 0.20 fold 
increase over basal (n=3), respectively. This response is consistent with previous 
results. 26 The effect of IFN-γ on carbachol-induced secretion was determined at two 
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times of incubation 15 min and 24 h. A 15 min treatment with IFN-γ did not have any 
significant effect on carbachol-induced secretion, in either rat or human goblet cells. 
In contrast, IFN-γ incubated for 24 h significantly blocked carbachol-induced 
secretion to 0.88 ± 0.06 and to 1.21 ± 0.23 in rat (p = 0.002, Figure 7b) and human 
cells (p = 0.05, Figure 7c), respectively. In rat cells a 120.0 % inhibition was 
obtained, whereas in human cells a 79.2 % inhibition was obtained.  
These data suggest that activation of a long-term pathway such as JAK-
STAT by IFN-γ can prevent cholinergic agonist stimulated secretion, but that 
stimulating a short-term pathway such as increasing the [Ca2+]i cannot.  
 
Figure 7. IFN-γ blocks Cch 
stimulated secretion of high 
molecular weight glycoproteins in 
rat and human goblet cells.  
Secretion from rat (a, b) and 
human (c) goblet cells is shown 
after a 2 h incubation with Cch 
(10-4 M), a 24 h incubation with 
IFN-γ (3 ng/ml), or a 15 min or 24 
h treatment with IFN-γ followed by 
a 2 h incubation with Cch. Data 
are mean ± SEM (n=3). * means 
statistical significance compared 
to basal values, and # is compared 
to Cch values. * or # p ≤ 0.05; ** or 
## p ≤ 0.01; *** or ### p ≤ 0.005. 
Cch, carbachol; IFN-γ, interferon-
gamma.	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IFN-γ Decreases Goblet Cell Proliferation 
Cell proliferation was measured in rat conjunctival goblet cells. A 24 h 
treatment with IFN-γ at 3 ng/ml decreased proliferation to 0.8 compared to basal 
value set as 1 (n=3) (p = 0.00018) (Figure 8). As expected carbachol 10-4 M did not 
have a significant effect on goblet cell proliferation after a 2 h treatment and IFN-γ 
added 24 h before carbachol did not alter proliferation either.  
 
 
Figure 8. IFN-γ inhibits proliferation of cultured rat conjunctival goblet 
cells. Proliferation of goblet cells in response to no addition, IFN-γ (3 
ng/ml) for 24 h, Cch (10-4 M) for 2 h, alone or after IFN-γ for 24 h. 
Data are mean ± SEM (n=3).  *** p ≤ 0.005. Cch, carbachol; IFN-γ, 
interferon-gamma. 
 
 
DISCUSSION  
 
 The role of the Th1 cytokine IFN-γ has been widely studied in a number of 
diseases, such as dry eye, Steven-Johnson syndrome, or Sjögren’s syndrome, 
where elevated levels of IFN-γ have been found. 27-29 In humans, IFN-γ correlates 
with disease severity. 30 Our results demonstrate that IFN-γ, which is found to be 
increased in several inflammatory diseases of the conjunctiva, has a direct effect on 
conjunctival goblet cell function. We found that IFN-γ increases [Ca2+]i, but did not 
stimulate goblet cell secretion. As a decrease in goblet cell mucin production plays a 
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critical role in ocular surface inflammation 31 the most important finding of the 
present study is that IFN-γ blocks two of the three processes used by goblet cells to 
increase mucin production: mucin secretion and goblet cell proliferation. That is, 
IFN-γ prevented the increase in [Ca2+]i  and stimulation of secretion caused by 
cholinergic agonists. In addition, IFN-γ itself reduced goblet cell proliferation. These 
in vitro studies using isolated goblet cells were performed to determine the effect of 
IFN-γ on goblet cells not contaminated by other cell types. In vivo, is likely that cross 
talk between goblet and non-goblet cells occurs, involving multiple signaling 
cascades that could alter goblet cell signaling pathways. Therefore, further research 
in vivo is warranted.  
 Cultured goblet cells responded to IFN-γ in a concentration-dependent 
manner. IFN-γ from 0.1 ng/ml to 3 ng/ml showed progressive increase in [Ca2+]i, 
whereas the highest concentration (10 ng/ml) did not. This suggests that at the 
highest concentration of IFN-γ, a Ca2+ inhibitory signaling pathway is being 
activated. Interestingly, all four concentrations of IFN-γ blocked the effect of 
cholinergic agonists in a very similar way. This result suggests that IFN-γ at high 
concentrations is not using a Ca2+-dependent mechanism to block cholinergic 
agonist-mediated Ca2+ responses. IFN-γ is known to activate other short-term 
signaling pathways 16 that will be investigated in future.  
 The mechanisms involved in short- and long-term responses induced by 
IFN-γ are likely to be different. Short-term blockade could be due to depletion of 
intracellular calcium reservoirs. Our results suggest that cholinergic agoinsts and 
IFN-γ are using, at least in part, the same intracellular Ca2+ reservoirs. Major Ca2+ 
reservoirs are the intracellular stores located in the endoplasmic reticulum 32 that are 
linked by Orai-1 and STIM1 to Ca2+ influx. 33,34 This intracellular store is depleted by 
thapsigargin. The findings that: 1) intracellular Ca2+ responses caused by cholinergic 
agonists and IFN-γ are both decreased after the addition of thapsigargin, and 2) the 
recovery of the intracellular Ca2+ response after the re-addition of extracellular Ca2+ 
supports this hypothesis. In agreement with our hypothesis is the finding that 
cholinergic agonist treatment for 15 min also inhibited IFN-γ induced Ca2+ responses 
and that a similar IFN-γ treatment inhibited the cholinergic Ca2+ response. 
 Cholinergic agonists bind to muscarinic receptors and IFN-γ binds to its own 
receptor, IFN-γ-R. The main signaling pathway activated by IFN-γ-R is JAK-STAT,17 
a pathway probably not activated by muscarinic receptors. However, several of the 
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alternative pathways activated by IFN-γ involve two kinases that form part of the 
muscarinic pathways, PI-3K and MEK1/2,16 suggesting that an interaction based on 
these pathways may be occurring. For that reason we used specific inhibitors of 
these two kinases. We found that when PI-3K was blocked the response to 
cholinergic agonists was inhibited, but the response to IFN-γ was not altered. In 
contrast, when MEK1/2 was inhibited, goblet cell response to cholinergic agonists 
remained unaltered, while response to IFN-γ was significantly blocked. Even though 
cholinergic agonists and IFN-γ use the same cellular Ca2+ stores, the mechanism by 
which they use these stores appears to be different. The short-term effect could also 
be independent of Ca2+, occur before the rise in intracellular Ca2+, or involve a direct 
effect on the muscarinic receptors. Because both IFN-γ and cholinergic agonists 
blocked one another’s responses, a cross desensitization of both receptors may be 
occurring.  
 A hallmark of dry eye disease is reduced mucin secretion. Although the 
levels of [Ca2+]i were not significantly blocked after 24 h incubation with IFN-γ alone, 
secretion induced by cholinergic agonists was reduced when there was a previous 
24 h incubation with IFN-γ. This result is similar to the report of Contreras-Ruiz et al. 
of a reduction of cholinergic agonist-mediated mucin secretion of mouse goblet cells 
exposed to IFN-γ for 24 h. 35 As a 24 hr treatment of IFN-γ does not alter cholinergic 
agonist increase in [Ca2+]i it is possible that activation of the JAK-STAT pathway that 
involves stimulation of transcription factors and synthesis of proteins could be 
responsible for the inhibition of secretion.  
 We showed in this study that IFN-γ decreases cultured goblet cell 
proliferation. This conclusion is supported by published results that associated 
increased IFN-γ levels with low numbers of goblet cells and increased apopotosis. 
18,36 Interestingly, in some cells, IFN-γ stimulation led to JAK2-dependent 
transactivation of epidermal growth factor receptor (EGFR).13 As activation of the 
EGFR is known to stimulate conjunctival goblet cell proliferation, it is unlikely that the 
JAK-STAT pathway plays a role in the IFN-γ blockade of cell proliferation. Blockade 
of goblet cell proliferation induced by IFN-γ could use another long-term mechanism 
or signaling pathway different from that used to decrease secretion.  
 A decrease in goblet cell proliferation could result from inhibition of the cell 
cycle or stimulation of apoptosis. When IFN-γ is present in the goblet cell 
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apoptotic processes begin, as demonstrated by Zhang et al.18 IFN-γ has been 
involved in goblet cell apoptosis through both extrinsic and intrinsic apoptosis 
pathways. 18 The main organelles that regulate Ca2+ homeostasis are also the main 
sites of apoptotic regulation. 37 Thus, there could be an interaction between 
apoptotic and other Ca2+ pathways that explain the long-term effect on IFN-γ on 
proliferation.  
 In previous studies, rat conjunctival goblet cells were found to behave in a 
similar manner as human goblet cells. 38-40 Similarly, in the current study in both rat 
and human goblet cells, IFN-γ blocked carbachol-mediated increase in [Ca2+]i and 
secretion in both species. Thus rat conjunctival goblet cells are an excellent model 
for human goblet cells, especially considering the difficulty in obtaining human 
conjunctiva. 
The main limitation of using primary cultures is the high variability between 
experiments. We observed that especially in calcium experiments, where only a few 
cells are analyzed, increasing the risk of higher variation. In addition, in the case of 
human cells, that variability may be increased due to the use of cells from both male 
and females, as well as from elderly donors. However, even with those limitations, 
we found several significant effects.  
 We conclude that IFN-γ affects multiple processes that control the amount of 
mucin produced by goblet cells. IFN-γ itself decreases goblet cell number by 
blocking proliferation and potentially by stimulating apoptosis. In addition, we have 
shown that the normal goblet cell increase in [Ca2+]i and mucin secretion, usually 
mediated by cholinergic agonists, is blocked by this Th1 cytokine. Taking all these 
data together, we conclude that the presence of IFN-γ could explain the mucin 
deficiency typically found in dry eye disease  6 since goblet cell number is diminished 
and the secretion of the remaining cells is blocked.  
 
 
METHODS  
 
Materials 
RPMI-1640 cell culture medium, penicillin/streptomycin, and L-glutamine 
were purchased from Lonza (Walkerville, IL). Fetal bovine serum (FBS) was from 
Atlanta Biologicals (Norcross, GA).  
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Antibodies against CK4, CK7, and MUC5AC were from Abcam (Cambridge, 
MA). The antibody against IFN-γ receptor was from Novus Biologicals (Littleton, 
CO). Secondary antibodies were from Jackson Immunoresearch (West Grove, PA). 
Lectins UEA-1 and HPA were from Sigma-Aldrich (St. Louis, MO). 
Primers for human IFN-γ receptor were from OriGene Technologies, Inc. 
(Rockville, MD), and those for rat were from SABioscience-Qiagen (Frederick, MD). 
The Superscript First-Strand Synthesis system for reverse transcription polymerase 
chain reaction (RT-PCR) was from Invitrogen, (Carlsbad, CA). SYBR Green PCR 
Master Mix was from Applied Biosystems (Carlsbad, CA).  
Recombinant Rat IFN-γ and recombinant Human IFN-γ (carrier-free) were 
purchased from BioLegend Inc. (San Diego, CA). Carbachol was purchased from 
Sigma (St. Louis, MO). Fura-2/AM was from Life Technologies (Grand Island, NY). 
The 35mm Glass Bottom Culture Dishes were from MatTek Corporation (Ashland, 
MA). Thapsigargin and 2-APB were from Sigma-Aldrich, and LY294002 and U0126 
were from Tocris Bioscience (Minneapolis, MN).  
Enzyme-linked lectin assay (ELLA) was from Pierce Biotechnology 
(Rockford, IL) and Amplex Red was from Invitrogen. The Cell Counting Kit-8 was 
purchased from Dojindo Molecular Technologies (Gaithersburg, MD). 
 
Animals 
Male Sprague-Dawley rats between 4 and 5 weeks of age were obtained 
from Taconic Farms (Germantown, NY). All experiments followed the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research, and were 
approved by the Schepens Eye Research Institute Animal Care and Use 
Committee. Rats were anesthetized with CO2 for 2 min and then euthanized by 
decapitation. Forniceal and bulbar conjunctival tissues were removed from both 
eyes.  
 
Human Tissue 
Human conjunctival tissues were obtained from Heartland Lions Eye Bank 
(Columbia, MO) and Michigan Eye Bank (Ann Arbor, MI). This study adhered to the 
Tenets of the Declaration of Helsinki and was approved by the Schepens Eye 
Research Institute Human Studies Internal Review Board. Received tissues were 
normal bulbar and forniceal conjunctival tissues.  
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Cell Culture 
 Tissue samples were obtained from 29 rats and from 12 human donors. Rat 
and human conjunctival goblet cells were grown in organ culture as previously 
described. 38,41 Briefly, conjunctival tissue was carefully minced into small pieces, 
and placed in six-well plates. When cell outgrowth was observed, tissue explants 
were removed. Conjunctival cells were cultured from every sample, although goblet 
cells were not obtained from each piece. As early as 24 h after establishment of 
organ culture, cell outgrowth from the explant was observed. Cells were fed with 
RPMI-1640 medium supplemented with 10% FBS, 2 mM L-glutamine, and 100 
µg/ml penicillin-streptomycin. Cells were maintained at 37º C in 5% CO2, and the 
medium was changed every other day. After 7-10 days, cells were trypsinized and 
passaged. Cells in passage 1 were used for all experiments. 
 
Immunofluorescence microscopy 
First-passage cultured cells were grown on glass cover slips and fixed in 
methanol or formaldehyde. To confirm that the cultured cells were goblet cells, these 
cells were stained with antibody against CK7, CK4, MUC5AC, and the lectins UEA-1 
conjugated to FITC or HPA conjugated to tetramethylrhodamine (TRITC). Cells were 
incubated for 2 h with a blocking solution. Thereafter, primary antibody anti-CK7, 
anti-CK4, or anti-MUC5AC at 1:100 dilution was added. After one hour, cover slips 
were washed with PBS, and then secondary antibody conjugated with Cy2 or Cy3 
(at 1:200 dilution), and UEA-1 or HPA (at 1:500 dilution) were added for one hour. 
To detect cell nuclei, 6-diamidino-2-phenylindole (DAPI) was added to the mounting 
medium. The same protocol was used to determine the presence of IFN-γ receptor, 
using an anti-IFN-γ-R antibody. Negative controls included the omission of primary 
antibodies. Specificity of primary antibodies and lectins had been previously tested. 
Cells were viewed by fluorescence microscopy (Eclipse E80i, Nikon, Tokyo, Japan). 
Micrographs were taken with a digital camera (Spot, Diagnostic Instruments, Inc, 
Sterling Heights, MI). 
 
RNA Isolation and Real Time Reverse Transcript PCR (RT2-PCR) 
Briefly, RNA was extracted with TRIzol and total RNA was isolated 
according to manufacturer’s instructions. One microgram of purified total RNA was 
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used for complementary DNA (cDNA) synthesis using the Superscript First-Strand 
Synthesis system for RT-PCR.  
RT2-PCR reaction was performed with 10 ng cDNA, 1 µl primers (Table 1) 
and 10 µl SYBR Green PCR Master Mix in a final volume of 20 µl. Conditions of the 
PCR reaction were: denaturation at 95°C for 10 min, and 40 cycles of 95°C for 15 s 
and 60°C for 60s. After the 40 cycles there was a final cycle of 95°C for 90 s. All 
reactions were performed in duplicate. The levels of GAPDH for each sample were 
used as endogenous controls. Non template controls (NTC) included the omission of 
cDNA. To assure the specificity of the PCR products, a melting curve analysis was 
performed. For the posterior analysis of mRNA expression levels, the 2-ΔΔCt method 
was used. 42  
 
Table 1. Primers sequences 
Primer Primer sequence/Reference Source 
GAPDH 
Sense: 5’-GAACGTGAAGGTCGGAGTCAAC-3’ Sigma-Aldrich 
(St.Louis, MO) Antisense: 5’-CGTGAAGATGGTGATGGGATTTC-3’ 
MUC5AC 
Sense: 5’-CCCACAGAACCCAGTACAA -3’ 
Sigma-Aldrich 
Antisense: 5’-AATGTGTAGCCCTCGTCT -3’ 
Human IFN-γ-R1 Ref: HP200396 
OriGene 
Technologies, Inc. 
(Rockville, MD) 
Rat IFN-γ-R1 Ref. PPR06409A Qiagen (Frederick, MD) 
 
 
Measurement of [Ca2+]i 
First-passage cultured goblet cells were grown on 35 mm glass-bottom 
culture dishes for 1 day. Cells were then incubated in KRB buffer (containing 120 
mM NaCl, 25 mM NaHCO3, 10 mM HEPES, 4.8 mM KCl, 1.2 mM MgCl2, 1.2 mM 
NaH2PO4, 1 mM CaCl2) with 0.5% BSA, 8 µM pluronic acid F127, 250 µM 
sulfinpyrazone, and 0.5 µM of Fura-2/AM for 1 h at 37º C. Fura-2/AM is a fluorescent 
molecule that indicates the intracellular Ca2+ levels ([Ca2+]i). After incubation, cells 
were washed with KRB buffer containing sulfinpyrazone, and the dishes were 
observed using a Ca2+ imagining system, InCyt Im2 (Intracellular Imaging, 
Cincinnati, OH). This system allows measuring the ratio of Fura-2 using excitation 
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wavelengths of 340 and 380 nm, and an emission wavelength of 505 nm. A mean of 
10 cells per dish was selected, and [Ca2+]i was measured in each individual cell. A 
basal reading was done for at least 15 seconds before addition of agonists or 
inhibitors. Data are presented as the change in peak [Ca2+]i, that was calculated by 
subtracting the basal value from the [Ca2+]i peak.  
 
High Molecular Weight Glycoconjugate Secretion 
For secretion assays, first-passage goblet cells were cultured in 24-well 
plates and grown to confluence. After serum starving for 24 h, cells were incubated 
with buffer alone (basal), carbachol (10-4 M), or IFN-γ (3 ng/ml) for 24 h in serum-
free RPMI 1640 supplemented with 0.5% bovine serum albumin. Goblet cell 
secretion was measured using ELLA. UEA-1 lectin conjugated to horseradish 
peroxidase was used to detect high molecular weight glycoconjugates, including the 
mucin MUC5AC produced by rat and human goblet cells. After incubation, the 
culture medium was collected and the amount of lectin-detectable glycoconjugates 
was measured. After collection of supernatant for the ELLA, cells in the 24-well plate 
were removed and sonicated. The cell homogenate was analyzed for total amount 
of protein using the Bradford protein assay. Bovine submaxillary mucin was used for 
the standard curve.  
To perform the ELLA, standards and supernatants were placed into 96-well 
microplates and dried overnight at 60º C. The manufacturer’s protocol was followed. 
UEA-1 was detected using Amplex Red. In the presence of hydrogen peroxide, 
Amplex Red is oxidized producing a fluorescent molecule. Fluorescence was then 
quantified using a fluorescence ELISA reader (Bio-Tek, Winooski, VT), using 530 
nm and 590 nm excitation and emission wavelengths, respectively. The amount of 
high molecular weight glycoconjugate secretion was normalized to total protein in 
the homogenate, and expressed as fold increase over basal. Basal value was set   
at 1.  
 
Proliferation  
Proliferation was measured using Cell Counting Kit-8. Briefly, cells were 
serum starved for 24 h, treated with IFN-γ (3 ng/ml), for 24 h, and then stimulated 
with carbachol (10-4 M) for 2 h. After stimulation, WST-8 product was added to the 
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wells and after a 45 min incubation, absorbance was read in a spectrophotometer, 
following manufacturer’s instructions.  
 
Data Presentation and Statistical Analysis 
Data were presented as mean ± standard error of the mean (SEM). 
Student’s t-test was performed to analyze data and p ≤ 0.05 was considered 
statistically significant. 
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A NEW 3D MODEL OF 
HUMAN CONJUNCTIVA 
 
 
 
 
 
 
¿Por qué repetir los errores antiguos habiendo tantos errores nuevos que cometer? 
------------------------------------------------------------------------------------------------ 
“Why repeat the old errors, if there are so many new errors to commit?” 
 
― Bertrand Russell 
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PURPOSE. To develop a complete and optimized method to expand in culture human
conjunctival epithelial cells from cadaveric donor samples.
METHODS. Epithelial cells were obtained from cadaveric conjunctival tissue (n ¼ 47).
Preplating and differential trypsinization were optimized to eliminate stromal contamination.
Epithelial cells were grown with five different media: control, epithelial growth factor (EGF)-
enriched, H2O2-supplemented, fibroblast-conditioned, and human serum media. Adhesion,
proliferation, colony forming efficiency (CFE), and percentage of CK19þ and Ki67þ cells were
determined with the five different media. Cells were characterized by immunofluorescence
and/or Western blotting techniques for the expression of CK4, CK7, CK19, MUC5AC,
vimentin, FSP-1, Ki67, E-cadherin, and zonula occludens (ZO)-1 markers. In addition, cells
were treated with TNF-a and levels of secreted IL-6 were measured by enzyme-linked
immunosorbent assay.
RESULTS. Pure epithelial cell cultures were obtained. Human serum medium showed the best
properties in proliferation and CFE, while maintaining epithelial phenotype. Cells with this
medium were passaged up to five times, although they maintained all epithelial characteristics
only through passage 3. Cultured cells expressed epithelial markers, but not stromal ones.
The number of MUC5ACþ cells increased throughout the passages, whereas Ki67þ cell
numbers decreased. Cells in culture maintained adherens and tight junctions, and responded
to TNF-a treatment by releasing more IL-6, showing that they can be used for inflammation
assays.
CONCLUSIONS. We have developed a complete protocol to expand conjunctival epithelial cells
from cadaveric tissue. This culture system responded to an inflammatory stimulus, so it could
be used to develop a more complex in vitro model of inflammation.
Keywords: conjunctival epithelial cells, cell culture, cadaveric donor
The conjunctiva is the mucous membrane that covers theocular surface from the limbus to the posterior surface of
the eyelids. It is composed of stroma and epithelium, which
consists of 2 to 7 layers of stratified squamous epithelial cells. In
the more external layers, goblet cells, which are specialized
epithelial cells, produce mucin.1 Epithelial conjunctival cells
are essential for maintaining a healthy ocular surface, having
themselves an immunomodulatory role2 that makes them an
important target of study. To elucidate the effect of cytokines or
drugs in the conjunctiva, a good in vitro system resembling the
in situ epithelium is needed; however, a good model for this has
not yet been developed.
Most of the reported in vitro studies of conjunctiva are done
using established cell lines. To the best of our knowledge, the
only human conjunctival cell lines that have been previously
described are the Chang conjunctival cell line,3 the Wong-
Kilbourne derivative of Chang conjunctival epithelial cells
(American Type Culture Collection 20.2, Manassas, VA), the
IOBA-normal human conjunctiva (NHC) cell line,4 and the
ConjEp-1/p53DD/cdk4R/TERT (HCjE) cell line.5 These lines
have many advantages, such as availability and homogeneous
results. However, in many ways they are not a fair represen-
tation of the original tissue.6,7 This fact makes primary cell
cultures a more valuable in vitro working tool.
Conjunctival primary cell cultures of different species have
been established, such as rat,8 rabbit,9 and mouse and
monkey,10 among others. There are obvious interspecies
differences, so it is not always possible to use them because
the results cannot be readily extrapolated to the human
situation.
The main source of human tissue for conjunctival cell
culture is conjunctival biopsy,6,11–13 which can be done for
patients undergoing cataract or other scheduled surgeries.14
Although the procedure of the biopsy is not very aggressive,
some ethical concerns exist when doing biopsies for research
alone, even if donors have signed informed consent releases.
Additionally, tissue availability may be limited. For those
reasons, the use of cadaveric tissues provides a promising
alternative to biopsy tissues.
Independent from the source of tissues, epithelial primary
cell cultures are very often established with the aide of feeder
layers, usually murine 3T3 fibroblasts15 because they improve
culture performance. However, this strategy has some risks,
especially if the final destination of the culture cells is for
Copyright 2013 The Association for Research in Vision and Ophthalmology, Inc.
www.iovs.org j ISSN: 1552-5783 7143
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ESTUDIO 5 
 
 En los estudios que constituyen el Capítulo 1 de esta memoria se pudo ver 
que las líneas celulares no son adecuadas para realizar todo tipo de ensayos, ya 
que su fenotipo difiere notablemente del que expresan en realidad las células a las 
que representan. Es por ello, que trabajar con cultivos primarios resulta esencial. En 
el estudio 4 se utilizaron cultivos primarios de células caliciformes, siguiendo el 
protocolo publicado por el grupo de la Profesora Darlene A. Dartt, del Schepens 
Eye Research Institute.  
 Se ha considerado necesario desarrollar y optimizar algún protocolo que 
permita también tener cultivos primarios de otros dos tipos celulares conjuntivales: 
fibroblastos y células epiteliales no caliciformes. El desarrollo de dicho protocolo se 
describe en el estudio 7. 
  
 
STUDY 5 
 
The study 1 of this thesis report showed that cell lines are not appropriate to 
perform some type of studies, because their phenotype differs from the one of 
primary cells that originate them. For that reason, research done using primary 
cultures is essential. In the Study 4, primary goblet cell cultures were performed 
following the protocol published by Prof. Darlene A. Dartt group, from the Schepens 
Eye Research Institute.  
We consider necessary to optimize a protocol to obtain primary cultures from 
conjunctival epithelial non-goblet cells and conjunctival fibroblasts. This study 7 
presents the development of that protocol.  
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A New Human Primary Epithelial Cell Culture Model to Study Conjunctival 
Inflammation 
 
ABSTRACT 
Purpose. To develop a complete and optimized method to expand in culture human 
conjunctival epithelial cells from cadaveric donor samples. 
Methods. Epithelial cells were obtained from cadaveric conjunctival tissue (n = 47). 
Preplating and differential trypsinization were optimized to eliminate stromal 
contamination. Epithelial cells were grown with five different media: control, epithelial 
growth factor (EGF)-enriched, H2O2-supplemented, fibroblast-conditioned, and 
human serum media. Adhesion, proliferation, colony forming efficiency (CFE), and 
percentage of CK19+ and Ki67+ cells were determined with the five different media. 
Cells were characterized by immunofluorescence and/or Western blotting 
techniques for the expression of CK4, CK7, CK19, MUC5AC, vimentin, FSP-1, Ki67, 
E-cadherin, and zonula occludens (ZO)-1 markers. In addition, cells were treated 
with TNF-α and levels of secreted IL-6 were measured by enzyme-linked 
immunosorbent assay. 
Results. Pure epithelial cell cultures were obtained. Human serum medium showed 
the best properties in proliferation and CFE, while maintaining epithelial phenotype. 
Cells with this medium were passaged up to five times, although they maintained all 
epithelial characteristics only through passage 3. Cultured cells expressed epithelial 
markers, but not stromal ones. The number of MUC5AC+ cells increased throughout 
the passages, whereas Ki67+ cell numbers decreased. Cells in culture maintained 
adherens and tight junctions, and responded to TNF-α treatment by releasing more 
IL-6, showing that they can be used for inflammation assays. 
Conclusions. We have developed a complete protocol to expand conjunctival 
epithelial cells from cadaveric tissue. This culture system responded to an 
inflammatory stimulus, so it could be used to develop a more complex in vitro model 
of inflammation. 
 
Keywords: conjunctival epithelial cells; cell culture; cadaveric donor 
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INTRODUCTION 
 
The conjunctiva is the mucous membrane that covers the ocular surface 
from the limbus to the posterior surface of the eyelids. It is composed of stroma and 
epithelium, which consists of 2 to 7 layers of stratified squamous epithelial cells. In 
the more external layers, goblet cells, which are specialized epithelial cells, produce 
mucin.1 Epithelial conjunctival cells are essential for maintaining a healthy ocular 
surface, having themselves an immunomodulatory role2 that makes them an 
important target of study. To elucidate the effect of cytokines or drugs in the 
conjunctiva, a good in vitro system resembling the in situ epithelium is needed; 
however, a good model for this has not yet been developed. 
Most of the reported in vitro studies of conjunctiva are done using 
established cell lines. To the best of our knowledge, the only human conjunctival cell 
lines that have been previously described are the Chang conjunctival cell line,3 the 
Wong-Kilbourne derivative of Chang conjunctival epithelial cells (American Type 
Culture Collection 20.2, Manassas, VA), the IOBA-normal human conjunctiva (NHC) 
cell line,4 and the ConjEp-1/p53DD/cdk4R/TERT (HCjE) cell line.5 These lines have 
many advantages, such as availability and homogeneous results. However, in many 
ways they are not a fair representation of the original tissue.6,7 This fact makes 
primary cell cultures a more valuable in vitro working tool. 
Conjunctival primary cell cultures of different species have been established, 
such as rat,8 rabbit,9 and mouse and monkey,10 among others. There are obvious 
interspecies differences, so it is not always possible to use them because the results 
cannot be readily extrapolated to the human situation. 
The main source of human tissue for conjunctival cell culture is conjunctival 
biopsy,6,11–13 which can be done for patients undergoing cataract or other scheduled 
surgeries.14 Although the procedure of the biopsy is not very aggressive, some 
ethical concerns exist when doing biopsies for research alone, even if donors have 
signed informed consent releases. Additionally, tissue availability may be limited. 
For those reasons, the use of cadaveric tissues provides a promising alternative to 
biopsy tissues. 
Independent from the source of tissues, epithelial primary cell cultures are 
very often established with the aide of feeder layers, usually murine 3T3 fibroblasts15 
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because they improve culture performance. However, this strategy has some risks, 
especially if the final destination of the culture cells is for transplantation.16 Thus, the 
optimization of the culture procedure and the culture medium is the main concern 
when culturing epithelial cells without using feeder layers. Several supplements 
have been described to promote epithelial proliferation. The main one is epithelial 
growth factor (EGF),17 but there are some others. For instance, Pan et al.18 reported 
higher adhesion, migration, and proliferation levels in corneal cells when adding 
small amounts of H2O2 to the medium. Finally, the main source of growth factors is 
serum, and for that reason its inclusion in the culture system is an issue of great 
importance. 
Notwithstanding some obvious problems such as elderly donors and the 
elapse of days between eye extraction and cell culture, the aim of this research was 
to establish an optimized protocol for expanding human conjunctival cells derived 
from cadaveric donors. Here, we demonstrate optimized procedures for isolating 
and culturing conjunctival epithelial cells from cadaveric tissue and efficiently 
expanding the cells in the absence of feeder layers. Our results provide a good in 
vitro model to deepen the knowledge of human conjunctiva and may eventually 
provide abundant cells for transplantation to save vision in diseased and 
traumatized eyes. 
 
 
MATERIALS AND METHODS 
 
Human Conjunctival Tissues 
Healthy human conjunctival tissues were obtained from corneoscleral 
buttons from cadaveric donors (n = 47, from 40 donors). Fifty-seven and half percent 
of donors were male and 42.5% were female, with a mean age and SEM of 80.5 ± 
1.23 years. The average interval between the death of the donor and harvesting of 
the conjunctival tissue was 2 to 3 days. Corneoscleral buttons were obtained with 
informed research consent from Barraquer Eye Bank of Barcelona (Spain). This 
study was in strict accordance with the tenets of the Declaration of Helsinki and 
Spanish Regulations concerning the use of human tissues for biomedical research, 
and had the approval of institutional review board of the University of Valladolid. 
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Human bulbar conjunctiva was carefully isolated from the rest of tissues, and used 
for research purposes. 
 
Isolation and Culture of Conjunctival Cells 
Human fibroblasts were obtained from conjunctival tissue. The epithelium 
was gently scraped, and then the underlying stroma was cut in small pieces 
(approximately 2 mm2/piece), that were plated in 12-well plastic plates (Nunc, 
Roskilde, Denmark). Fibroblast culture medium was composed by Dulbecco's 
modified Eagle's Medium (DMEM)/F12 supplemented with 10% fetal bovine serum 
(FBS), 2.5 µg/mL fungizone, and 5000 units/mL penicillin/streptomycin (all from 
Invitrogen, Inchinnan, UK). 
Human conjunctival epithelial cells were obtained by disaggregation of the 
conjunctivas using either an enzymatic method or a combined enzymatic and 
mechanical method. Briefly, conjunctival tissue was incubated with dispase (1.2 
U/mL; Invitrogen) for 2 hours, at 37°C in 5% CO2. After that, loosened epithelial 
cells were recovered with the help of a pipette. In the combined method, additional 
mechanical scraping was performed. The dispase solution containing the cells was 
then centrifuged for 5 minutes at 900 rpm. The recovered cells were left in 0.25% 
trypsin/EDTA composed by 2500 mg/L trypsin and 380 mg/L sodium EDTA 
(Invitrogen) for 5 minutes at 37°C, and then centrifuged and resuspended in five 
different culture media. The control medium was composed of DMEM/F12 
supplemented with 2.5 µg/mL fungizone, 5000 units/mL penicillin/streptomycin, 1 
µg/mL insulin, 0.5 µg/mL hydrocortisone (Sigma-Aldrich, St. Louis, MO), 0.1 µg/mL 
cholera toxin (Gentaur, Brussels, Belgium), 2 ng/mL EGF, and 10% FBS (all from 
Invitrogen unless otherwise indicated). The four other media were based on the 
control medium, with the following variations: EGF-enriched medium contained 10 
ng/mL EGF; H2O2-supplemented medium contained 20 µM hydrogen peroxide 
solution (Sigma-Aldrich); fibroblast-conditioned medium was prepared as described 
below (in the “Preparation of Fibroblast-Conditioned Medium” section); and human 
serum medium had 10% of human serum (Lonza Group Ltd., Basel, Switzerland), 
instead of FBS. In addition, epithelial cells were also obtained using the explant 
technique.11 Conjunctival tissue was carefully cut in small pieces, and plated in 12-
well plates, using the same culture media described above. Explants were fed by 
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superficial tension until cell growth was observed. After that, more culture medium 
was added. 
Cells were maintained in standard conditions (humidified atmosphere of 5% 
CO2 at 37°C), and the medium was changed every other day. Cell viability was 
evaluated with 0.4% trypan blue solution (Sigma-Aldrich). 
 
Purification Techniques 
To assure the purity of the epithelial culture, two combined techniques were 
used to eliminate contaminating fibroblasts: preplating and differential trypsinization 
with 0.25% trypsin/EDTA. Different times of preplating (1, 2, and 3 hours) and 
trypsinization (2, 5, and 10 minutes) were assayed for effectiveness in eliminating all 
contaminating stromal cells. To determine if cultured cells were epithelial or stromal 
cells, immunostaining for the epithelial marker cytokeratin (CK) 19 and against the 
stromal marker vimentin was performed. 
 
Preparation of Fibroblast-Conditioned Medium 
Fibroblasts isolated as described above were grown until confluence in 80-
cm2 flasks, and they were mitotically inactivated using 10 µg/mL mitomycin C 
(Sigma-Aldrich). Then, 15 mL control culture medium were added. After 24 hours, 
the medium was collected, centrifuged at 1000 rpm for 3 minutes, and the 
supernatant was frozen until used. This procedure was repeated for 7 days. 
Recovered media from the same flask were mixed and filtered through a 0.20-µm 
filter (Sartorius Stedim Biotech GmbH, Goettingen, Germany). 
 
Cell Adhesion Assays With Different Media 
To evaluate adhesion, 20,000 cells/cm2 were seeded in 96-well plates 
(Nunc) and allowed to adhere for 24 hours. After that, medium with nonattached 
cells was removed, and the recovered cells were counted in a hemocytometer 
(Bright-Line Hemacytometer, Sigma-Aldrich). Plating efficiency was calculated using 
the following equation: 
 𝑃𝑙𝑎𝑡𝑖𝑛𝑔  𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦  (%) =   100𝑥(𝑁º  𝑜𝑓  𝑠𝑒𝑒𝑑𝑒𝑑  𝑐𝑒𝑙𝑙𝑠 − 𝑁º  𝑜𝑓  𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑  𝑐𝑒𝑙𝑙𝑠)  𝑁º  𝑜𝑓  𝑠𝑒𝑒𝑑𝑒𝑑  𝑐𝑒𝑙𝑙𝑠  
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 Additionally, the DNA content of the attached cells after 24 hours was 
measured. After removing the media, cells were washed with PBS and Hoechst 
33342 dye (Sigma-Aldrich) was added. After 3 minutes of incubation, cells were 
washed with PBS, and fluorescence was measured at 355 nm excitation and 465 
nm emission wavelengths, using a fluorescence plate reader (SpectraMax M5; 
Molecular Devices, Sunnyvale, CA). That measure is proportional to the amount of 
DNA present in the sample. Three independent experiments were performed in 
triplicates. 
 
Cell Proliferation Assays With Different Media 
To evaluate proliferation, the Alamar Blue (R) colorimetric indicator assay 
(AbD Serotec, Oxford, UK) was used. Alamar Blue is a nontoxic fluorescent dye that 
does not affect viability or proliferation. For proliferation assays, 20,000 cells/cm2 
were seeded in 96-well plates. The Alamar Blue assay was performed at days 1, 2, 
3, 4, 7, 11, and 14. Cells were incubated in medium with 10% vol/vol Alamar Blue 
for 4 hours. After incubation, that medium was recovered, and its fluorescence was 
measured at 560 nm excitation and 590 nm emission wavelengths, using the 
SpectraMax M5 fluorescence plate reader (Molecular Devices). Four independent 
experiments were performed in triplicates. 
 
Colony Forming Efficiency 
For the colony forming efficiency (CFE) assay, 500 cells were seeded in 
each well of a 6-well plates, with the five different culture media. After 7 days, the 
number of colonies with more than eight cells in each well was counted. Additionally, 
the colony size was measured by counting the number of cells in each colony. 
 
Characterization of Conjunctival Cells by Immunocytochemistry 
Fibroblasts and epithelial cells from the established conjunctival cultures 
(passages 1–3) were grown in 8-well multichamber Permanox slides (Nunc). When 
cells reached confluence, they were fixed with ice cold methanol. 
Immunocytochemistry for different epithelial cells (E-cadherin, CK19, and CK7), 
goblet cells (MUC5AC), stromal cells (vimentin and FSP-1), and proliferating cells 
(Ki67) markers (Table 1) was then performed on the fixed cells. For MUC5AC and 
Ki67 staining, cells were blocked in PBS with 4% donkey serum (Sigma-Aldrich) and 
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0.3% Triton X-100 (Sigma-Aldrich) for 1 hour at room temperature (RT). For 
MUC5AC, Ki67, and zonula occludens (ZO)-1, the slides were incubated with 
primary antibodies (Table 1) for 1 hour at 37°C. For E-cadherin, CK19, CK7, 
vimentin, and FSP-1, the slides were incubated with primary antibodies (Table 1) 
overnight at 4°C. Alexa Fluor-conjugated secondary antibodies were applied for 1 
hour at RT. Cell nuclei were counterstained with Hoechst dye. The preparations 
were viewed under an epifluorescence microscope (Leica DMI 6000B; Leica 
Microsystems, Wetzlar, Germany). Negative controls included the omission of 
primary antibodies. All antibodies had been previously tested in our laboratory. The 
number of positive cells for each marker was counted in five different photographs 
from at least three independent experiments. 
 
Characterization of Conjunctival Cells by Western Blotting 
Cultured conjunctival epithelial cells from passages 1 to 5 and conjunctival 
fibroblasts were homogenized in ice cold radioimmunoprecipitation assay (RIPA) 
buffer supplemented with the protease inhibitors 100 µL/ml phenylmethylsulfonyl 
fluoride, 6 µL/ml aprotinin, and 100 nM sodium orthovanadate (all from Sigma-
Aldrich). After incubation on ice for 30 minutes, samples were centrifuged at 14,000 
rpm for 30 minutes at 4°C. The supernatants were collected, and the protein 
concentration was measured using the BCA assay (Pierce, Rockford, IL). 
Proteins in each sample were separated by SDS-PAGE on 10% acrylamide 
gels (Bio-Rad Laboratories, Hercules, CA) according to the method of Laemmli.19 
The separated proteins were transferred to nitrocellulose membranes.20 Membranes 
were blocked in Tris-buffered saline (TBS; Bio-Rad Laboratories) containing 0.05% 
Tween-20 BioXtra (Sigma-Aldrich), 5% milk, and 4% FBS for 1 hour at RT. 
Membranes were incubated with primary antibodies (CK19, CK4, CK7, MUC5AC, 
vimentin, E-cadherin, and ZO-1; Table 1) at 4°C overnight. Proteins recovered as 
described above from human colorectal adenocarcinoma HT29-MTX cells (a kind 
gift by Thécla Lesuffleur, PhD) served as positive controls for CK19 and MUC5AC 
expression.21 Then the membranes were washed with TBS and incubated with 
horseradish peroxidase-conjugated secondary antibodies (Jackson Immuno-
Research Laboratories, Inc.) for 1 hour at RT. Immunoreactive bands were 
visualized by a chemiluminescence method using the ChemiDoc gel documentation 
system (Bio-Rad Laboratories), and images were analyzed with the Quantity One 
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software (Bio-Rad Laboratories). Quantitation of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) assured equal gel loading. Two independent experiments 
were performed. 
 
Table 1. Antibody Sources and Concentrations 
Antibody Host and 
Type 
Dilution 
for IMF 
Dilution 
for WB 
Code Source 
CK19 Mouse mo. 1:50 1:1000 MO888 Dako, Glostrup, 
Denmark 
CK4 Mouse mo. - 1:250 C-5176 Sigma-Aldrich 
CK7 Mouse mo. 1:100 1:200 MS-
1352-P0 
ThermoScientific, 
Rockford, IL 
MUC5AC Mouse mo. 1:500 1:500 MAB-
2011 
EMD Millipore 
Corporation, Billerica, 
MA 
Vimentin Mouse mo. 1:500 1:200 SC-6260 Santa Cruz 
Biotechnology, Santa 
Cruz, CA 
FSP-1 Mouse mo. 1:100 - Ab11333 Abcam, Cambridge, 
UK 
Ki67 Mouse mo. 1:50 - M7240 Dako 
E-cadherin Mouse mo. 1:100 1:1000 610151 BD Bioscience, 
Franklin Lakes, NJ 
ZO-1 Rabbit po. 1:50 1:250 617300 Invitrogen 
AlexaFluor 
448 anti-
mouse IgG 
Donkey 1:150 - A21202 Invitrogen 
AlexaFluor 
647 anti-
mouse IgG 
Goat 1:200 - A21236 Invitrogen 
AlexaFluor 
448 anti-
rabbit IgG 
Donkey 1:100 - A21206 Invitrogen 
Texas Red 
anti-
mouse IgG 
Donkey - 1:5000 715-075-
150 
Jackson Immuno-
Research Laboratories, 
Inc., West Grove, PA 
Goat anti-
rabbit IgG 
Goat - 1:2000 c-2004 Santa Cruz 
Biotechnology 
mo., monoclonal; po., polyclonal. 
 
 
In Vitro Inflammation Model 
Cells from passages 0 to 3 were cultured in 24-well plates at a cell density of 
25,000 cells/cm2. When cells reached confluence they were stimulated with 25 
ng/mL TNF-α (PeproTech, London, UK) for 24 hours. After that, supernatants were 
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collected, and levels of IL-6 were measured with an enzyme-linked immunosorbent 
assay (IL-6 ELISA; Diaclone, Besançon, France), following the manufacturer's 
instructions. Nonstimulated cells were used as controls for each experiment. Three 
independent experiments were performed for each cell passage. 
 
Statistical Analysis 
Statistical analyses were done using Statistical Procedures for the Social 
Sciences software (SPSS 15.0; SPSS Inc., Chicago, IL). Data were expressed as 
means ± SEM. Levene's test was used to evaluate the equality of variance. When it 
existed, a one-way ANOVA was performed, followed by pairwise comparisons 
(Tukey test). When there was no equality of variance, a robust test (Brown-Forsythe 
test) was performed, followed by pairwise comparisons with Games-Howell test. 
Differences were considered to be significant when P was less than or equal to 0.05. 
 
 
RESULTS 
 
Acquisition and Purification of Conjunctival Epithelial Cells 
Epithelial cells were efficiently expanded from single cell suspensions and 
from explants. There were no significant differences in cell numbers obtained 
between the two disaggregation methods. However, recovered cell viability was 
significantly higher with the enzymatic method than with the combined enzymatic 
and mechanical one (P = 0.0024, Fig. 1A). Explants promoted more rapid expansion 
of cells. After 11 days, a mean of 98,707 ± 12,967 cells/explant were obtained. In 
addition, this technique was easier and faster to perform. For those reasons, 
expansion from explants was used for the rest of the studies, except for adhesion 
and colonies assays. 
Purification of the cultures by either preplating or differential trypsinization 
produced epithelial cells with no contaminating fibroblasts. By discarding cells 
attached after preplating for 2 hours or by removing cells after 5 minutes of 
trypsinization, we obtained pure epithelial cell cultures (Fig. 1B). 
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Figure 1. Establishment of epithelial cell culture. Two disaggregation methods were studied 
(A). Briefly, the enzymatic method consisted of a 2 hour incubation with dispase and 5 
minutes incubation with trypsin/EDTA. The combined method included a mechanical scraping 
between both incubations. Viability of recovered cells was significantly higher with the 
enzymatic method (P = 0.0024) than with the combined one (n = 9). Two purification 
techniques were assayed (B). After 2 hours of preplating all the fibroblasts were attached. 
After 5 minutes of contact with trypsin, all the fibroblasts were detached, whereas most of the 
epithelial cells still remain attached to the culture surface (n = 3). ***P ≤ 0.005. 
 
Evaluation of Five Different Cell Culture Media 
To evaluate the suitability of the five different culture media in maintaining 
epithelial cell cultures, different parameters were analyzed: (1) cell adhesion to the 
plastic culture surface, (2) cell growth and proliferation, (3) colony-forming efficiency, 
and (4) maintenance of the epithelial phenotype (CK19+ cells) and proliferative 
capacity (Ki67+ cells). 
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Cell Adhesion 
Cell adhesion was measured in passage 0 cells at 24 hours, using two 
different indicators: seeding efficiency and DNA content of attached cells (Fig. 2). 
Fibroblast-conditioned medium resulted in better promotion of cell attachment. 
Seeding efficiency of cells cultured with this medium was significantly higher when 
compared with that of cells cultured with control (P = 0.023), EGF-enriched (P = 
0.035), and human serum (P = 0.005) media. There were no significant differences 
in DNA content among the cells in the different media. 
 
Figure 2. Cell adhesion. The suitability of five different culture media in promoting cellular 
attachment was measured in passage 0 cells with two procedures. (A) Seeding efficiency was 
higher in cells cultured with the fibroblast-conditioned medium than in those of the control (P = 
0.023), EGF-enriched (P = 0.035), and human serum (P = 0.005) media. (B) No significant 
differences were found in the DNA content of attached cells cultured with the different media. 
*P ≤ 0.05; ***P ≤ 0.005. 
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Cell Proliferation 
Cell proliferation with the five different media was assayed at different time 
points from days 1 to 14 (Fig. 3) in passage 1 cells. At day 11, proliferation rates 
with fibroblast-conditioned and human serum media were significantly greater than 
that of the control medium (P = 0.015 and P = 0.008, respectively). Cells cultured 
with H2O2-supplemented medium did not survive for 14 days. Cell proliferation rate 
was significantly higher with human serum medium after 14 days when compared 
with that of cells cultured with control (P < 0.001), EGF-enriched (P < 0.001), and 
fibroblast-conditioned (P = 0.002) media. Fibroblast-conditioned medium also 
allowed higher proliferation rates compared with control and EGF-enriched media (P 
< 0.001 and P < 0.001, respectively) at day 14. 
 
 
Figure 3. Cell proliferation. The effectiveness of different media in inducing cell proliferation 
was evaluated with Alamar Blue assay in passage 1 cultured cells. The highest proliferation 
rates were reached with the human serum medium, followed by the fibroblast-conditioned 
medium. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005, compared with control. 
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Colony Forming Efficiency and Colony Size. 
Passage 0 cells grown in human serum medium showed the highest CFE 
(control, P = 0.049; H2O2-supplemented, P = 0.028; Fig. 4A). Furthermore, colonies 
formed using human serum medium were significantly larger than those formed 
using the four other culture media (control, P = 0.001; EGF-enriched, P = 0.001; 
H2O2-supplemented, P = 0.001; fibroblast-conditioned, P = 0.006; Fig. 4B). 
 
 
Figure 4. Colony forming efficiency and colony size. The number and size of colonies was 
measured in passage 0 cells cultured with the different media. Cells cultured in human serum 
medium showed the highest CFE (A). These colonies were also the largest ones (B). *P ≤ 
0.05; **P ≤ 0.01; ***P ≤ 0.005. 
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Epithelial Phenotype and Proliferation Capacity 
Cells from passage 1 grown in the different media were evaluated for CK19 
expression (n = 3). There were no significant differences among the five media (Fig. 
5). Evaluation of Ki67 expression (n = 3), a marker for proliferative capacity, was 
also performed. Fibroblast-conditioned and human serum media maintained the 
proliferative capacity of cultured cells significantly better than the control medium (P 
= 0.002 and P = 0.019, respectively; Fig. 5). 
 
 
Figure 5. Percentage of positive cells for CK19 and Ki67. There were no significant 
differences in CK19+ cell numbers between cells cultured in the different media. Fibroblast-
conditioned and human serum media showed a higher percentage of Ki67+ cells than the 
control medium. *P ≤ 0.05; ***P ≤ 0.005. 
 
Characterization of Cells Grown in Human Serum Medium 
As the human serum medium showed better results than the others, cells at 
different passages cultured in this medium were characterized by 
immunocytochemistry and Western blotting (Fig. 6). Cells from passages 1, 2, and 3 
grown in human serum medium were evaluated by immunofluorescence assay for 
six different markers (Table 2). In addition, epithelial cells from passages 0, 1, 2, 3, 
and 5, and human conjunctival fibroblasts were also evaluated by Western blotting 
(Fig. 6). Cells from passages 0 to 3 were positive for epithelial markers CK4, CK19, 
and CK7, and negative for stromal markers vimentin and FSP-1, whereas the 
opposite was true for fibroblasts. Epithelial cells from passage 5 showed an 
intermediate phenotype characterized by some expression of both epithelial and 
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stromal markers and by different morphology. By immunofluorescence, some cells 
expressing MUC5AC were detected, but it was not detected by Western blotting. 
There was a significant increase in the amount of cells expressing MUC5AC from 
passage 1 to 3 (P = 0.05), and a decrease in the percentage of cells expressing 
Ki67 from passage 1 to 2 (P = 0.021) and passage 3 (P = 0.003). 
 
Figure 6. Characterization of cells cultured in human serum medium. Representative images 
of the different markers. All cells were positive for CK19 and CK7 ([A, B], respectively), 
whereas few MUC5AC-expressing cells were detected (C). Cells with proliferative capacity 
were identified by Ki67 staining (D). Cultured epithelial cells did not show staining for the 
stromal markers vimentin (E) or for FSP-1 (F). Scale bars: 30 µm (A–F). Also, some markers 
were evaluated by Western blotting (G). HT-29 cells were used as control for CK19 and 
MUC5AC. P0-P5: epithelial cells from passages 0 to 5. Fib: human conjunctival fibroblasts. 
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Table 2. Percentage of Positive Cells for Each Marker in Passages 1 Through 3 
Marker Specificity % P1 + Cells % P2 + Cells % P3 + Cells 
E-cadherin Epithelium; 
adherens junctions 
99.9 ± 0.1 99.57 ± 0.43 100 ± 0 
CK19 Stratified epithelium 99.6 ± 0.23 100 ± 0 99.75 ± 0.2 
CK7 Secretory 
epithelium 
99.73 ± 0.14 99.9 ± 0.06 99.9 ± 0.08 
MUC5AC Mucin, goblet cells 0 ± 0 5.82 ± 2.91 8.82 ± 0.41 
Vimentin Stromal cells 8.72 ± 2.92 7.2 ± 2.75 18.05 ± 3.63 
FSP-1 Fibroblasts 0.27 ± 0.27 0.32 ± 0.19 0.46 ± 0.38 
Ki67 Proliferating cells 39.12 ± 2.16 27.36 ± 2.08 17.68 ± 1.99 
 
 
Evaluation of Intercellular Junctions 
Cells cultured in human serum medium expressed E-cadherin and ZO-1, 
which means that they maintained adherens and tight junctions, respectively (Fig. 
7). Immunofluorescence assays confirm that both proteins were expressed in the 
plasma membranes between neighboring cells. In Western blots, immunoreactive 
bands appeared for each protein at the appropriate molecular weight (120 KDa for 
E-cadherin and 225 KDa for ZO-1). Both proteins were expressed in epithelial cells 
from passage 0 to 3. Epithelial cells in passage 5 and fibroblasts did not express 
either E-cadherin or ZO-1. 
 
Figure 7. Adherens and tight junctions in cultured conjunctival epithelial cells. (A) 
Representative image of E-cadherin (left) and ZO-1 (right) expression in cultured cells. Scale 
bars: 30 µm. (B) The same proteins were also detected by Western blotting in epithelial cells 
from different passages. 
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In Vitro Inflammation Assay 
Cells treated with TNF-α secreted higher amounts of IL-6 than non-
stimulated cells (Fig. 8). This increase of IL-6 secretion in cultured cells was 
statistically significant in passages 0 (P < 0.001), 1 (P = 0.009), and 3 (P < 0.001). 
Cells in passage 2, also tended to secrete more IL-6, but the increase was not 
significant (P = 0.089). 
 
 
Figure 8. IL-6 secretion by epithelial cells treated with TNF-α. Treated cells from passages 0, 
1, and 3 showed a significant increase in the secretion of IL-6 compared with untreated cells 
(P < 0.001, P = 0.009, and P < 0.001, respectively). **P ≤ 0.01; ***P ≤ 0.005. 
 
 
DISCUSSION 
In this study we developed an optimized method for expanding human 
conjunctival epithelial cells from cadaveric donors for at least 3 passages. Others 
have used cadaveric samples as a source for conjunctival primary cultures.22 
However, they pooled tissues from 8 to 10 eyes to produce enough cells for culture. 
In contrast, with our method we obtained enough cells from each eye to establish 
one culture per eye, obviating the need to pool samples from different eyes. Some 
other authors also used cadaveric samples, but they only required a small amount of 
 
CHAPTER 2                       Study 5. A new human primary epitelial cell culture model 
	   250 
cells for their studies, so they did not optimize cell expansion nor did they establish 
long-term cultures. 
One of the most common problems that researchers face when working with 
primary epithelial cell cultures is stromal cell contamination, which has huge 
implications.23 This problem is not usually reflected in the literature, but it produces a 
high number of failed experiments, which means a waste of resources. We decided 
to try two combined techniques to eliminate fibroblasts from our epithelial cultures: 
preplating and differential trypsinization. Usually, researchers remove stromal cells 
from cultures by scraping away the contaminating cells. However, this procedure is 
quite subjective, and it is used only when the contamination by the stromal cells is 
big enough to be detected. The influence of the cocultured stromal cells, until they 
are removed, can alter some results.24 Recently, it has been demonstrated that the 
effects of coculture can persist for weeks after epithelial cell isolation.25 In addition, 
in some experiments a coculture situation can exist without knowing. 
With our two simple strategies of preplating and trypsinization, we avoided 
the risk of fibroblast contamination. Neither procedure is based on morphologic 
evaluation; rather we used the inherent differential properties of epithelial and 
stromal cells, which make the procedures more objective. These procedures may 
result in the loss of some epithelial cells; however, the improved reliability of the 
outcomes achieved by almost completely eliminating the possibility of stromal 
contamination is worth it. Something similar happens with feeder layers. While we 
may have obtained higher efficiency rates using feeder layers, without them we 
avoided zoonosis and some other risks, such as transmission of prions and animal 
viruses.16,26 Another important advantage of our culture procedure without feeder 
layers is the simplicity of it. 
As the initial cell numbers are being limited with the purification techniques, 
and feeder layers are not being used, we consider the use of an optimized culture 
medium of paramount importance. We started by using the culture medium that 
maintains an immortalized conjunctival epithelial cell line.4 With this medium as a 
starting point, the effect of different supplements and growth factors in growth and 
differentiation was evaluated. With EGF and H2O2 we did not obtain the expected 
results. Contrary to the description by Pan et al.18 in corneal epithelial cells, even 
small amounts of H2O2 adversely affected the viability of our conjunctival epithelial 
cells. 
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Several studies have revealed the importance of the signals that cells 
receive in their native tissues. In mimicking the stem cell niche in culture, epithelial 
cells better maintain progenitor cell-like in vivo characteristics.27 Most of the signals 
received by conjunctival epithelial cells come from conjunctival fibroblasts.28 For that 
reason we used fibroblast-conditioned medium. As expected, the results with this 
medium were better compared with control medium. Proliferation rates and Ki67 
levels were significantly higher, and there was an increase in cell attachments at 24 
hours. These results are in accordance with a published report.29 However, the best 
results came from human serum medium. Although cell adhesion with this medium 
was worse than with the control one, the promotion of growth as shown by Ki67 
proliferation assay and the CFE was good enough to compensate for that 
inconvenience. These results are in contrast with some others.30,31 With human 
serum, we not only obtained better results, but we also avoided the use of animal 
serum, such as FBS. Although FBS is widely accepted, when using cultured cells for 
tissue engineering or transplants it is better to avoid the use of animal products so 
as to reduce the risk of zoonosis and possible rejection.16,30 Great efforts are being 
made to design a medium without animal products. Recently, Ang et al.31 proposed 
the use of cord-blood serum as an alternative to adult human serum and FBS. They 
reached proliferation rates similar to those obtained with FBS, while their results 
were worse when using adult human serum. Although we think that cord blood is an 
interesting source of serum, its use in our cultures was not justified. Our results with 
human serum were very good and cord-blood serum availability is lower, and its 
price is higher than that of human serum. In addition, with this culture medium we 
could see that cells began to stratify when maintained in culture after reaching 
confluence (data not shown). Thus, human serum medium is the better choice for 
our purposes. Moreover, in the future it may be possible to use autologous serum to 
culture human cells for transplantation. 
With the selected human serum culture medium, we analyzed different 
markers to determine the resulting phenotype of the cultured cells. Cells from 
passages 0 to 3 expressed all of the epithelial markers analyzed, and they did not 
show stromal characteristics. However, a small percentage of cells positive for 
cytokeratins were also positive for vimentin, although immunofluorescence staining 
intensity was weak. The absence of detectable FSP-1 protein suggested that these 
cells were not fibroblasts. Some authors suggested that cells expressing CK19 and 
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vimentin at the same time could be epithelial stem cells.32,33 Further studies with this 
population of cells could help to test this hypothesis. 
Cells from passage 5 showed an intermediate morphology and phenotype 
between epithelial and stromal cells. A possible explanation for this observation is 
that the cells were undergoing an epithelial-mesenchymal transition,34 since they 
began to express vimentin at the same time that E-cadherin expression was 
reduced. In our cells, we observed by immunofluorescence assay a small amount of 
MUC5AC that increased throughout the passages through passage 3. This could be 
due to an increase in cell differentiation that occurred concurrently with the decrease 
in cell proliferation shown by the number of cells expressing Ki67+. However, in 
contrast with immunofluorescence microscopy, MUC5AC was not detected by 
Western blotting. The small percentage of MUC5AC-producing cells was probably 
not enough to allow immunoblot detection. Also, the homogenization process to 
isolate the protein could damage the MUC5AC. These results indicate the 
importance of characterizing the cultures by both immunohistochemistry and 
Western blotting. 
In situ, the conjunctiva functions as a barrier for small particles and 
microorganisms, although the conjunctival barrier is not as tight as corneal barrier.35 
The effectiveness of this barrier depends not only on mucous production, but also 
on intercellular junctions.36 We showed that the cultured conjunctival epithelial cells 
maintained tight junctions (ZO-1) and adherens junctions (E-cadherin). These 
results indicate that the cultured cells could potentially act in vitro as a biological 
barrier. 
Finally, we performed an in vitro inflammation assay to determine if the 
cultured cells were responsive to a well-known inflammatory stimulus. We analyzed 
the secretion of IL-6 because it is one of the most important molecules in 
conjunctival inflammation. Tumor necrosis factor-α is reported to induce IL-6 
secretion by conjunctival epithelial cells in vitro.37 The measured increase in IL-6 
secretion by the TNF-α–treated cells in our culture system indicates that cultured 
cells respond to cytokines. We expected these results because TNF-α is one of the 
major stimuli for the secretion of IL-6. We observed an increased release of IL-6 
while the cells passaged in culture. This may have been due to increased cellular 
differentiation (as suggested by increased numbers of MUC5AC-positive cells and 
decreased numbers of Ki67 positive cells) that could make them more sensitive to 
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several signals. Although the study of only one cytokine is not enough to represent 
the complexity of ocular surface inflammation, the ability of our cultured conjunctival 
epithelial cells to respond to TNF-α and secrete IL-6 opens the possibility of using 
them in other more complex inflammation assays. 
Optimizing the culture of human conjunctival cells is an issue of great 
importance, not only to perform in vitro experiments, but also for tissue engineering. 
We have developed, to the best of our knowledge, the first complete and optimized 
protocol to expand human conjunctival cells from cadaveric donors. We have shown 
the feasibility of using this source of tissue for cell culture. Moreover, we have 
demonstrated that it is possible to subculture these cells up to three times without 
losing the unique characteristics of the native epithelia. We obtained good 
performances despite the disadvantages of this underestimated source of tissue. 
Our results suggest that an even higher efficiency could be reached in the future if 
small cell samples from living donors are used for further transplantation purposes. 
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ESTUDIO 6 
 
 Hasta el momento se ha demostrado cómo obtener los tres tipos celulares 
necesarios para el desarrollo de un modelo conjuntival completo: células epiteliales, 
células caliciformes y fibroblastos. Pero dicho modelo debe ser, necesariamente, 
tridimensional.  
 Para elaborar el modelo tridimensional se emplearán técnicas de ingeniería 
de tejidos. Además de las células, es necesario un andamiaje polimérico. Este 
estudio aborda el análisis de distintos biomateriales para su uso como andamiaje de 
células conjuntivales y concluye con la elección de uno que resulta adecuado para 
el cultivo de las células conjuntivales: las matrices de fibrina. 
 
 
STUDY 6 
 
The procedures to obtain the different cell types needed to develop a new and 
complete in vitro model of human conjunctiva have been shown until now. But our 
purpose is to achieve the construction of a three-dimensional model. 
Tissue engineering techniques will be used to construct the three-dimensional 
model. Apart from cells, a polymeric scaffold is also needed. In this study, we 
address the analysis of several biomaterials to be used as scaffolds for conjunctival 
cells. The study finishes with the election of the most appropriate biomaterial in our 
hand: fibrin-based matrices. 
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Selection of the Appropriate Scaffold to Culture Conjunctival Cells 
 
ABSTRACT 
 
This study analyzed two formulations of gellan gum/spermidine hydrogels and 
fibrin-based matrices made with human plasma as scaffolds for human conjunctival 
cells.  
The conjunctival epithelial cell line IOBA-NHC was used to study cell 
adhesion, proliferation, and viability to the different biomaterials.  
Gellan gum hydrogels were more transparent than fibrin matrices, whereas 
fibrin matrices handling was easier. Conjunctival epithelial cells adhered better to the 
surface of fibrin matrices than to gellan gum hydrogels. The highest cell proliferation 
rate measured with alamarBlue® reagent was found when cells were cultured on the 
surface of fibrin matrices. To further investigate the negative results obtained in the 
gellan gum hydrogels, cell viability was measured with the In Vitro Toxicology assay, 
XTT based. With that experiment we could corroborate that gellan gum hydrogels 
were cytotoxic to conjunctival cells, because viability levels were under 25%, similar 
to the levels obtained with the toxicity positive control benzalkonium chloride (BAK).  
In summary, in this study we found that gellan gum/spermidine hydrogels 
were not compatible with the studied cells. On the contrary, fibrin-based matrices 
allowed conjunctival epithelial cell growth not only on the surface of the matrices but 
also inside them. In conclusion, fibrin-based matrices can be use as scaffolds to 
culture conjunctival epithelial cells.  
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INTRODUCTION 
 
 The experimental systems that have been used to study conjunctiva are 
based in two-dimensional (2D) cultures. However, they do not recapitulate the three-
dimensional (3D) organization of tissues. (Shamir and Ewald, 2014) Then, the 
information that can be extracted from 2D cultures is incomplete to understand the 
biology of the tissue. To develop a 3D model that recapitulates the human 
conjunctival tissue, a scaffold that represents the stroma is needed.  
 The term scaffold is used in regenerative medicine to describe the non-
cellular component of the engineered tissue. It gives support to cells and adds a 3D 
structure. Usually, natural or synthetic biomaterials that are biocompatible and 
biodegradable are used as scaffolds. Some of the most promising scaffolds are 
hydrogels, which are 3D networks formed by highly hydrophilic polymers that imbibe 
great amounts of aqueous fluids.  
In this research, two types of hydrogels were studied to determine their 
convenience to be used as scaffolds in an engineered conjunctiva: 1) hydrogels 
made from gellan gum and spermidine, and 2) fibrin-based matrices. Gellan gum is 
a polysaccharide produced by the bacteria Sphingomonas elodea (Prajapati et al., 
2013). It is water-soluble, and is widely used as a food aditive. Spermidine is a 
natural polyamine, which exerts crucial roles in cell survival and anti-aging 
properties (Ramot et al., 2011; Minois, 2014). Fibrin is a natural protein present in 
the serum. When an injury occurs, thrombin converts fibrinogen to fibrin, forming a 
clot. Fibrin has been extensively used as a scaffold for tissue engineering (Ahmed et 
al., 2008). 
The purpose of this study is to find an appropriate biomaterial to be used as 
a scaffold for human conjunctival cells.  
 
 
METHODS 
 
Gellan Gum/Spermidine Hydrogels  
 Two different formulations of gellan gum/spermidine hydrogels were 
obtained from the Department of Pharmacy and Pharmaceutical Technology, 
 
CHAPTER 2                      Study 6. Selection of scaffolds to culture conjunctival cells 
	   265 
Faculty of Pharmacy, University of Santiago de Compostela. Formulation 1 (F1) 
composition was 5 mg/ml gellan gum and 2 mg/ml spermidine. Formulation 2 (F2) 
composition was 5 mg/ml gellan gum, 2 mg/ml spermidine, 6 mg/ml condroitin 
sulphate, and 20 mg/ml albumin.  
 
Fibrin Matrix Preparation 
Fibrin matrices were prepared from human fresh frozen plasma that was 
obtained from Centro de Hemoterapia y Hemodonación de Castilla y León 
(CHEMCYL, Valladolid, Spain). Matrices were produced by mixing plasma (400 
µl/ml) with 40 µl/ml tranexamic acid (Rottapharm, Valencia, Spain) and 40 µl/ml 
calcium chloride (Braun, Barcelona, Spain), all diluted in DMEM/F12 culture medium 
(Invitrogen-GIBCO, Inchinnan, UK).   
 
Cell Culture 
IOBA-NHC conjunctival cells (Diebold et al. 2003) from passages 70 to 75 
were used in all the experiments. Cells were grown in DMEM/F-12 medium  
supplemented with 10% FBS, 5,000 U/ml penicillin, 5 mg/ml streptomycin, 2.5 µg/ml 
fungizone, 2 ng/ml human EGF, 1 µg/ml bovine insulin, hydrocortisone (Sigma-
Aldrich, St. Louis, MO, USA), and 0.5 µg/ml (all from Invitrogen unless otherwise 
indicated).  Cells were maintained at 37º C in a 5% CO2-95% air atmosphere and 
the medium was changed every other day.  
 
Biomaterials Analysis under Phase Contrast Microscope 
 The structure of the biomaterials and the morphology of the cells in contact 
with them was evaluated by phase contrast microscopy, using the Eclipse TS100 
microscope from Nikon (Tokyo, Japan). Micrographs were taken every other day 
from day 1 to day 19. 
 
Sample Processing and Staining 
Gellan gum/spermidine hydrogels and fibrin matrices were washed with PBS 
and fixed with 4% formaldehyde. Fixed samples were processed and paraffin-
embedded. Then, five µm sections were cut and collected in poly-L-lysine coated 
slides. Sections were then stained with hematoxylin and eosin (H/E) and viewed 
under the light microscope Eclipse TS100. 
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Cell Proliferation Measurement with the Cell Proliferation Assay Reagent 
alamarBlue® 
 To evaluate proliferation, the non-toxic fluorescence dye alamarBlue® (AbD 
Serotec, Oxford, UK) was used. Cells grown on the surface of gellan hydrogels or 
fibrin matrices were incubated in medium with 10% alamarBlue® for 6 hours. Then, 
the medium was recovered, and its fluorescence was measured at 560 nm 
excitation and 590 nm emission wavelengths, using the SpectraMax M5 
fluorescence plate reader (Molecular Devices, Sunnyvale, CA, USA). Cells grown in 
plastic were used as control. The fluorescence measure obtained for the control at 
24 hours was set as 1. Then, fold increase was calculated.  
 
Cell Viability Measurement with the In Vitro Toxicology Assay kit, XTT based   
 Viability of cells in contact with gellan gum hydrogels was evaluated with the 
XTT test (Sigma-Aldrich). This is a colorimetric assay based on the tetrazolium 2,3-
bis[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt 
(XTT). Cells were incubated with XTT diluted in fresh phenol red-free RPMI medium 
(Invitrogen-GIBCO) for 17 hours at 37º C. As a control of cytotoxicity 0.001% 
benzalkonium chloride (BAK) was used. After incubation, absorbance of each well 
was measured at 450 nm (reference wavelength: 620 nm). The absorbance value 
obtained is proportional to the number of viable cells.  
 
Statistical Analysis 
 Data were shown as mean ± standard error of the mean (SEM). To analyze 
differences between means a Student t test was performed. Differences were 
considered to be significant when p ≤ 0.05.  
 
 
RESULTS 
 
Macroscopic Evaluation 
The macroscopic appearance of the different biomaterials differs notably. 
Both formulations of gellan gum/spermidine hydrogels were completely transparent, 
while fibrin matrix was opaque.  
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The manipulation was also very different depending on the composition. 
Gellan gum/spermidine hydrogels were hard to manipulate, because they broke 
easily. On the contrary, fibrin matrix could be holded with forceps without damaging 
it, as observed in Figure 1.   
 
Figure 1. Photographs from the two formulations of gellan hydrogels and from a 
fibrin matrix. The transparency of gellan hydrogels can be observed.  
 
 
Conjunctival Cells Adhered to Fibrin Matrices Better than to Gellan 
Gum/Spermidine Hydrogels 
A small amount of the conjunctival epithelial cells added to gellam gum 
hydrogels were able to adhere to their surface, as seen in Figure 2. Most of the 
seeded cells showed rounded morphology and do not adhere to the surface of the 
hydrogels after 24 hours, as observed by phase contrast microscopy. On the 
contrary, cells seeded on to fibrin matrices showed good adhesion.    
 
 
Figure 2. Rounded cells that are not attached can be seen in F1 and F2 gellan gum 
formulations micrographs (left and middle). Cells growing over a fibrin matrix are shown in the 
right micrograph.  
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Gellan gum/spermidine hydrogels and fibrin matrices were fixed, processed, 
and stained with hematoxylin/eosin to check if conjunctival cells were able to cover 
the surface of the materials.  
In the two different formulations of gellan gum/spermidine hydrogels no cells 
were observed (Figure 3a, b). By contrast, conjunctival cells added above fibrin 
matrices (Figure 3c) or incorporated inside them (Figure 3d) remained viable and 
proliferate. 
 
Figure 3. Sections of seeded gellan hydrogels (a, b) and fibrin matrices 
(c, d) stained with hematoxylin/eosin. No cells were observed in F1 (a) or 
F2 (b) hydrogels. Conjunctival cells grew on the surface of fibrin matrices 
(c) and inside them (d). Magnification: X10 (a, b), and X20 (c, d). 
 
Cells Cultured on the Surface of Fibrin Matrices Showed the Highest 
Proliferation Rates 
 The proliferation rate of conjunctival epithelial cells grown on the surface of 
gellan gum hydrogels and fibrin matrices, and inside fibrine matrices was evaluated 
periodically up to 21 days. Cells grown on standard plastic cell culture surface were 
used as control. The two gellan gum hydrogel formulations studied showed similar 
results. A small increase in proliferation was observed until day 9. After that day, 
proliferation rate decreased and maintained lower levels up to day 21. However, that 
proliferation rate was always significantly lower than that of those cells grown in 
plastic (Figure 4).  
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Figure 4. Cell proliferation rates were measured with alamarBlue® 
assay. Significantly lower levels were observed when the cells were 
cultured on the surface of gellan gum hydrogels (red and blue lines).  
 
The proliferation in fibrin matrices was evaluated using the fibrin matrices in 
two different ways: as scaffolds (culturing the cells inside the matrix) and as 
supports (culturing the cells on the surface of the matrix). Conjunctival epithelial cells 
proliferate in both conditions, although the proliferation rates were higher when cells 
were grown on the surface of the matrices (Figure 5, blue line). 
 
 
Figure 5. Cell proliferation rates were measured with alamarBlue® 
assay. Significantly higher levels were observed when the cells were 
cultured on the surface of fibrin matrices (blue line). 
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Gellan Gum/Spermidine Hydrogels Decreased Conjunctival Cell Viability 
 The low cell adhesion and cell proliferation rates obtained when conjunctival 
epithelial cells were seeded in gellan hydrogels could be due to cytotoxicity. To 
address this issue, cell viability was measured with the in vitro toxicology assay XTT. 
The values obtained for cells growing in plastic (positive control) were set as 1. The 
conjunctival epithelial cell viability percentage significantly decreased when cells 
were seeded on both gellan gum hydrogel formulations compared to that of cells 
seeded on plastic (Figure 6). Moreover, viability levels were similar to those obtained 
with BAK, the negative control. 
 
 
             Figure 6. Cell viability measured with the XTT test. BAK, benzalkonium chloride.  
 
 
DISCUSSION 
 
 The identification of a good scaffold is an important and difficult issue that 
must be set up before starting the development of an engineered tissue. In this 
research we analyzed the feasibility of two potential scaffolds for conjunctival 
modelling: gellan gum/spermidine hydrogels and fibrin matrices.  
 The epitheliall cell line IOBA-NHC derived from human conjunctiva was 
used to perform the first assays, because primary cultures are not always available.  
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Gellan gum hydrogels have been proposed for several clinical applications 
(Cencetti et al., 2011; Lee et al., 2012; Douglas et al., 2014), including drug delivery 
to the posterior segment of the eye (Chen et al., 2012; Duan et al., 2015). Despite 
the good results showed by other authors, we observed cytotoxicity and we were not 
able to maintain human conjunctival viable cells on the gellan gum/spermidine 
hydrogels. Therefore, we renounced to use these hydrogels as scaffolds for 
conjunctival cells. 
 On the contrary, fibrin matrices allowed conjunctival epithelial cell culture. 
IOBA-NHC cells attached to the matrices, and they were able to proliferate for 21 
days on the surface of them. Moreover, cells on the surface of fibrin matrices 
exhibited the best proliferation rates, even higher than those in plastic. Fibrin has 
excellent properties that led researchers and clinicians to extend its use. It is 
routinely used as glue in different surgical procedures, including conjunctival grafts 
after pterygium excesion (Sandra et al., 2014; Malhotra et al., 2015). In addition, 
fibrin has also been used as a scaffold for different engineered tissues, such as 
dermis (De la Puente et al., 2011), cornea (Han et al., 2002; Alaminos et al., 2006), 
and even for rabbit conjunctiva (Safinaz et al., 2014). Therefore, our results are in 
agreement with published reports.  
 In summary, in this study we analyzed two types of biomaterials that could 
be used in conjunctival tissue engineering. Our results led us to conclude that fibrin 
matrices are a good scaffold to develop a 3D model of human conjunctiva. 
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Chapter 3 
DEVELOPMENT OF A THREE-
DIMENSIONAL MODEL OF 
HUMAN CONJUNCTIVA 
 
 
 
 
 
 
 
 
“No vayas donde te lleve el camino,  
ve donde no hay camino y deja un rastro” 
------------------------------------------------------------------------------- 
“Do not go where the path may lead,  
go instead where there is no path and leave a trail” 
 
― Ralph Waldo Emerson 
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ESTUDIO 7 
 
 En el estudio anterior se analizaron distintos biomateriales para obtener uno 
que resultara adecuado para desarrollar un modelo tridimensional de conjuntiva 
humana. Previamente habían sido optimizados los protocolos de cultivo de las 
células a partir de las muestras disponibles. Por lo tanto, ya se dispone de todos los 
materiales necesarios para elaborar un modelo tridimensional: células y andamiaje.  
 En este estudio se lleva a cabo el desarrollo y la caracterización de un 
nuevo modelo tridimensional de conjuntiva humana, elaborado con células 
primarias y matrices biocompatibles preparadas a partir de fibrina humana.  
 
 
STUDY 7 
 
The previous study analyzed different biomaterials to select the most 
appropriate one to culture human conjunctival cells. Formerly, we developed the 
protocols to isolate and expand conjunctival cells from available sources. Therefore, 
the materials needed to develop a three-dimensional model, cells and scaffolds, are 
now available.  
This study presents the development and characterization of a new three-
dimensional model of human conjunctiva made with primary cells and biocompatible 
fibrin matrices.  
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Development of a Three-Dimensional Model of Normal Human Conjunctiva 
 
ABSTRACT 
 
Aim: The aim of this study was to develop a three-dimensional model of human 
conjunctiva that can be used to perform physiology and pathophysiology 
experiments within one week.  
Methods: Fibrin-based matrices (derived from human plasma or cryoprecipitate) 
were used as scaffolds to develop the three-dimensional model. Cells were obtained 
from conjunctival tissue obtained from cadaveric donors. Immunofluorescent 
staining against CK19, HPA, and Ki67 was performed on the cells cultured in fibrin 
matrices. Proliferation was measured with alamarBlue® assay. The structure of the 
matrices and the morphology of the cells were studied with scanning electron 
microscopy (SEM). 
Results: Fibrin-based matrices supported conjunctival cell growth. Epithelial cells 
grew on the surface of the scaffold and stratified in different layers, which numbers 
increased over time. Epithelial cells retained epithelial markers and some of them 
had mucins. Fibroblasts showed better proliferation rates on plasma matrices, 
whereas epithelial cells proliferated more on cryoprecipitate matrices. In addition, 
the number of Ki67 positive epithelial cells was higher in cryoprecipitate matrices. 
SEM micrographs showed that epithelial cells covered the surface of the scaffold 
and had microvilli. Fibroblasts were integrated in the scaffold and showed elongated 
shape.   
Conclusions: A new three-dimensional model of human conjunctiva has been 
developed. The different results obtained with the two types of fibrin-based matrices 
showed that this model is versatile. The results also suggested that epithelial cells 
grown on the surface of fibrin scaffolds are polarized, indicating functionality.  
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INTRODUCTION 
 
The conjunctiva is the mucous membrane that lines with the limbal cornea 
and covers the inner surface of the eyelids. Although this tissue has been less 
studied than the cornea, it is essential for the maintenance of the ocular surface.  
The conjunctiva is in the cause and/or suffers the consequences of several 
pathologies, such as dry eye disease, Sjögren’s syndrome, and allergic 
conjunctivitis, among others. These are high-prevalent diseases, what makes 
imperative its study.  
However, there are not complete in vitro models to study human conjunctiva. 
In vitro studies are often performed in immortalized cell lines, what can be very 
useful for initial approaches. Nevertheless, researchers should be cautious when 
extrapolating these results. It has been demonstrated that cell line behavior can 
differs significantly from primary cells directly obtained from the tissue.  
In addition to this limitation, in vitro models are usually cell monolayers that do 
not recapitulate the three-dimensional complexity of the native tissue. Consequently, 
there is a large gap between our knowledge of cellular processes and our 
incomplete understanding of the biology at the tissue level (Shamir y Ewald, 2014). 
The conjunctiva is comprised by the epithelium anchored to the underlying stroma. 
Therefore, a good model of conjunctiva should contain, at least, a three-dimensional 
scaffold representing the stroma with fibroblasts inside, and a stratified epithelium 
anchored to that scaffold. In addition, the epithelium should maintain mucus-
secretion capacity.  
Tissue engineering has provided the necessary knowledge to combine 
biomaterials and different cell types to produce tissue equivalents that can be used 
for research or transplantation. In the last years, some attempts to elaborate 
conjunctival equivalents have been reported, most of them focused to clinical use 
(Schrader et al., 2009; Zhou et al., 2014). There are a few three-dimensional models 
of conjunctiva that can be used to perform in vitro experiments, although not all of 
them include stroma and fibroblasts (Chung et al., 2007). One main disadvantage of 
these models is the time needed to obtain them. Usually, researchers must wait for 
at least three weeks to use them. This is time-consuming and often it is very 
expensive.  
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Different biomaterials have been used in tissue engineering, such as 
collagen, agarose, gelatin (Rosellini et al., 2007), or fibrin (Chung et al., 2015). Fibrin 
is a natural biopolymer that is derived from the plasma protein fibrinogen. It is 
biocompatible, degradable, and promotes cell adhesion, what makes it an excellent 
material for tissue engineering (Li et al., 2015).  
Hence, the aim of this research is to develop a three-dimensional model of 
human conjunctiva that can be used within a week, using for that purpose a 
biocompatible scaffold based on fibrin, and primary cells obtained from human 
cadaveric conjunctival tissue.  
  
 
MATERIALS AND METHODS 
 
Human Conjunctival Tissues 
Human conjunctival tissues were obtained from corneoscleral buttons from 
cadaveric donors (n = 11). Corneoscleral buttons were obtained with informed 
research consent from Barraquer Eye Bank of Barcelona (Spain). This study was in 
strict accordance with the tenets of the Declaration of Helsinki and Spanish 
Regulations concerning the use of human tissues for biomedical research, and had 
the approval of Institutional Review Board of the University of Valladolid. Human 
bulbar conjunctiva was carefully isolated from the rest of tissues, and used for 
research purposes.  
 
Isolation and Culture of Conjunctival Cells 
Conjunctival cells were cultured as previously described (García-Posadas et 
al., 2013). Briefly, conjunctival tissue was carefully cut in small pieces, and plated in 
12-well plates. Fibroblasts and epithelial cells were isolated by preplating and 
differential trypsinization. Fibroblasts were cultured in supplemented DMEM/F12 
(with 2.5 µg/ml fungizone, 5000 units/ml of penicillin/streptomycin, and 10% human 
serum), and used in passage 3. Epithelial cells culture medium was composed of 
DMEM/F12 supplemented with 2.5 µg/ml fungizone, 5000 units/ml of 
penicillin/streptomycin, 1 µg/ml insulin, 0.5 µg/ml hydrocortisone (Sigma-Aldrich, St. 
Louis, MO, USA), 2 ng/ml EGF, and 10% human serum (Ref. 14-498E, Lonza Group 
Ltd., Basel, Switzerland), all from Invitrogen-GIBCO (Inchinnan, UK) unless 
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otherwise indicated. Primary epithelial cells at passage 1 were used for all the 
experiments.  
Cells were maintained in standard conditions (humidified atmosphere of 5% 
CO2 at 37ºC), and the medium was changed every other day.  
 
Fibrin-Based Matrices Preparation 
Fibrin-based matrices were used as scaffolds to develop the three-
dimensional model. They were prepared from human fresh frozen plasma or 
cryoprecipitate, obtained from Centro de Hemoterapia y Hemodonación from 
Castille and Leon (CHEMCYL, Valladolid, Spain). Matrices were produced by mixing 
plasma (400 µl/ml) or cryoprecipitate (333 µl/ml) with 40 µl/ml tranexamic acid 
(Rottapharm, Valencia, Spain) and 40 µl/ml calcium chloride (Braun, Barcelona, 
Spain), all diluted in fibroblast culture medium (described in the previous section, 
“Isolation and culture of conjunctival cells”).   
 
Cell Seeding in Fibrin Scaffolds 
Fibroblasts were incorporated inside the scaffolds by adding 100,000 cells/ml 
to the plasma or cryoprecipitate at the preparation time.  
Epithelial cells were seeded on the surface of fibrin scaffolds 24 hours after 
fibrin polymerization, with a cell density of 100,000 cells/cm2. 
 
Histological Processing  
At different time points, complete constructs of fibrin matrices with conjunctival 
cells were fixed with 4% formaldehyde after rinsing in PBS for three times. Fixed 
samples were processed and embedded in paraffin. Five µm sections were cut and 
collected in poly-L-lysine coated slides. Slides were kept at -80ºC until use. Sections 
were stained with hematoxylin and eosin (H/E) and viewed under the light 
microscope Eclipse TS100 (Nikon, Tokyo, Japan). 
  
Immunofluorescence Assays 
Paraffin slides were deparaffinized in xylene, and rehydrated in decreasing 
concentrations of ethanol. Antigen retrieval was performed in 0.01% trypsin for 10 
minutes. Sections were rinsed in PBS and blocked with 4% donkey serum (Sigma-
Aldrich) and 0.03% Triton X-100. A primary antibody against CK19 (Dako, Glostrup, 
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Denmark; 1:50 dilution) was applied overnight at 4º C, and a primary antibody 
against Ki67 (Abcam, Cambridge, UK; 1:50 dilution) was applied for 1 hour at 37º C. 
After washing 3 times with PBS, AlexaFluor® 488 or AlexaFluor® 647 secondary 
antibody (Invitrogen) were applied for 1 hour at room temperature.  
To identify glycoconjugates, a lectin staining was used. The agglutinin 
obtained from Helix pomatia (HPA) was used at 1:500 dilution, for 30 minutes at 
room temperature. HPA lectin binds to high molecular weight glycoconjugates 
secreted by goblet cells. Nuclei were counterstained with Hoechst dye (Sigma-
Aldrich) in all the slides. The preparations were viewed under an epifluorescence 
microscope (Leica DMI 6000B; Leica Microsystems, Wetzlar, Germany). Negative 
controls included the omission of primary antibodies. 
 
Cell proliferation assays  
To evaluate proliferation, the non-toxic fluorescence dye alamarBlue® (AbD 
Serotec, Oxford, UK) was used. The alamarBlue® assay was performed at days 3 
and 7. Matrices were incubated in medium with 10% alamarBlue® for 6 hours. After 
incubation, that medium was recovered, and its fluorescence was measured at 560 
nm excitation and 590 nm emission wavelengths, using the SpectraMax M5 
fluorescence plate reader (Molecular Devices). Four independent experiments were 
performed. 
 
Scanning Electron Microscopy  
Fibrin-matrices were evaluated by scanning electron microscopy (SEM). 
Matrices were cut and fixed with 2.5% glutaraldehyde, dehydrated in a graded 
ethanol series, and dried in a critical point drier. Samples were then viewed in a 
scanning electron microscope ESEM QUANTA 200 FEG (FEI Company, Hillsboro, 
OR, USA).  
 
Statistical Analysis 
Statistical analysis was done using the Statistical Package for the Social 
Sciences software (SPSS 15.0, SPSS Inc., Chicago, IL, USA). Data were calculated 
as means ± standard error of the mean (SEM). To compare means a one-way 
analysis of variance (ANOVA) was done after assuring equality of variance 
(Levene’s test). After that, pairwise comparisons (Tukey test) were performed. In the 
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absence of variance equality, a robust test was performed (Welch test), and the 
Games-Howell test was used for pairwise comparisons. Differences were 
considered to be significant when p ≤ 0.05. 
 
 
RESULTS 
 
Fibrin-Based Matrices Supported Conjunctival Cell Growth 
Fibrin matrices supported human conjunctival cell growth. Both fibroblasts and 
epithelial cells can be maintained in the scaffolds for at least 21 days, as observed 
in the hematoxylin/eosin staining (Figure 1). Conjunctival epithelial cells stratified on 
the surface of the scaffolds. The number of layers increased over time, ranging from 
1-2 layers at day 3 to 5-6 layers at day 14. 
 
 
Figure 1. Micrographs showing conjunctival constructs stained with hematoxylin/eosin. 
The number of epithelial cell layer increased over time. Magnification: X20. 
 
 
Epithelial Cells Maintained Epithelial Phenotype when Cultured on Fibrin 
Scaffolds 
 A problem that often occurs when culturing epithelial cells is epithelial-
mesenchymal transition (EMT). To assure that the epithelial cells cultured in the 
matrices were not suffering EMT, the conjunctival epithelial marker CK19 was 
analyzed at different days. Cultured epithelial cells on both plasma and 
cryoprecipitate matrices expressed CK19 at all times (Figure 2). 
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Figure 2. Representative microphotographs of CK19 staining. Epithelial cells maintained 
CK19 staining up to day 14. Fibroblasts that do not express CK19 are indicated by arrows. 
Magnification: X20 
 
In addition, the presence of mucus-secretory cells was analyzed using the 
HPA lectin. HPA-stained cells were observed at days 3 and 7, but almost none at 
day 14 (Figure 3). This indicates that goblet-like cells are present in the scaffolds at 
least up to seven days.  
 
Figure 3. Representative microphotographs of HPA lectin staining. Cells in the matrices 
produce mucins at days 3 and 7, but they do not produce them at day 14. Magnification: X20. 
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Cell Proliferation in the Matrices 
 Conjunctival cells proliferate in the matrices, as shown by the alamarBlue® 
assay results (Figure 4). Epithelial cells showed better proliferation rates in 
cryoprecipitate matrices, whereas fibroblasts proliferated better in plasma scaffolds. 
When both cell types where analyzed together, no statistically significant differences 
were observed, what would suggest a crosstalk between both cell types to modulate 
each other proliferative behaviour. 
 
 
Figure 4. Conjunctival cells proliferate at different rates when seeded in plasma or 
cryoprecipitate matrices. 
 
 
In addition, the expression of the proliferation marker Ki67 was analyzed in 
cell-seeded plasma and cryoprecipitate matrices to determine the proliferative 
capacity of epithelial cells at 3, 7, and 14 days. Several positive-stained cells were 
observed in both types of matrices (plasma and cryoprecipitate) at all studied times 
(Figure 5).  
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Figure 5. The proliferation marker Ki67 was studied in plasma and cryoprecipitate matrices. 
The number of cells that stained for Ki67 (arrows) decreased at 14 days. Magnification: X20. 
 
However, significant differences were observed when the percentage (%) of 
positive cells in each condition was compared (Figure 6). The number of positive 
cells was significantly higher in cryoprecipitate matrices compared to plasma 
matrices at days 3 and 7 (p = 0.012 and p = 0.023, respectively). In cryoprecipitate 
scaffolds, a significant decreased in the percentage of positive cells was observed 
over time, from 38.97 ± 4.63 % at day 3 to 35.28 ± 7.92 % at day 7 and 10.96 ± 2.48 
% at day 14 (p = 0.015 for day 3 and p = 0.0004 for day 7).  
 
Figure 6. The % of positive cells for the proliferation marker Ki67 was higher in 
cryoprecipitate scaffolds than in plasma ones at days 3 and 7. That % 
significantly decreased after 14 days. 
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Epithelial Cells and Fibroblasts Maintained Cell Morphology in the Fibrin 
Scaffolds 
 The morphology of fibroblasts and epithelial cells incorporated to both 
plasma and cryoprecipitate scaffolds was estudied by SEM. Scaffold structure was 
similar in both cases, although slightly greater density of fibrils was observed in 
cryoprecipitate matrices compared to that of plasma matrices (Figure 7).  
 
 
Figure 7. Plasma (a) and cryoprecipitate (b) scaffold structure. Higher densitiy of fibrils was 
observed in cryoprecipitate matrices (b). Magnification: X12,000 for a, and X20,000 for b. 
  
 
Fibroblasts were evenly distributed inside the fibrin scaffolds and maintained 
their elongated shape in plasma (Figure 8a) and cryoprecipitate matrices (Figure 
8b). Epithelial cells form layers in which polygonal shaped cells were identified in 
close contact with each other, in both plasma (Figure 8c) and cryoprecipitate 
matrices (Figure 8d). Also, microvilli were observed in the surface of epithelial cells 
cultured on the surface of both plasma and cryoprecipitate scaffolds. A detail of the 
microvilli is shown in Figure 9.  
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Figure 8. SEM micrographs showing fibroblasts (a, b) and epithelial cells (c, d) in plasma (a, 
c) and cryoprecipitate (b, d) conjunctival constructs. Fibroblasts are integrated in the scaffold, 
whereas epithelial cells are covering all the matrix surface. Magnification: X8,000 for a, 
X19,000 for b, X3,500 for c, X1,600 for d.  
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Figure 9. SEM microphotographs from the surface of the three-dimensional model. Epithelial 
cells were covered by microvilli (a). A detail of the microvilli at higher magnification (b). 
Magnification: X10,000 for a, and X30,000 for b.  
 
 
DISCUSSION 
 
 In this study we have developed a new three-dimensional model of human 
conjunctiva using for that purpose a biocompatible scaffold made of fibrin and 
primary epithelial and stromal cells.  
Conjunctival epithelial cells stratified on the surface of fibrin scaffolds. This is 
essential to mimic a normal conjunctival epithelium. Other authors have also 
described conjunctival primary cell stratification in vitro (Chung et al., 2007), but their 
model was limited to the epithelium.  
The epithelial cells maintained CK19 staining up to 14 days, showing that 
the cells in the matrices keep their epithelial phenotype. This is important because 
EMT often occurs in cell culture. When this happens, cells are no longer actual 
epithelial cells and turn to a fibroblastic phenotype (Costa et al., 2015). Therefore, 
results obtained from cultures showing EMT are not completely reliable.  
An important function of the conjunctiva is to secrete mucins that lubricate 
and protect the ocular surface. The specialized cells that secrete MUC5AC in the 
ocular surface are conjunctival goblet cells. These cells can be identified with HPA 
lectin that stained high molecular weight glycoconjugates contained in the goblet cell 
secretory products. In our constructs, we found some cells that stained with HPA at 
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days 3 and 7, in both plasma and cryoprecipitate matrices. However, no HPA 
staining was found at 14 days. There could be two explanations to this finding. It 
could happen that at 14 days goblet cells had secreted all their contents. Then, even 
if goblet cells are present in the culture, they cannot be identified with HPA lectin 
staining. The other possibility is that goblet cells that were present at 7 days died 
before 14 days. Goblet cells are difficult to culture, and for this reason it is plausible 
that they are not able to grow in the three-dimensional culture for a long time.  
 Although fibrin has been widely used as a scaffold in tissue engineering, to 
the best of our knowledge this is the first time that two types of fibrin matrices, 
derived from plasma or cryoprecipitate, are compared. Differences found between 
both matrices reveal how different is the behavior of stromal and epithelial cell types 
in contact with them. While epithelial cells grew better in cryoprecipitate matrices, 
fibroblasts did it better in plasma ones. The reasons of this differential performance 
can be different for each cell type.  
 Fibroblasts were incorporated inside the fibrin scaffolds. Then, the space 
that the fibrin fibrils let inside can be the main reason why fibroblasts proliferate 
better in plasma matrices. On the contrary, epithelial cells showed the best results in 
cryoprecipitate matrices. Cryoprecipitate contains more growth factors than plasma. 
Epithelial cells need many different nutrients to grow in vitro. This could be the 
reason why epithelial cells exhibited higher proliferation rates in cryoprecipitate 
matrices. 
 The morphological study performed by SEM revealed some interesting data. 
First, we could see that the fibroblasts maintained their elongated shape and 
interacted with the fibrin. The epithelial cells completely covered the matrix surface. 
We could clearly identify microvilli in the epithelial cells, what means that there is 
some polarization in the same way that happens in the native tissue. Cell polarity is 
essential for the function of epithelial tissues (Roignot et al., 2013), including the 
conjuntiva. Alteration in conjunctival epithelia microvilli was observed in several 
diseases, such as Sjögren’s syndrome and graft versus host disease, among other 
pathologies (Mancel et al., 1993; Tatematsu et al., 2012). 
 In summary, we have developed a three-dimensional model of human 
conjunctival tissue that can be used within a week. In that period, epithelial cells 
seeded on the surface of the scaffolds proliferated and stratified in different layers, 
showing polarization and presence of goblet cell-like cells that can secrete mucins. 
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In addition, fibroblasts are maintained inside the scaffolds. Thus, we have a 
functional three-dimensional model that can be used to perform in vitro studies. 
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ESTUDIO 8 
 
Una vez desarrollado un modelo tridimensional de conjuntiva humana 
normal, el siguiente y último objetivo era lograr que dicho modelo sirviera para 
representar distintas enfermedades inflamatorias de la superficie ocular, así como 
para llevar a cabo estudios relacionados con el ácido hialurónico.  
 En este estudio se somete al modelo tridimensional a distintas condiciones 
para intentar simular parcialmente el síndrome de ojo seco y las alergias oculares. 
También se lleva a cabo un estudio de los receptores de ácido hialurónico.  
 
 
STUDY 8 
 
After developing the three-dimensional model of human conjunctiva, only the 
last objective of this thesis remained unconcluded. To address this objective, a last 
study was planned to test whether the three-dimensional construct developed is 
useful to study ocular surface inflammation. 
In this last study, an in vitro simulation of an inflammatory microenvironment 
was done. The three-dimensional model of human conjunctiva is exposed to 
different conditions to simulate some of the main changes observed in ocular 
surface diseases, such as dry eye or allergic conjunctivitis. In addition, we analyze 
changes in hyaluronan receptor expression.  
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Simulation of Inflammatory Diseases in the Three-Dimensional Model of 
Human Conjunctiva 
 
ABSTRACT 
 
In this study, a proof of concept for the use of a three-dimensional model of 
human conjunctiva to study ocular surface inflammation is presented. The three-
dimensional model was made with primary cells and fibrin matrices derived from 
cryoprecipitate. In this study, four different experimental conditions were analyzed: 
control, air-lifted culture, desiccation, and IL-13 treatment. Desiccation condition was 
used to mimic dry eye disease, and IL-13 treatment was intended to mimic allergy. 
Matrices were kept in culture for 7 days and after that they were processed and 
analyzed. Matrices were stained with hematoxylin/eosin to observe changes in 
morphology. Ki67 proliferation marker, high molecular weight glycoconjugates 
identified by HPA lectin, and hyaluronan receptors CD44 and RHAMM expression 
was analyzed by immunofluoresence. MUC5AC, IL-6, and sCD44 secretion was 
evaluated by ELISA. An increase in epithelial stratification was observed in air-lifted 
matrices compared to control. In addition, increased numbers of cells stained with 
HPA lectin and upregulated MUC5AC secretion was observed in that condition. 
Increased MUC5AC secretion was also found in constructs exposed to desiccating 
conditions or IL-13. Some Ki67 positive cells were observed in all conditions, 
althought the greater numbers were found in air-lifted condition. The inflammatory 
status of cells was evaluated by IL-6 levels, and those levels were found elevated in 
air-lifted and desiccating conditions, but not in IL-13 treated constructs. Finally, 
CD44 and RHAMM hyaluronan receptors were elevated in IL-13 matrices, and 
decreased in desiccating conditions. These results are in agreement with previous 
data obtained from patients with inflammatory diseases, such as atopic 
keratoconjunctivitis or rosacea. In conclusion, it is possible to use the three-
dimensional model of human conjunctiva to study ocular surface inflammatory 
diseases.  
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INTRODUCTION 
 
Inflammatory ocular surface diseases are very prevalent among global 
population. Patients demand more eficacious new treatments for their diseases and, 
at the same time, governments and pharmaceutical companies are worried about 
the cost of the research needed to develop new drugs (Bielory and Syed, 2013).   
The conjunctiva is involved in the majority of inflammatory ocular surface 
diseases, playing an active role in the pathophisiology of those conditions. The 
conjunctiva has a conjunctival-associated lymphoid tissue (CALT) that is a key 
player in inflammation (Knop and Knop, 2010). But also, the most abundant cells in 
the conjunctiva, epithelial cells, including goblet cells, and fibroblasts, participate in 
these processes (Fukuda et al., 2006; Cavet et al., 2013; Dartt and Masli, 2014).  
Current in vitro models to study conjunctival inflammation are usually 
composed of just one cell type that is cultured as a cell monolayer. These models do 
not recapitulate the complexity of the whole tissue, and interactions between 
different cells, and between cells and the extracellular matrix can not be studied.  
In a previous study from our group (García-Posadas et al., manuscript in 
preparation), we engineered a three-dimensional model of normal human 
conjunctiva using fibrin-based scaffolds. Two different constructs were introduced, 
one using a plasma matrix and the other one using a cryoprecipitate matrix as 
scaffold. Epithelial cells showed better proliferation rates in cryoprecipitate scaffolds, 
and for that reason cryoprecipitate matrices were chosen to develop a three-
dimensional model of inflammed conjunctiva.  
There are several factors that induce inflammation in conjunctival tissue in the 
different diseases. In dry eye disease, desiccation is one condition that triggers the 
inflammatory response (Tost et al., 2012). In allergy, the presence of large amounts 
of some Th2-type cytokines, such as interleukin 13 (IL-13) (Leonardi et al., 2006), is 
the cause of some of the signs observed in allergic patients, such as mucus 
hypersecretion. For that reason, desiccation and IL-13 treatment were used as 
experimental conditions to try to mimic some of the features observed in conjunctival 
diseases and to develop a three-dimensional model of inflammed human 
conjunctiva.  
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MATERIALS AND METHODS 
 
Conjunctival Cell Culture 
Conjunctival cells were cultured as previously described (García-Posadas et 
al., 2013) from conjunctival tissues obtained from cadaveric donors (n = 8). 
Corneoscleral buttons were obtained with informed research consent from 
Barraquer Eye Bank of Barcelona (Spain). This study was in strict accordance with 
the tenets of the Declaration of Helsinki and Spanish Regulations concerning the 
use of human tissues for biomedical research, and had the approval of Institutional 
Review Board of the University of Valladolid. 
Fibroblasts were grown inside the fibrin-based scaffolds. The cells were 
incorporated to them while they were prepared, adding 100,000 cells/ml to the 
cryoprecipitate. Epithelial cells were seeded on the surface of the scaffolds 24 hour 
after they were prepared, at a cell density of 100,000 cells/cm2. 
 
Fibrin Scaffold Preparation 
Fibrin scaffolds were prepared from cryoprecipitate obtained from Centro de 
Hemoterapia y Hemodonación from Castille and Leon (CHEMCYL, Valladolid, 
Spain). Scaffolds were produced by mixing 333 µl/ml cryoprecipitate with 40 µl/ml 
tranexamic acid (Rottapharm, Valencia, Spain) and 40 µl/ml calcium chloride 
(Braun, Barcelona, Spain), all diluted in Dulbecco’s Modified Eagle Medium/Nutrient 
Mixture F-12  (DMEM/F12) culture medium (Invitrogen, Inchinnan, UK).   
 
Experimental Conditions 
 Four different experimental conditions were used in this study, as seen in 
Figure 1. Constructs cultured for 7 days in standard submerged conditions were 
used as controls. In addition, other constructs were cultured submerged for 3 days 
and then, 3 days in air-lifted conditions. To simulate some of the features found in 
dry eye patients, a desiccating condition was also used. To simulate desiccation, 
constructs were placed without medium in the culture hood for two hours. The 
existing flow in the hood desiccates the constructs. Finally, the last experimental 
condition that was analyzed in this study consisted in IL-13 treatment. Constructs 
were cultured in submerged conditions for 6 days, and in the seventh day they were 
incubated with 20 ng/ml IL-13 (PeproTech, London, UK) for 24 hours.  
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Figure 1. Schematic showing the protocol used in the different experimental conditions. 
 
Histological Processing  
At day 8, constructs exposed to each experimental condition were rinsed in 
PBS and fixed with 4% formaldehyde. Fixed matrices were processed and 
embedded in paraffin. Five µm sections were cut and collected in poly-L-lysine 
treated slides. Sections were then stained with hematoxylin and eosin (H/E) or kept 
at -80ºC until further use for immunoflourescent staining.  
 
Immunofluorescent Staining 
 Paraffin slides were deparaffinized in xylene, and rehydrated in decreasing 
concentrations of ethanol. After antigen retrieval with 0.01% trypsin, sections were 
blocked in PBS with 4% donkey serum (Sigma-Aldrich, St. Louis, MO, USA) and 
0.03% Triton X-100. Primary antibodies against Ki67 (Abcam, Cambridge, UK), 
CD44 (Calbiochem-Merck, Darmstad, Germany), and RHAMM (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) were applied to the slide. After washing 3 
times with PBS, AlexaFluor 488 secondary antibody (Invitrogen) was applied for 1 h 
at room temperature. For HPA lectin staining 1:500 dilution of HPA was used for 30 
min at room temperature. Nuclei were counterstained with Hoechst dye (Sigma-
Aldrich) in all the slides. The preparations were viewed under an epifluorescence 
microscope (Leica DMI 6000B; Leica Microsystems, Wetzlar, Germany). Negative 
controls included the omission of primary antibodies. 
 
CHAPTER 3                               Study 8. Simulation of inflammation in the 3D model 
	   305 
Secreted Protein Determination by Enzyme-Linked Immunosorbent Assay  
 The levels of secreted proteins MUC5AC, IL-6, and sCD44 were measured 
by enzyme-linked immunosorbent assay (ELISA) technique in culture supernatants 
recovered from the constructs exposed to the four experimental conditions. 
Commercial kits used are listed in Table 1. The assays were performed according to 
the manufacturer’s protocols.  
 
Table 1. Commercial ELISA kits used in the study 
Protein Manufacturer Detection range 
MUC5AC Shanghai Yehua Biological Technology Co., Ltd., Shanghai, China 5-1000 ng/ml 
IL-6 Diaclone, Besançon, France 6.25-200 pg/ml 
sCD44 eBioscience, Vienna, Austria 62.5-4000 pg/ml 
 
Data Presentation and Statistical Analysis 
Data were presented as mean ± standard error of the mean (SEM). 
Student’s t-test was performed to analyze data and p ≤ 0.05 was considered 
statistically significant. 
 
 
RESULTS 
 
Conjunctival Constructs Exposed to Experimental Conditions Experienced 
Structural Changes 
Conjunctival constructs were fixed at day 7, processed, and stained with 
hematoxylin/eosin to analyze cell distribution and potential structural changes 
(Figure 2). When constructs were cultured in air-lifted conditions, higher stratification 
was observed. However, when air-lifted cultures were additionally exposed to 2 
hours of desiccation, the number of epithelial layers was reduced. 
 
 
Figure 2. Hematoxylin/eosin section of matrices in control (a), air-lifted (b), desiccation (c) or 
IL-13 (d) conditions. Magnification: X20. 
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Conjunctival constructs thickness in the four experimental conditions was 
measured in 6 independent experiments, and mean values were compared. Control 
constructs had 558,12 ± 49.42 µm thickness, whereas constructs treated with IL-13 
were significantly thicker (871.75 ± 46.37 µm, p = 0.0008) than control constructs 
(Figure 3). Constructs under the desiccating condition were slightly thinner (503.22 ± 
35.05 µm) than control constructs, although difference was not statistically 
significant. 
 
 
Figure 3. Matrix thickness in the different experimental conditions. 
Mean values from 6 independent experiments. ***p ≤ 0.005. 
 
 
Mucous Secretion of Cells in Conjunctival Constructs Changes in the 
Experimental Conditions 
 The presence of mucus was evaluated in the constructs by two different 
techniques. First, constructs exposed to the four experimental conditions were 
stained with the HPA lectin (Figure 4). High molecular weight glycoconjugates 
identified by HPA lectin were observed in all the experimental conditions. Increased 
numbers of stained cells were observed in air-lifted condition (Figure 4b), whereas a 
decrease was found in IL-13 treated constructs (Figure 4d). 
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Figure 4. HPA lectin staining (red) was detected in control (a), air-lifted 
(b), desiccation (c), and IL-13 (d) constructs. Magnification: X40. 
 
 In addition, mucin secretion in the constructs was evaluated by MUC5AC 
ELISA (Figure 5). MUC5AC secreted levels increased from 177.37 ± 3.03 ng/ml in 
the control matrices to 207.54 ± 11.52 ng/ml in air-lifted culture (p = 0.020), to 
215.18 ± 10.23 ng/ml in IL-13 desiccating condition (p = 0.0026), and to 204.44 ± 
10.71 ng/ml in IL-13 treated constructs (p = 0.0074). 
 
Figure 5. MUC5AC levels secreated by goblet cells present in the 
constructs was analyzed by ELISA. An increased in secretion in all the 
experimental conditions was observed compared to control values. 
Mean values from 6 independent experiments. *p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.005. 
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Cell Proliferation Rate in Conjunctival Constructs Changed under 
Experimental Conditions 
 Constructs were stained with an anti-Ki67 antibody to determine the 
presence of cells with proliferative capacity in the model at day 7. Positive cells were 
observed in all the experimental conditions (Figure 6), although the greatest 
numbers were found in the constructs cultured in air-lifted conditions (Figure 6b). 
 
 
Figure 6. Representative microphotographs showing Ki67 positive cells 
(arrows) in control (a), air-lifted (b), desiccation (c), and IL-13 (d) conditions. 
Magnification: X40. 
 
Conjunctival Constructs Exposed to Experimental Conditions Exhibited 
Inflammatory Responses 
The secreted levels of the inflammatory cytokine IL-6 were measured by 
ELISA to determine whether the different experimental conditions produced an 
inflammatory response in the cells contained in the three-dimensional model (Figure 
7). Cells in the control constructs basaly released 2,230.4 ± 1,076.7 ng/ml IL-6, and 
that secretion was significantly increased to 9,879.8 ± 2,371.6 ng/ml (p = 0.0088) 
and to 12,023.0 ± 2,766.9 ng/ml (p = 0.0040) in air-lifted and desiccating conditions, 
respectively. Matrices treated with IL-13 secreated 3,553.5 ± 1,702.2 ng/ml that was 
not significantly different from levels secreated by control matrices.  
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Figure 7. The inflammatory cytokine IL-6 was secreted by conjunctival cells in 
the fibrin scaffold. In air-lifted culture and desiccation conditions, IL-6 levels 
were significantly increased. Mean values from 6 independent experiments. 
**p ≤ 0.01; ***p ≤ 0.005. 
 
 
Hyaluronan Receptors Expression in the Constructs Changed in the 
Experimental Conditions  
 Hyaluronan receptors expression was evaluated in the constructs. CD44 
and RHAMM expression was analyzed by immunofluorescence (Figure 8), and 
sCD44 release was measured by ELISA (Figure 9).  
 Epithelial cells in the constructs expressed the hyaluronan receptor CD44 in 
all experimental conditions. In the air-lifted condition, where several epithelial layers 
are found, CD44 was distributed mainly in the basal layers (Figure 8b). However, in 
IL-13 treated matrices, all epithelial cell layers expressed CD44 (Figure 8d). 
Fibroblasts did not express CD44 except in the desiccating condition (Figure 8c).  
 In control constructs RHAMM was expressed by most epithelial cells and, 
with lower intensitiy, by fibroblasts (Figure 8e). The distribution and intensity was 
similar in air-lifted matrices (Figure 8f). However, in the desiccating condition no 
RHAMM expression was observed in neither epithelial cells nor fibroblasts (Figure 
8g). Finally, in IL-13 treated matrices (Figure 8h) higher intensity was found in the 
fibroblasts inside the fibrin scaffold, compared to control constructs.  
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Figure 8. CD44 (green, a-d) and RHAMM (red, e-h) hyaluronan receptors were expressed by 
epithelial cells in the conjunctival constructs. Magnification: X40.  
 
 Conjunctival cells basally secreated 10.30 ± 1.14 ng/ml sCD44 in the control 
constructs (Figure 9). Significantly higher levels were released in the air-lifted 
condition (15.65 ± 2.34 ng/ml, p = 0.05), whereas no changes were observed in 
desiccation or IL-13 conditions.   
 
Figure 9. sCD44 was secreted in the three-dimensional model. In the 
air-lifted condition that secretion was increased compared to the control.  
Mean values from 5 independent experiments. *p ≤ 0.05. 
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DISCUSSION 
  
 In this study, we presented a proof of concept for the use of a three-
dimensional model of human conjunctiva to study ocular surface inflammation. The 
model was exposed to different experimental conditions such as air-lifted culture, 
desiccation, or cytokine treatments and after that, morphological and functional 
changes were observed. 
 Epithelial cells growing on the surface of the fibrin scaffold showed higher 
stratification when cultured in air-lifted condition. The ability of epithelial cells to 
stratiffy when cultured in those conditions was already published. Chung et al. 
(2007) reported human conjunctival epithelial cell stratification and several authors 
referred similar results in other mucosal epithelia (de Borja Callejas et al., 2014). 
Thus, these results corroborated that epithelial cells in our three-dimensional model 
are able to respond as they were expected to do.  
 One of the main functions of the conjunctiva that is altered in ocular surface 
infllammatory diseases is mucin secretion. Changes in mucous secretion were 
observed in the experimental conditions. When the three-dimensional model of 
human conjunctiva was characterized, some goblet-like cells were observed. In this 
study, we found that those goblet-like cells were presented in all the conditions, and 
that its numbers increased in the air-lifted condition. Again, this response was 
already reported be several authors in other mucosal epithelium models (Yokoyama 
et al., 2007; Kesimer et al., 2009). In addition, MUC5AC secretion was measured in 
the constructs, and the presence of this mucin was found in all conditions. In the 
conjunctiva, MUC5AC is exclusively secreted by goblet cells. Therefore, our results 
confirm the presence of goblet cells in the three-dimensional model. Moreover, an 
increase in MUC5AC secretion was found in air-lifted, desiccation, and IL-13 
conditions compared to control constructs. Our results are consistent with those of 
De Paiva et al., and Contreras-Ruiz et al., that reported elevated MUC5AC secretion 
in murine goblet cells exposed to IL-13 (De Paiva et al., 2011; Contreras-Ruiz et al., 
2014). The important effects of IL-13 on conjunctival goblet cells are the main 
reason why we choose this cytokine to simulate allergic conditions, instead of using 
the hallmark allergy cytokine IL-4.  
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 Interleukin 6 has been used in several studies as a marker of inflammation. 
J. Zhang et al. described overexpression of IL-6 in dry eye patients which correlates 
with the symptomatic severity of disease (Zhang et al., 2013). In this research we 
measured IL-6 secreted levels, and found that in the air-lifted and in the desiccating 
conditions IL-6 levels were significantly increased, what is in accordance with the 
previously mentioned report. That IL-6 overexpression was indicative of an 
inflammatory status of the cells in the constructs, what supports the idea of using 
this model to study ocular surface inflammatory disease. Specifically, IL-6 is found 
elevated in dry eye disease, and the highest levels of IL-6 in our model were found 
in the desiccating condition, which try to mimic dry eye inflammation.   
 Finally, hyaluronan receptors were studied in the constructs exposed to the 
experimental conditions. Interestingly, we found some changes in the receptors 
expression. CD44 and RHAMM expression was increased in IL-13 treated matrices. 
In our previous study with hyaluronan receptors in patients with inflammation, 
increased mRNA levels were found in immune-atopic diseases, including atopic and 
vernal keratoconjunctivitis, where IL-13 is elevated (García-Posadas et al., 2014). 
On the contrary, in the desiccating condition that mimics dry eye, RHAMM is not 
expressed. This result is also in agreement with the results obtained in patients, 
where a decrease in RHAMM expression was observed in patients with immune 
non-atopic diseases (García-Posadas et al., 2014). Finally, sCD44 was secreted in 
all conditions, and significantly more in air-lifted condition. In our study with patients 
we detected sCD44 in tears of just 32% of the subjects. We also found that IOBA-
NHC cells exposed to IL-13 secreted lower levels of sCD44 than untreated cells. In 
the current study we did not find significant differences with IL-13 treatment, what 
remarks once again the differences between cell lines and primary cells. 
 In summary, we have validated the three-dimensional human conjunctival 
model for its use to study ocular surface inflammation. In addition, we have shown 
that by exposing the constructs to desiccation for just two hours it is possible to 
reproduce some of the features found in dry eye disease, and that treating the 
conjunctival constructs with IL-13 mimic some of the responses found in allergic 
diseases. Bearing all this in mind we can conclude that this three-dimensional model 
is functional, respond to several stimuli and, therefore, it can be use to study ocular 
inflammatory diseases.  
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EPÍLOGO/EPILOGUE 
 
 
 
 
 
 
 
“Quien mira hacia afuera, sueña. Quien mira hacia adentro, despierta.” 
------------------------------------------------------------------------------------------------- 
“Who looks outside, dreams; who looks inside, awakes” 
 
― Carl Jung 
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Fortalezas y limitaciones 
 
En esta tesis doctoral se ha desarrollado un nuevo modelo tridimensional de 
conjuntiva humana que presenta varias ventajas frente a los modelos existentes: 
• Está elaborado con células primarias que muestran mayor similitud con el 
tejido original que las líneas celulares. 
• Es un modelo tridimensional con varias capas de células epiteliales, por lo 
que los resultados obtenidos en él serán presumiblemente más similares a 
los obtenidos in vivo que aquellos obtenidos en modelos celulares en 
monocapa. 
• En este modelo hay tres tipos celulares fundamentales, como son las 
células epiteliales, las células caliciformes y los fibroblastos conjuntivales. 
La mayoría de modelos disponibles incluyen solo un tipo celular, por lo 
que este modelo es más completo.  
 
A pesar de los avances obtenidos con el desarrollo de este nuevo modelo 
tridimensional, el trabajo presentado en esta tesis tiene varias limitaciones: 
• La fuente empleada para obtener las células es tejido conjuntival humano 
y, en consecuencia, es una fuente limitada. 
• Además, la disponibilidad del tejido para investigación no es regular, lo 
que supone un inconveniente a la hora de planificar experimentos.  
• El modelo tridimensional desarrollado no representa al completo la 
complejidad de la conjuntiva humana, puesto que no tiene 
vascularización, inervación, ni presencia del CALT. 
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Strenghts and limitations 
 
In this Doctoral Thesis report we have developed a new three-dimensional 
model of human conjunctiva. This model has several advantages over the existing 
ones: 
• It is made with primary cells, more similar to the original tissue than cells 
lines.  
• This three-dimensional model with several epithelial cell layers will 
presumibly allow to obtain more valuable results than those taken from 
monolayer cultures.  
• This model comprises three conjunctival cell types: epithelial cells, goblet 
cells, and fibroblasts. Therefore, it is more complete than most current 
models, which are just limited to one cell type. 
 
Despite the progress made with the development of the model, this thesis 
present several limitations: 
• The source used to get the cells is human conjunctival tissue and, in 
consequence, is a limited source. 
• Furthermore, as the tissue availability is uncertain, experiments cannot be 
scheduled. 
• The three-dimensional model does not completely recapitulate the 
complexitiy of the conjunctival tissue, since vascularization, inervation, and 
CALT are not represented in the model.  
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Perspectivas futuras 
 
- Estudiar  la interacción entre las células epiteliales y los fibroblastos en las 
matrices, y la interacción de las células con la propia matriz. 
- Perfeccionar los modelos de enfermedad, probando distintos tiempos de 
desecación y varias concentraciones de IL-13.  
- Completar el modelo tridimensional incluyendo, además, células 
endoteliales que representen la vascularización conjuntival. 
 
 
 
 
Future perspectives 
 
- To study the interaction between epithelial cells and fibroblasts, and 
between cells and fibrin-scaffolds.  
- To improve disease models, testing for that purpose different desiccation 
times and several IL-13 concentrations.  
- To complete the three-dimensional model including endothelial cells that 
could represent conjunctival vascularization. 
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Conclusiones generales  
 
1. Se ha demostrado que los receptores CD44 y RHAMM están implicados en la 
inflamación de la superficie ocular y su expresión varía dependiendo de la 
patología. Esto debería ser tenido en cuenta a la hora de administrar fármacos 
o lágrimas artificiales que contengan ácido hialurónico. Además, el estudio 
comparativo de los receptores de ácido hialurónico en muestras obtenidas de 
pacientes y en líneas celulares ha corroborado una vez más que hay que ser 
cautos con los resultados obtenidos en líneas celulares, puesto que estos 
difieren muy a menudo de los que se obtienen con muestras más directas.  
2. Las distintas citoquinas que se encuentran elevadas en determinadas 
patologías inflamatorias que afectan a la conjuntiva tienen efectos diferenciales 
sobre la función de las células caliciformes. Se ha demostrado que el IFN-γ es 
capaz de interaccionar con agonistas colinérgicos para modular esta función, lo 
que indica que las células caliciformes tienen un papel en la protección de la 
superficie ocular que va más allá de la simple secreción de mucinas. 
3. El tejido conjuntival obtenido de donante cadáver es una fuente adecuada de 
células para desarrollar cultivos primarios de células epiteliales, células 
caliciformes y fibroblastos conjuntivales, algo que no estaba optimizado hasta 
el momento. Esta fuente de material humano puede ayudar a reducir el uso de 
las líneas celulares que tan a menudo muestran resultados discrepantes con 
los obtenidos directamente de individuos sanos. 
4. Las matrices de fibrina son un buen biomaterial para emplear como andamios 
en cultivos tridimensionales de conjuntiva humana, puesto que permiten la 
adhesión y la proliferación de células epiteliales, caliciformes y no caliciformes, 
y de fibroblastos. 
5. Se han establecido unas condiciones estándar con un único medio de cultivo 
en las que es posible realizar un co-cultivo de fibroblastos, células epiteliales y 
células caliciformes en una matriz tridimensional de fibrina. En estas 
condiciones el crecimiento de cada tipo celular alcanza un equilibrio que 
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permite desarrollar un modelo de conjuntiva humana adecuado para llevar a 
cabo estudios de hasta dos semanas. 
6. Se ha podido elaborar y validar un modelo tridimensional de conjuntiva con una 
estructura similar a la conjuntiva humana, con un epitelio estratificado y 
polarizado en el que se encuentran células caliciformes que, además, son 
capaces de secretar MUC5AC de manera diferencial en respuesta a estímulos 
clínicamente relevantes, tales como la desecación o la presencia de citoquinas 
inflamatorias.  
 
 
 
 
 
  
 
EPÍLOGO/EPILOGUE 
	   325 
General conclusions 
 
1. We demonstrated that CD44 and RHAMM hyaluronan receptors are implicated 
in ocular surface inflammation. Expression of the hyaluronan receptors 
changed depending on the etiology of the disease. This should be taken into 
account when artificial tears or drugs containing HA are prescribed to patients. 
In addition, comparison of the results based on cell lines and on fresh samples 
obtained from patients highlighted once again the caution that researchers 
should exert when extrapolating results obtained from cell lines.  
2. Cytokines that are altered in several ocular surface inflammatory diseases, 
such as dry eye and ocular allergy, had differential effects on goblet cells. We 
showed that IFN-γ interacts with cholinergic agonists to modulate goblet cell 
function in terms of proliferation and secretion, indicating that goblet cells have 
a protective role beyond mucin secretion. 
3. Conjunctival tissue obtained from cadaveric donors, a resource that has been 
neglected for a long time, provided suitable conjunctival epithelial cells and 
fibroblasts to construct the conjunctival models. This source of human tissue 
can help to reduce the use of human cell lines, which can drift far from the 
originating healthy human tissues in terms of marker expression. 
4. Fibrin-based matrices were a good biomaterial to develop a three-dimensional 
scaffold for human conjunctival cells. The properties of these matrices likely 
facilitated cell adhesion and allowed the proliferation of different cell types.  
5. We established standard conditions with a specific culture medium to co-culture 
conjunctival fibroblasts, epithelial cells, and goblet cells. In these conditions, the 
performance of each cell type reached an equilibrium that allowed development 
of an appropriate three-dimensional model suitable to perform different 
laboratory studies up to two weeks.  
6. We designed, constructed, and validated an in vitro three-dimensional 
conjunctival model with a structure similar to that of the native human 
conjunctival tissue. The model included a stratified and polarized epithelium 
containing goblet cells that secreted mucins in response to relevant stimuli, 
such as desiccation or cytokine exposure.  
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